Microfluidic high-content phenotypic screening on a Caenorhabditis elegans model by Letizia, Maria Cristina
POUR L'OBTENTION DU GRADE DE DOCTEUR ÈS SCIENCES
acceptée sur proposition du jury:
Prof. C. Guiducci, présidente du jury
Prof. M. Gijs, directeur de thèse
Prof. A. deMello, rapporteur
Prof. M. Carminati, rapporteur
Prof. J. Auwerx, rapporteur
Microfluidic high-content phenotypic screening
on a Caenorhabditis elegans model
THÈSE NO 8528 (2018)
ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE
PRÉSENTÉE LE 27 AVRIL 2018
 À LA FACULTÉ DES SCIENCES ET TECHNIQUES DE L'INGÉNIEUR
LABORATOIRE DE MICROSYSTÈMES 2
PROGRAMME DOCTORAL EN MICROSYSTÈMES ET MICROÉLECTRONIQUE 
Suisse
2018
PAR
Maria Cristina LETIZIA

Eva’s only fault has been the one of wanting to know more, to experiment and search
with her own sources the laws of the Universe and of her own body, and to refuse the
teachings from “above”. Eva, basically, represents the curiosity of science against the
passive acceptance that belongs to faith.
— Margherita Hack
A mia madre e mio padre

Acknowledgements
I am tremendously grateful to all the people who have contributed - personally and
professionally - to this Thesis. Firstly and foremost, I truly thank my supervisor Prof.
Martin Gijs. Thank you Martin for hiring me, even if I had no previous experience in
the ﬁeld. I could not have made it tho this end without your constant technical and
scientiﬁc guidance. Beside your precious and inspiring help during the diﬀerent stages
of my projects, I thank you for believing in me (often more than I could do!) and for
always treating me with great humanity and respect, a quality that I strongly value in a
supervisor. With your positive attitude and competence, you signiﬁcantly contributed
to make my PhD years this pleasant and stimulating. If ever I found myself managing
a small group, I will try to be as professionally and personally supportive as you are.
Thank you so much.
I am grateful to Prof. Carlotta Guiducci, Prof. Johan Auwerx, Prof. Marco Carminati
and Prof. Andrew deMello, for accepting to read my Thesis, for their precious scientiﬁc
criticism and their feedbacks.
I want to thank Melis for her help with all the possible administrative issues, for the
French-Italian tandems, for the sincere chats and for being a friend. Despite being super
busy, you have always found time to care about me.
I thank all the collaborators at Laboratory of Integrative Systems Physiology for helping
me with the sample preparation and with the interpretation of the results. A special
acknowledgment goes to Laurent, for turning biology into something I could understand,
and to Vincenzo, for being so kind and always available to answer my questions and for
introducing me to the power of "a’ cazzimma" and "sta senza pensier".
I will never stop thanking Matteo, for his constant guidance during my PhD journey. I
am grateful for the survival tricks and tips that you shared with me, thanks to which I
eventually learned to stand on my own feet.
Thanks to all my past and present colleagues and friends at LMIS2, for being a fun and
harmonious bunch of young scientists. I enjoyed hanging out with you, especially when
nobody - including me - had to pretend to be smart . I will miss our time together.
A special thought to Roger and Baris, my ﬁtness and chill-time buddies, for getting
together where we needed to be. I also thank Tuan and Li, probably the most genuine
and adorable weirdos I know, for the nice open-hearted chats and for oﬀering their help
many times. A very special acknowledgment goes to Raphaël, for his incredible patience
v
Acknowledgements
and countless help in revising most of my scientiﬁc works. He is a great scientist and
person, I wish him all the best.
I thank all the friends I met in Lausanne in the last four years, especially Giulia,
Enrica, Enrica, Laszlo, Rima, Aldo, Andrea, Annalisa, Pietro, Diego, Saska, Matteo and
Svarricchio. You all left something memorable that I will always bring with me. I thank
my friend Barbara, for making our weekend-train-trips something to wait for and for our
"confessions" during the several pizza-beer evenings spent together.
I thank my lovely/grumpy friend Alessandra, for always staying in touch with me and for
understanding so naturally even the latent aspects of my personality. I am tremendously
grateful to my "polibavaglino" friends spread over Europe: "cu è riccu d’amici è poveru
di guài". Vi voglio bene.
I truly thank the most extraordinary women (and brilliant scientist as well!) I met in
this journey, Rima, Enrica and Enrica, for their authentic friendship and the uncountable
laughs out of the blue. Each in a diﬀerent way, you showed me how to spot light where
anyone else would only see darkness. You probably don’t realize how great you are. My
Lausanne years would not have been this pleasant and remarkable without you.
Grazie a Fulvio e Stefania per essersi presi cura di me, specialmente durante la scrittura
della tesi, e per avermi fatto sempre sentire di casa. Grazie per aver sinceramente gioito
con me anche dei più piccoli successi.
I thank my brother Marco, who agreed to share his ﬂat with his little sister. Thank you,
Marco, for showing me how important it is to be committed and believe in what you do.
Believe it or not, I also thank you for bringing entropy in our apartment, that otherwise
would have been too clean and boring.
Un gigantesco grazie ai miei genitori, Paola e Nino (Pino), le persone più generose al
mondo, per avermi aiutata e supportata, ovunque io fossi. Grazie per le valigie cariche
di coccole (diciamo così...), grazie a cui io e Marco ci siamo sempre sentiti come a casa.
Grazie Pino, per avermi trasmesso un po’ della tua vena artistica e del tuo vivere con
freschezza. Grazie mamma per non avermi mai detto "brava" e per avermi insegnato
a non accontentarmi mai. "Cu zappa, zappa a so’ vigna. Cu bonu a zappa, bonu a
vinnigna". Grazie a nonna Marghe, la vera scienziata della famiglia, per il tuo amore
inﬁnito. Grazie anche per i maglioni caldi fatti con amore per sopravvivere nella fredda
Svizzera e per avermi insegnato proverbi siciliani per ogni occasione. Trovarvi tutti a
casa nei ﬁne settimana a Milano è stata una gioia impagabile.
My deepest gratitude goes to Luca. You are my extra pair of shoulders and thanks to
your positive leverage, today I believe in myself and I barely know what stress is. Thank
you for your arms always open for me, through which you keep bringing sparkling joy to
my life. You are my sunshine.
Lausanne, 19 Mars 2018 Cristina
vi
Abstract
Caenorhabditis elegans is a performant model system for studying human biological
processes and diseases and for pre-clinical phenotyping screenings of compounds. Mi-
croﬂuidics has been instrumental in enabling C. elegans-based drug assays, facilitating the
worm handling and bringing robust and reproducible analysis protocols. In this Thesis, I
present phenotypic assays on C. elegans, enabled by microﬂuidic devices conveniently
designed.
First, I propose a strategy to track diﬀerent phenotypic traits of individual worms over
their life-cycle. Phenotypes - as duration of the diﬀerent developmental stages, length,
diameter and ﬂuorescent stress response at each developmental stage, fertility and sex
fate - were quantiﬁed for each animal, resulting in high-content phenome data. The
method was validated by analyzing the worm response to pharmacological and genetic
compounds known to activate mitochondrial stress-response pathways in diﬀerent species.
Interestingly, the analysis revealed speciﬁc sub-populations that allowed separating single
worms as responders or non-responders to a treatment, thereby elucidating pharmaceuti-
cal or therapeutic responses still overlooked.
Second, I propose a design-of-experiment approach to characterize the concentration-
dependent eﬀect of the drug doxycycline on the duration of C. elegans development. 13
experiments were performed following a Doehlert design, where diﬀerent doxycycline
concentrations were tested, while varying also temperature and food amount, which
are known to inﬂuence the duration of the C. elegans development. A microﬂuidic
platform was designed to test the doxycycline eﬀect on isolated worms, with full control
of temperature and feeding over the development. Our approach allowed maximizing the
understanding of the eﬀect of this antibiotic on the C. elegans development and paving
the way towards a standardized and optimized drug testing process.
Third, envisioning a platform where C. elegans on-chip feeding is fully controlled and
food consumption could be quantiﬁed as additional phenotype, I describe a method
to measure the concentration of solutions of Escherichia coli bacteria. I designed an
opto-electronic device that was integrated with and optically aligned to a microﬂuidic
chip. The absorbance of a bacterial solution was calculated according to the Lambert-
Beer’s law. The device was tested and calibrated, obtaining a linear relation between
the absorbance and the concentration of the solutions. Afterwards, the change of the
turbidity of the solution on the long-term was assessed. Based on our observations, a
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simple mathematical model for the change of absorbance over time was hypothesized.
In another study I performed a motility-based phenotypic assay on C. elegans, to quantify
the worm glucose uptake. Adult worms were isolated in a micro-chamber, a glucose
solution was injected and short videos were recorded, from which a motility score was
extracted.
Last but not least, in the frame of a collaborative project, I designed a 3D-printed
micro-channel to immobilize a single adult worm to perform metabolic phenotyping on a
worm subsection via nuclear magnetic resonance spectroscopy.
Envisioning a pivotal role for C. elegans in the drug screening pipeline, a unique microﬂu-
idic platform, integrating all the phenotypic assays described in this Thesis, would allow
for robust, fast and cost-eﬀective high-content screenings of compounds on this simple
yet powerful model system.
Keywords: Caenorhabditis elegans, microﬂuidics, lab on chip, phenotype, phenotypic
assay, high-content screening, heterogeneity, design of experiment, Escherichia coli,
absorbance, nuclear magnetic resonance, microfabrication, SU-8, soft lithography, PDMS
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Résumé
Caenorhabditis elegans est un modèle animal idéal pour l’étude des processus et maladies
de la biologie humaine mais aussi pour le criblage préclinique de nouvelles molécules. La
microﬂuidique a joué un rôle déterminant dans la mise au point de tests pharmaceutiques
basés sur C. elegans en facilitant leur manipulation et l’établissement de protocoles
d’analyse robustes et reproductibles. Dans cette Thèse, je présente des dispositifs micro-
ﬂuidiques conçu spéciﬁquement pour le criblage phénotypique de C. elegans.
Premièrement, je décris une stratégie pour suivre les diﬀérents traits phénotypiques
individuels des nématodes au long de leur cycle de vie. Ces marqueurs - la durée des
diﬀérentes étapes du développement, la longueur, le diamètre et la réponse au stress à
chaque stade de développement, la fertilité et le sexe - ont été quantiﬁés pour chaque
animal, résultant en une description à haute densité du phénome. La méthode a été
validée en analysant la réponse des nématodes à des traitements pharmacologiques et
génétiques connus pour activer les voies mitochondriales de réponse au stress chez dif-
férentes espèces. L’analyse a révélé des sous-populations spéciﬁques qui ont permis de
séparer les vers en répondeurs ou non-répondeurs à un traitement,suggérant de nouvelles
réponses pharmacologiques ou thérapeutiques.
Deuxièmement, je propose une approche expérimentale pour caractériser l’eﬀet de la
doxycycline sur la durée du développement de C. elegans. 13 expériences ont été réalisées
en suivant un plan de Doehlert pour tester diﬀérentes concentrations de doxycycline. Les
eﬀets de la température et de la quantité de nourriture, dont l’inﬂuence sur la durée du
développement de C. elegans est connue, ont aussi été étudiés. Une plateforme microﬂui-
dique a été conçue pour tester l’eﬀet de la doxycycline sur le développement de vers isolés,
avec un contrôle total de la température et de l’alimentation. Notre approche a permis
d’améliorer notre compréhension de l’eﬀet de cet antibiotique sur le développement de C.
elegans et ouvre la voie vers un processus normalisé et optimisé de criblage.
Troisièmement, une méthode pour mesurer la concentration de solutions de bactéries
Escherichia coli est développée en préparation d’une plate-forme où l’alimentation des
vers est entièrement contrôlée et quantiﬁée comme phénotype supplémentaire. J’ai conçu
un dispositif optoélectronique qui a été intégré à un puce microﬂuidique. L’absorbance
d’une solution bactérienne a été calculée selon le Lambert-Beer loi. L’appareil a été
testé et calibré, obtenant une relation linéaire entre l’absorbance et la concentration en
bactéries des solutions. Ensuite, le changement de la turbidité de la solution sur le long
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terme a été évalué. Sur la base de nos observations, un modèle mathématique simple
pour le changement de l’absorbance dans le temps a été émis.
Dans une autre étude, j’ai réalisé un test phénotypique basé sur la motilité de C. elegans,
pour quantiﬁer l’eﬀet du glucose. Des vers adultes ont été isolés dans une micro-chambre,
une solution hautement concentrée en glucose a été injectée et de courtes vidéos ont été
enregistrées, à partir desquelles un score de motilité était extrait.
Enﬁn dans le cadre d’un projet collaboratif, j’ai conçu des microcanaux par impression
3D pour immobiliser un seul ver adulte. Un phénotypage métabolique sur une section du
ver a ensuite été réalisé par spectroscopie de résonance magnétique nucléaire.
En envisageant un rôle central pour C. elegans dans les tests pharmaceutiques, une
unique plate-forme microﬂuidique intégrant tous les tests phénotypiques décrits dans
cette thèse permettrait un criblage à haute densité robuste et rentable sur ce modèle
animal simple mais puissant.
Mots-clés : Caenorhabditis elegans, microﬂuidique, laboratoire sur puce, phénotype,
test phénotypique, criblage à haut contenu, hétérogénéité, plan d’expérience, Escherichia
coli, absorbance, résonance magnétique nucléaire, microfabrication, SU-8, lithographie,
PDMS
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Sommario
Il nematode Caenorhabditis elegans rappresenta un ottimo modello per lo studio di
alcuni processi e malattie della biologia umana e per screening fenotipici di molecole
a livello pre-clinico. La microﬂuidica è stata una disciplina determinante nel testare
molecole e composti chimici sul C. elegans, perchè rispetto ai tradizionali protocolli
sperimentali manuali, consente di automatizzare gli esperimenti, rendendo le conseguenti
analisi robuste e riproducibili. In questa Tesi, presento diversi saggi fenotipici svolti su
C. elegans, resi possibili dallo sviluppo ad hoc di diversi chip microﬂuidici.
In primo luogo, presento una strategia per monitorare diversi fenotipi di singoli animali
durante il loro ciclo di vita. Fenotipi - come la durata delle diverse fasi di sviluppo, la
lunghezza e il diametro degli animali, la risposta allo stress per ogni fase di sviluppo, così
come fertilità e determinazione del sesso - sono stati quantiﬁcati per ciascun animale,
ottenendo così un set di dati fenoticipi "high-content", cioè ad alto contenuto informativo.
Questo metodo è stato validato analizzando la risposta degli animali a composti sia
farmacologici sia genetici, noti per attivare in altre specie risposte biologiche accomunate
da stress a livello mitocondriale. L’analisi ha rivelato la presenza di sotto-gruppi,
che hanno permesso di classiﬁcare i singoli nematodi come reattivi o non-reattivi al
trattamento, chiarendo così alcuni meccanismi farmacologi e terapeutici ﬁnora ignorati.
In secondo luogo, presento un "design of experiment", ovvero un piano di esperimenti
pensati ad hoc, per studiare come il tempo di sviluppo del C. elegans vari in funzione
della dose dell’antibiotico doxiciclina. Abbiamo condotto 13 esperimenti secondo un
"design of experiment" di tipo Doehlert, in cui sono state somministrate diverse dosi di
doxiciclina, variando allo stesso tempo anche la temperatura e la quantità di nutrimento,
due fattori noti per inﬂuenzare a loro volta il tempo di sviluppo del C. elegans. È
stata progettata una piattaforma microﬂuidica per testare l’eﬀetto della doxiciclina su
nematodi isolati, con pieno controllo della temperatura e della quantità di nutrimento.
Il nostro approccio ha permesso di massimizzare la comprensione dell’eﬀetto di questo
antibiotico sullo sviluppo del C. elegans e pone le basi per futuri protocolli standardizzati
e ottimizzati per testare farmaci.
In terzo luogo, immaginando una piattaforma microﬂuidica in cui l’alimentazione del C.
elegans sia completamente controllata e in cui il consumo di cibo possa essere quantiﬁcato
come ulteriore fenotipo, presento un metodo per misurare la concentrazione di soluzioni di
batteri Escherichia coli, di cui questi nematodi si nutrono. Ho progettato un dispositivo
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opto-elettronico integrato e otticamente allineato con un chip microﬂuidico. L’assorbanza
della soluzione è stata calcolata in base alla legge di Lambert-Beer. Il dispositivo è stato
testato e calibrato, ottenendo una relazione lineare tra l’assorbanza e la concentrazione
delle soluzioni. In seguito ci siamo chiesti come la turbidità della soluzione vari nel lungo
termine e, sulla base di risultati sperimentali, è stato ipotizzato un semplice modello
matematico per il cambiamento di assorbanza nel tempo.
In un altro studio ho eseguito un ulteriore saggio fenotipico basato sulla motilità dei C.
elegans, utilizzata come parametro per quantiﬁcare l’assorbimento del glucosio da parte
dei nematodi. C. elegans adulti sono stati isolati in una micro-camera, una soluzione di
glucosio è stata somministrata e sono stati quindi registrati brevi video da cui è stata
quantiﬁcata la motilità dei C. elegans.
Ultimo ma non meno importante, nel quadro di un progetto collaborativo, ho progettato
un microcanale, in seguito fabbricato con un’ innovativa stampante 3D, per immobilizzare
un singolo nematode adulto, al ﬁne di estrarre fenotipi di tipo metabolico, tramite
spettroscopia di risonanza magnetica nucleare.
Immaginando un processo di screening dei farmaci in cui il C. elagans sia un modello
chiave e insostituibile, una piattaforma microﬂuidica comprensiva di tutti i test fenotipici
descritti in questa tesi, aprirebbe la strada a screening veloci, aﬃdabili ed economici.
Parole chiave: Caenorhabditis elegans, microﬂuidica, lab on chip, fenotipo, saggio
fenotipicp, screening "high-content", eterogeneità, "design of experiment", Escherichia
coli, assorbanza, risonanza magnetica nucleare, microfabbricazione, SU-8, soft-litograﬁa,
PDMS
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1 Introduction
1.1 Caenorhabditis elegans as a model system
Caenorhabditis elegans (C. elegans) has become an attractive model in biological research
since the early 1960s, when Dr. Sydney Brenner realized that fundamental questions
about cellular diﬀerentiation and interaction, as well as organ development, could not be
answered by studying either simple unicellular model organisms, e.g. bacteria, or too
complex and higher-order animals, e.g. mammals. A genetically amenable and multicel-
lular model organism simpler than mammals, was therefore needed. The ideal solution
proved to be the roundworm C. elegans, a 1 mm-long nematode, with short development
time and life span, and transparent: the phenomena of cellular diﬀerentiation and organ
development could be ﬁnally followed in a quasi real-time fashion, directly under the
microscope.
Dr. Brenner’s publication in 1974 appointed C. elegans as a novel experimental model
organism [1]. By establishing and using the nematode C. elegans as an experimental
model system, possibilities were opened to follow cell division and diﬀerentiation from
the fertilized egg to the adult. Sydney Brenner, together with John Sulston and Robert
Horvitz, won the Nobel Prize in Physiology or Medicine in 2002, for having exploited
C. elegans to investigate key genes regulating organ development and programmed cell
death, and having shown that corresponding genes exist in higher species, including
human.
Since then, this animal has never lost his charm and it is nowadays a powerful model for
biological research. C. elegans has a short life cycle development (∼ 3 days) from egg
to adult and a relatively short life span of around 2 weeks, which makes this animal a
very convenient model to investigate developmental processes and aging. Its neuronal
circuitry has been mapped and its genome completely sequenced. Moreover, in the
laboratory environment C. elegans primarily feeds on E. coli bacteria, which can be
manipulated to express double-stranded RNA for the gene of interest. This represents a
powerful technique for gene silencing and investigation of loss-of-function phenotypes
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[2]. Furthermore, C. elegans shares many biological features with humans, such as the
development of muscles, nerves, digestive tract, production of eggs and sperm. C. elegans
and humans also share a high number of genes - 40% of worms’ genes have their human
counterpart - and molecular pathways [3]. Transgenic and mutant worms contribute
to modeling Alzheimer’s, Parkinson’s and Huntington’s diseases and to the discovery
of compounds that can treat these neurodegenerative diseases [4], [5]. Moreover, these
nematodes are transparent during all stages of embryonic and larval development, which
enables the observation of cells and organs development, as well as the visualization of
gene expression and signaling pathways, also thanks to the availability of a large number
of ﬂuorescent reporter-gene strains. C. elegans worms are predominantly hermaphrodite,
with males making up approximately 0.1% of wild-type populations. Hermaphrodite
adults have 959 somatic cells and their complete lineage is known [6]. This nematode has
one of the simplest and - by far - the best characterized nervous systems [7]. However,
despite this simplicity, both physiological behaviors – e.g. feeding, locomotion, egg-laying
– as well as complex behavioral traits – e.g. sensory responses, social behaviors, learning
– can be observed and studied in worms. For all these "natural gifts", C. elegans is a
powerful tool for drug discovery and for the understanding of the molecular and genetic
mechanisms underlying certain human diseases.
Generally, in a drug discovery process, thousands of chemicals with a disease relevance
are tested to ﬁnd so-called leads, i.e. small molecules with potential for drug development
(Figure 1.1) [8]. The ﬁrst step is usually performed in vitro, using either a biochemical
assay or a cell-based assay. The former consists in investigating the interaction of a
compound with an isolated target in an in vitro environment. On the other hand, the
cell-culture approach allows a more realistic interaction in a more physiological envi-
ronment [9]. Afterwards, preclinical testing of a drug in animal models is performed,
providing valuable data on the expected clinical performance of the drug [10]. Phenotypic
assays are developed by modeling a human disease in an animal model through genetic
manipulation, such as mutation of human disease gene orthologs, transgenic expression
of human disease genes, or gene knockout [9]. This phase, usually lasting about 2.5 years,
allows narrowing the number of compounds to a few molecules. About 6 years of clinical
trials are performed on humans, before the successful molecule is ﬁnally selected.
In this drug screening scenario, C. elegans is an excellent candidate for whole animal-based
high-throughput screening and would nicely feed the drug discovery pipeline, between
cell-based assays and tests on rodents (Figure 1.2). In fact, its ability to mimic human
disease cannot be reproduced by in-vitro or cellular-based models, and oﬀers higher
chances of identifying drugs that will ultimately be more eﬃcacious in humans; moreover,
being a whole organism, it allows evaluating simultaneously the drug eﬃcacy, toxicity,
absorption and distribution, and oﬀers a broad range of scorable phenotypes; furthermore,
the availability of genetic tools as RNAi feeding library simpliﬁes the identiﬁcation of
drug targets [11]. Finally, the maintenance costs of C. elegans are orders of magnitude
lower than the ones related to rodents, and the use of C. elegans in drug screening
processes does not raise ethical concerns.
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Figure 1.1 – An overview of the typical drug development pipeline. Starting with several
thousands of molecules, the ﬁrst 5 year-long step allows selecting about 250 molecules,
typically by performing high-throughput screening in vitro, using either biochemical assays or
cell-based assays. Afterwards, preclinical testing of a drug on animals is performed, providing
valuable data on the expected clinical performance of the drug. After this 2.5 year-long
phase, the number of compounds is narrowed down to a few molecules. Afterwards, about 6
years of clinical trials are performed on volunteers, until the successful molecule is ﬁnally
selected for Food and Drug Administration (FDA) approval.
3
Chapter 1. Introduction
Model 
selection
Phenotype
screening
Lead small 
molecules
Mammalian 
model testing
Clinical 
trial
Target 
 
Lead 
optimizationidentif ication
Cell-based 
assays
Figure 1.2 – Strategy for phenotype-based drug discovery. In phenotype-based assays in
small models such as C. elegans, no a priori knowledge is required about the mechanisms
underlying a disease process. In these phenotypic assays, a human disease is mimicked on a
simple animal model. Once an assay is established, compounds are screened manually or by
high-throughput methods. Once potential lead molecules are identiﬁed, genetic, biochemical
and computational approaches can be iteratively applied to ﬁnd the drug target and optimize
lead molecules on rodents, before moving to clinical trials. Figure adapted from [12].
Traditionally, C. elegans is maintained in laboratories on nematode growth medium
(NGM) agar poured into petri dishes. Plates are seeded with E. coli bacteria to feed
worms. However, traditional C. elegans maintenance is tremendously tedious and time-
consuming, because most of the procedures are performed manually by a laboratory
technician [13]. For example, to avoid worms crawling and starvation, worms need to be
daily transferred to NGM plates with fresh and abundant bacteria: the most common
method is to manually pick single animals by using a worm picker and transfer them to
the new fresh plate. Moreover, if the assay requires only worms of a precise age, worm
synchronization is necessary. In this case, worms of the desired stage are picked and
transferred in a new plate and cultured. As alternative, the un-synchronized population
can be immersed in a solution of bleach and caustic soda, which is lethal for all the
population except the embryos, which are protected by the egg shell: those surviving
embryos will be placed in a fresh plate and, once they hatch, the newborn synchronized
larvae will be cultured.
Beside the risk of damaging or killing the animals, traditional well-plate-based drug tests
present many limitations. In fact, when the drug of interest is spotted on the NGM
plate, an unknown amount of the compound is absorbed by the agar, making the worm
exposure to the drug diﬃcult to determine and the experiments poorly reproducible.
Moreover, NGM-based approaches strongly limit precise spatio-temporal control of the
administered drug. This limitation becomes particularly severe when a dose-test needs to
be performed, as tuning the drug concentration to the worm response becomes extremely
time-consuming and requires repetitive manual worm transfer in diﬀerent NGM plates
previously prepared with the diﬀerent drug doses to test.
In order to improve the understanding of a disease, its therapeutic targets, the mecha-
nisms of action of a compound on C. elegans, alternative interdisciplinary approaches
should be used, which make the drug testing process on C. elegans more robust, more
reproducible, less costly and less error-prone. During the last decade, more technological
approaches towards the automation of C. elegans culture and quantiﬁcation of phenotypes
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have been presented. In this direction, many well-based approaches were developed
[9], [11]. A pioneering approach for large-scale screening of drugs using C. elegans was
proposed in 2006 [14]. Worm manipulation was automated using the COPAS BIOSORT
instrument (Union Biometrica, US), and over 14 thousands of compounds were screened.
Semi-automated image acquisition was performed and phenotypes such as growth, lethal-
ity, motility and other morphological features were identiﬁed. Despite this approach
allowed the identiﬁcation of about 300 active molecules, it was limited by the visual
scoring of the phenotypes and by the fact that the assays were performed on well-shaped
agar plates [14]. The same year, an agar-free approach was described, where C. elegans
nematodes were cultured in liquid-ﬁlled in well-plates, allowing automated handling by
pipetting robots [15]. Avoiding the use of agar plates left place to the use of robotic worm
handlers and to more automated imaging platforms. This approach, however, was limited
to the larval 1 (L1) worm size. A more automated screening process, featuring automated
worm transfer, image acquisition and data analysis was published in 2010 [16]. However,
this approach, successfully used to quantify protein accumulation into the worm intestine,
required rather expensive laboratory equipment: animals were sorted using the COPAS
BIOSORT, and a dedicated high-content screening instrument was subsequently used
to automatically capture images and another to perform automated data analysis. An
alternative method for worm sorting was based on the so-called live-animal ﬂuorescence
activated cell sorter (laFACS), that allowed to sort worms according to the ﬂuorescent
measured signal [17]. Beside sorting, ﬂuorescent signals were also used as phenotypic
read-outs performed on worms in 1536-well plates [18]. However, a plate reader was used
to measure the overall ﬂuorescence signal in the well, but no images were captured.
Beside requiring expensive machines, most of these approaches were conceived for cells
analyses, and imaging and data analysis could not be easily adapted to C. elegans
applications. Moreover, worms in liquid environment are highly motile and therefore
inherently more challenging to image. Another limitation resides in the fact that worms
in liquid media tend to settle to the micro-well bottom, which makes robotic pipetting
and worms transfer challenging.
Microﬂuidics platforms have been recently emerged as powerful tool for phenotyping
screening on C. elegans [9], [19]–[21]. Microﬂuidic chips can easily be set up with stan-
dard microscopy instruments. Moreover, micro-channel dimensions matching worm size
facilitate precise handling of the nematodes. Worms can be easily loaded into the device
by injecting a worm suspension in a buﬀer medium - typically M9 or S medium - and
sorted based on their size [22], [23]. This automatic manipulation allows for realizing
reproducible experimental conditions, contrasting with the traditional manual manip-
ulation performed by biologists, which is laborious, time-consuming and leads to the
risk of damaging worms while handling [24]. Moreover, microﬂuidic technology allows
controlled ﬂow and precise chemical stimuli delivery [25]. It is possible to test a new
compound or the same compound at a new concentration on the same worm population
in the chip, just by washing away the previous compound and injecting the new one. One
of the most important applications of microﬂuidics has been high-throughput automated
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screening of worm populations, as it can greatly reduce the time required to study each
worm and allows collecting a great amount of data [26]. Multiple output parameters can
be monitored per experiment on the long term. Moreover, image processing tools enable
automation and reduce human bias; they are vital to handle the data collected in many
experiments.
1.2 Microﬂuidic systems, an overview
Lab-on-chip microﬂuidic systems potentially allow shrinking an entire laboratory to a
chip, enabling the implementation of analytical protocols using low reagent volumes,
short processing times, in a ﬂexible way and potentially at low cost. During the past two
decades, microﬂuidic systems have been developed rapidly and have contributed to the
development of many clinical and molecular diagnostic instruments [9], [27]–[30]. There
are several advantages of scaling down standard laboratories devices from the decimeter
scale to the 100 μm scale. Micro-channel height and width being in the micrometer scale,
microﬂuidic devices consume very low ﬂuid volumes, therefore requiring less reagents and
related costs, and producing less waste. A linear reduction by a factor of 103 translates
to a volume reduction by a factor of 109: instead of handling 1 L or 1 mL, a microﬂuidic
system could easily work with volumes down to 1 nL or 1 pL. Such small volumes
allow for very fast analysis, eﬃcient detection protocols, which becomes particularly
advantageous when large amounts of sample are unavailable. Thanks to the small
channel size, microﬂuidic chips can have high compactness, which opens the possibility
for massive chip parallelization and for high-throughput analyses [31]. Moreover, with
channel dimensions matching a biological’s sample size, microﬂuidic devices have allowed
the manipulation of biological entities as small as a cell, paving the way for safe platforms
for chemical or biological studies, where a multitude of functions can be integrated and
automated [28], [31].
Interestingly, the interplay between many diﬀerent forces and the change of the relative
importance of these forces in the micro-regime as compared to the macro-regime, need to
be taken into account [27]. Surface eﬀects that often can be neglected at the macro-scale
become increasingly dominant in microﬂuidic circuits. From a physics point of view,
liquid phenomena such as laminar ﬂow, ﬂuidic resistance, diﬀusion and capillary forces
become dominant at the micrometer scale and need to be considered in the design of a
microﬂuidic device.
The ﬂow regime is characterized by the Reynolds number Re, which is the ratio of inertial
forces to viscous forces, deﬁned by Equation 1.1, where v is the mean ﬂow velocity, D is
the channel diameter, ρ is the ﬂuid density and μ is the ﬂuid viscosity [32].
Re = vDρ
μ
(1.1)
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Re helps predicting the ﬂow pattern. If Re < 2000, a laminar ﬂow proﬁle is observed,
while turbulences and inertial forces dominate for higher Re [33]. Typically, due to the
small dimensions of a micro-channel, Re  100, which makes the ﬂow pattern predictable
and allows the transport of biological entities in a very controlled and deterministic way.
In a Poiseuille ﬂow regime, the ﬂuid is driven through a long, straight and rigid channel
by imposing a pressure diﬀerence ΔP between the two ends of the channel. The average
ﬂow rate Q of a liquid within a micro-channel is proportional to the imposed pressure
diﬀerence, according to Equation 1.2
Q = ΔP
R
, (1.2)
being R the ﬂuidic resistance of the channel [27]. For straight rectangular channels
with width w and height h, when h < w, the ﬂuidic resistance is given by the Poiseuille
Equation 1.3:
R = 12μL
1 − 0.63 h
w
1
h3w
. (1.3)
Beside pressure gradients, another interesting aspect of the device operations is the
passive motion of particles in presence of a concentration gradient via Brownian motion,
known as diﬀusion [27], [31]. The velocity of the spherical diﬀusing particle is given by
the diﬀusion constant D, which is deﬁned by Einstein Equation 1.4
D = kBT6πrμ, (1.4)
where kB is the Boltzmann’s constant, T is the temperature in Kelvin and r is the radius
of the diﬀusing particle. In a time interval t, the root mean square distance l travelled
by a particle is given by Equation 1.5
l =
√
2Dt. (1.5)
Consequently, in the same time interval t and in absence of an external force ﬁeld, small
molecules can travel longer distances than large molecules.
Furthermore, microﬂuidic chips have intrinsically larger surface-to-volume ratio, due to
the small length scale of the channels [27], [31]. Such larger surface area can be exploited
to increase the rate of heat and mass transfer. Moreover, the large surface-to-volume ratio
makes capillary forces and surface tension more dominant phenomena in micro-channels.
From an engineering point of view, a microﬂuidic system is made of a set of operation
units, such as ﬂuid transport, metering, mixing, particle separation/concentration etc,
each of which is committed to a building block. In fact, a microﬂuidic system normally
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consists of micro-channels for sample transportation and active elements to manipulate
the sample, such as pumps, valves, mixers, separators/concentrators [31], [34].
Pumping strategies usually rely on mechanical pressure, electro-osmotic force, heat
transfer, electro-wetting, etc. As an alternative, passive microﬂuidic systems exist, where
ﬂuid is driven by forces such as gravity, capillary action, absorption or pressure generated
by manual action [35].
Microvalves are widely used to regulate and control the activation of ﬂow, as well as
to seal samples [31], [36]. If microvalves include a moving part actuated by magnetic,
electric, piezoelectric or thermal actuation methods, they are classiﬁed as active, as
opposed to passive microvalves. The formers are usually complex and costly, as they
require external equipment. The latters - on the other hands - are simpler and easy to
miniaturize and integrate in the ﬂuidic system. Passive microvalves can have moving
parts that open in response to a forward ﬂow or can simply rely on channel geometry
and capillary forces [36].
Micromixers are other important ﬂuidic components, which usually rely either on particle
diﬀusion or on chaotic advection [31], [37]. Chaotic advection can signiﬁcantly improve
mixing and it is achieved by breaking the ﬂow pattern by inserting obstacles or structures
in the micro-channel [38]. Other micromixers are instead actuated by external energy
inputs, including electrokinetic, acoustic, magnetic sources or integrated micropumps
and microvalves [31].
1.3 Thesis outline
In this Thesis, I present diﬀerent phenotypic assays on C. elegans nematodes that were
enabled by the use of microﬂuidic devices that I opportunely designed. The state of
the art related to each phenotypic assay is provided in the introductory part of each
corresponding Chapter.
In the technology-oriented Chapter 2, I illustrate the fabrication of the microﬂuidic
devices that I designed. Brieﬂy, the chip layout was transferred to a photomask, that
was later used to transfer the pattern on SU-8 photoresist coated on a silicon wafer.
Such a wafer was then used as a mold to obtain in a further step a polydimethylsiloxane
(PDMS)-glass microﬂuidic device. The last part of Chapter 2 gives an illustration of the
setup that I assembled and used to perform the experiments described in the following
Chapters.
In Chapter 3, I describe a new strategy to track diﬀerent phenotypic traits of individ-
ual C. elegans nematodes throughout their full life-cycle – i.e. their embryonic and
post-embryonic development. Phenotypes - such as duration of the diﬀerent stages of
development, length, diameter and ﬂuorescent stress response at each stage of develop-
ment, fertility and sex fate - were monitored and quantiﬁed for each animal, resulting in
high-content phenome data at single-worm resolution.
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In Chapter 4, a design-of-experiment approach to characterize the concentration-dependent
eﬀect of the drug doxycycline on the duration of C. elegans development is proposed. To
cover the experimentation space, 13 experiments were designed and performed following
a 3-factors Doehlert design, where diﬀerent doxycycline concentrations were tested, while
varying also temperature and food amount, which are known to inﬂuence the duration of
the C. elegans development. We designed a microﬂuidic platform to isolate and culture
C. elegans larvae, while testing the doxycycline eﬀect with full control of temperature
and feeding over the entire development.
Envisioning a microﬂuidic platform where C. elegans on-chip feeding is fully controlled
and food consumption could be quantiﬁed as additional phenotype, I propose a method
to measure the concentration of solutions of Escherichia coli bacteria, which is described
in Chapter 5. I designed an opto-electronic device that was integrated with and optically
aligned to a microﬂuidic chip. The absorbance of a bacterial solution was calculated
according to the Lambert-Beer’s law. The device was tested and calibrated with diﬀer-
ent bacterial solutions of known concentration, obtaining a linear relation between the
absorbance and the concentration of the injected solutions.
In another study, described in Chapter 6, I measured C. elegans motility as a parameter
to quantify the glucose uptake, upon exposure to either a high glucose concentration
or to the molecule dynasore. For this purpose, I isolated adult worms in a microﬂuidic
chamber, I injected the compound under investigation and recorded short videos, from
which a motility score was extracted for each tested condition.
Last but not least, in the frame of a collaborative project, I designed a 3D-printed
micro-channel to trap and immobilize a single adult C. elegans to perform metabolic
phenotyping on a worm subsection via nuclear magnetic resonance spectroscopy. These
results are presented in Chapter 7.
Finally, in Chapter 8, I summarize this work and provide a future outlook, envisioning
microﬂuidic-based phenotypic screenings on C. elegans as a pivotal step in the drug
screening pipeline.
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2 Fabrication of microﬂuidic de-
vices and experimental setup
Abstract This Chapter illustrates the fabrication of the microﬂuidic devices that I
designed. Brieﬂy, for all the designs, the chip layout was transferred to a photomask, that
was later used to transfer the pattern on SU-8 photoresist coated on a silicon wafer. Such
a wafer was then used as a mold to obtain in a further step a PDMS-glass microﬂuidic
device.
The fabrication of the diﬀerent photomasks and molds was carried out at the Center of
MicroNanoTechnology, at EPFL. The fabrication and assembling of the microﬂuidic chip
was performed using the Laboratory of Microsystems facilities.
In the last part of the chapter, I describe the microﬂuidic setup that was conceived,
assembled and used to perform the experiments described in Chapters 3, 5, 6 and 7.
In order to perform the experiments described in Chapter 4, a dedicated setup was
designed, which is detailed in Section 4.3.1.
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2.1 Mask fabrication
The layout of the microﬂuidic chip was designed by using the computer-aided design
software Clewin. The photomask fabrication was carried out at EPFL Center of Micro-
NanoTechnology (CMi). A 5”×5” blank mask made of a transparent glass plate covered
by a layer of chromium and chromium oxide and by a layer of positive photoresist on
top (sketch in Figure 2.1a) was used. First, a high-speed pattern generator (VPG200,
Heidelberg, Germany) transferred the design pattern by rastering the mask surface with
a high-power laser beam (λ=355 nm) that opportunely exposed the photoresist (Figure
2.1b), that was then developed (developer AZ351B, Clariant, Germany) and rinsed
(Figure 2.1c). The remaining photoresist pattern acted as a mask during subsequent
wet etching in an acid/oxidizer solution of the chromium layer (Figure 2.1d), which was
consequently removed, leaving on the glass plate transparent windows replicating the
initial pattern. Finally, the layer of non-exposed photoresist was stripped (Figure 2.1e)
in a butyrolactone solution.
d
e
Glass Cr
Cr2O3
Photoresist
a
c
b
Exposed 
photoresist
Figure 2.1 – Schematic of the process-ﬂow to fabricate of a photomask. a) 5”×5” photomask
made of a transparent glass plate and a thin layer of chromium and chromium dioxide,
covered with positive photoresist. b) A high-power and high-speed laser source (λ=355 nm)
exposes the photoresist, transferring a design previously made. c) The exposed photoresist is
developed and rinsed. d) The chromium layer is etched, transferring in this way the design
on the glass plate. e) The photoresist is removed by stripping.
2.2 Mold fabrication
The microﬂuidic devices presented in Chapters 3, 4, 5 and 6 were fabricated starting
from a silicon mold (100/p/ss/0.1-100, single-side polished 10 cm-wafer) patterned with
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negative photoresist SU-8 (Gersteltec, Switzerland) following a design customized to the
experimental application.
The wafer was ﬁrst cleaned with an oxygen plasma etcher (GigaBatch, PVA TePla,
Germany) (Figure 2.2a). For the chip designs that required the fabrication of a SU-8
layer thicker than 40 μm (such as the one described in Chapters 4 and 5), the wafer was
ﬁrst coated with an SU-8 adhesion layer to improve the following adhesion of the thicker
SU-8 layer on the substrate. Otherwise, the layer of the desired thickness was directly
patterned on silicon. To pattern the adhesion layer, SU-8 was spin-coated at 1176 rpm
to achieve a 2-μm thickness (LSM200 coater, Sawatec, Switzerland) (Figure 2.2b); the
photoresist was then soft-baked following the standard soft-baking curves, reaching a
maximum temperature of 90 ◦C (LSM200, Sawatec, Switzerland) (Figure 2.2c), and
exposed in mask-less mode to UV light (λ=365 nm, MJB4, Heidelberg Instruments,
Germany) (Figure 2.2d).
Using the same machines, the SU-8 layer of the desired thickness was then patterned,
either directly on silicon or on the adhesion layer. After spin-coating (Figure 2.2e), the
SU-8 was soft-baked (Figure 2.2f) and exposed to light (Figure 2.2g) using the mask
fabricated following the process ﬂow described in Figure 2.1. Afterwards, post-exposure
bake (LSM200, Sawatec, Switzerland) (Figure 2.2h) and development of the non-exposed
SU-8 in propylene glycol methyl ether acetate (PGMEA) and isopropanol (IPA) (Figure
2.2i) were performed.
The process ﬂow was optimized to prevent SU-8 delamination from the substrate (Figure
2.3a, red arrows), which was due to over-polymerization of the photoresist. To avoid
this undesired eﬀect, several exposure doses were tested, where the exposure time was
progressively reduced by 10% (Figure 2.3b), 20% (Figure 2.3c) and 30% (Figure 2.3d),
starting from the exposure time recommended by the resist producer. The decrease of
the exposure time determined an increase in the number of cracks in the SU-8 (Figure
2.3c-d, red arrows). However, as the presence of these small defects did not aﬀect the
further fabrication steps, we opted for a decrease of the exposure time by 30%.
The last photolithographic step was the hard-bake of the SU-8 pattern (Figure 2.2j)
and was only performed to fabricate those chips that required an additional 90 μm SU-8
layer on top of the ﬁrst one, such as the ones described in Chapters 3 and 6. This step
consisted in a 6 h-long baking step during which the temperature was ﬁrst increased
from 30 ◦C to 130 ◦C at a rate of 1 ◦C/min, then kept at 130 ◦C for 2 h and ﬁnally
brought down to 30 ◦C at the same rate. Thanks to the hard-bake, in fact, the thermal,
chemical and physical stability of the ﬁrst 40 μm SU-8 layer was signiﬁcantly improved,
in order to prevent it from damaging during the patterning of the second 90 μm SU-8
layer. Moreover, the hard-bake step completed the polymerization of the photoresist,
removing therefore the cracks on the ﬁrst SU-8 layer. The beneﬁcial eﬀect of hard-bake
can be appreciated in Figure 2.4. Compared to the mask design (Figure 2.4a), the pattern
fabricated without applying the hard-bake step clearly showed abnormal features and
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to UV
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Figure 2.2 – Schematic of a SU-8 patterning process-ﬂow. a) Oxygen plasma cleaning of
the silicon wafer substrate. b) Spin-coating of the 2 μm SU-8 adhesion layer. c) Soft-bake of
the 2 μm SU-8 adhesion layer. d) Mask-less exposure of the 2 μm SU-8 adhesion layer. e)
Spin-coating of additional SU-8 layers of either 40, 60, 80 or 90 μm-thickness. f) Soft-bake
of SU-8 photoresist. g) Exposure of the photoresist using a previously fabricated photomask.
h) Post-exposure bake of the SU-8 photoresist. i) Development of the non-exposed SU-8
photoresist. j) Hard-bake performed only on the thick SU-8 layer, before patterning of an
eventual additional SU-8 photoresist.
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d
a
c
b
Figure 2.3 – Detail of representative 40 μm SU-8 micro-channels patterned upon diﬀerent
exposure doses. a) Pattern obtained using the exposure dose recommended by the resist
producer, in this case 166 mJ/cm2. SU-8 delaminated in some spots (lighter corners pointed
by the red arrows) typically due to over-exposure. b) Pattern obtained by reducing the
exposure dose by 10%, still showing severe delamination. c) Pattern obtained by reducing
the exposure dose by 20%, showing improved adhesion of SU-8 to the substrate. Cracks (red
arrow), however, appear due to insuﬃcient polymerization. d) Pattern obtained by reducing
the exposure dose by 30%, showing signiﬁcantly improved adhesion and some cracks (red
arrow). Scale bar = 100 μm.
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a b
40 μm  SU-8,
1st layer 
90 μm  SU-8,
2nd layer 
c
Figure 2.4 – Chemical and thermal stress on a representative portion of a SU-8 mold. a)
Design of the chip, where the 40 μm-thick SU-8 is colored in dark blue and the second
90 μm-thick layer on top of the ﬁrst is colored in light blue. b) Pattern with abnormal
conﬁguration and poor adhesion, as channels are no longer straight and are laying on diﬀerent
focal planes, indicating detachment. This undesired result was due to chemical and thermal
stresses on the ﬁrst 40 μm-thick layer upon fabrication of the superior 90 μm-thick layer.
c) Pattern obtained by performing a hard-bake. The design accurately replicates the mask
design in panel a). Scale bar = 50 μm.
poor adhesion, due to chemical and thermal stresses occurring during the fabrication of
the top layer (Figure 2.4b). On the other hand, when a hard-bake was performed, the
resulting pattern accurately replicated the mask design (Figure 2.4c). After hard-bake,
the second 90 μm SU-8 layer was patterned using the same steps described in Figure
2.2e-i for the fabrication of the ﬁrst layer.
2.3 Fabrication and assembling of the microﬂuidic chip
The microﬂuidic devices are prepared by soft lithography [39], using PDMS (Sylgard 184
Dow Corning) and glass. A SU-8/silicon mold (see Figure 2.5a) was placed in a container.
The PDMS base was thoroughly mixed with the curing agent at a 10:1 weight ratio,
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Figure 2.5 – Schematic of fabrication of a PDMS-glass chip by replica molding. a) SU-8
and silicon mold obtained by photolithography as described in Figure 2.2. b) The mixture of
PDMS base and curing agent is poured on the mold, until the desired thickness is achieved.
c) The PDMS mixture is cured at 80 ◦C for 1 h in an oven. d) Each PDMS chip is diced
and removed from the mold, and e) holes are punched to create ﬂuidic connections. f) The
clean surfaces of PDMS and glass slide are activated by air plasma before the bonding step.
g) Tubes are inserted into the PDMS holes.
starting in this way the curing process. The mixture was poured on the mold into the
container, until the desired PDMS thickness was achieved (Figure 2.5b). If air bubbles
were entrapped, the whole container was kept under vacuum until evacuation of all the
bubbles. In order to accelerate the curing process, the container was cured at 80 ◦C for 1
h (Figure 2.5c). Afterwards, the solidiﬁed PDMS was removed from the mold (Figure
2.5d), each PDMS chip was diced and ﬂuidic inlets and outlets were made by punching
holes into it (Figure 2.5e). The PDMS chip was then bonded with a 26 mm × 76 mm
glass slide upon air-plasma activation of both surfaces (Figure 2.5f). Finally, tygon tubes
with 0.51 mm inner and 1.52 mm outer diameters (Fisher Scientiﬁc, Switzerland) were
plugged in the PDMS holes (Figure 2.5g).
2.4 Experimental setup
The microﬂuidic chip (Figure 2.6a) was integrated onto an inverted microscope (Figure
2.6b) (Axio Observer, Zeiss, Germany) equipped with two illumination systems: (i) a
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precisExcite High-Power LED Illumination system (Visitron, Puchheim, Germany) for
brightﬁeld imaging and (ii) a Lambda DG4 illumination system (Sutter instruments,
Novato, CA, US) for ﬂuorescence imaging. A black and white camera (ORCA-ER, Hama-
matsu, Japan) (Figure 2.6c) was connected to the microscope optical path and controlled
by VisiView Premier Image acquisition software (Visitron, Puchheim, Germany). The
microscope was equipped with a motorized xyz-stage (Figure 2.6d) that had an ASI piezo
controller for z-displacement (Visitron, Puchheim, Germany). The automated imaging
process was controlled using VisiView. The microﬂuidic operations were controlled using
Nemesys syringe pumps (Figure 2.6e) and relative control software (Cetoni, Korbussen,
Germany). Given the relatively long time scale of each experiment, the syringe dedicated
to E. coli delivery was provided with a stirring system in order to prevent bacteria from
sedimenting at the bottom of the syringe. I placed a magnetic rod (1 mm × 1 mm ×
2 mm) (Supermagnete, Uster, Switzerland) inside the syringe (Figure 2.6f). A rigid
tube with small magnet rods blocked inside and ﬁxed to the axis of a DC motor 6/9 V
(Arduino, Ivrea, Italy) was positioned adjacent to the syringe (Figure 2.6g). The rotation
of the motor axis and its rods induced agitation in the magnet inside the syringe. The
rotation of the motor axis was controlled by a microcontroller (Arduino, Ivrea, Italy)
and it was synchronized to the syringe control, so that E. coli was stirred before being
injected in the microﬂuidic system.
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(a)
(b)
(d)
(c)
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Figure 2.6 – Microﬂuidic setup. a) Microﬂuidic device with tubings plugged inside. b)
Inverted optical microscope, (Axio Observer, Zeiss, Germany). c) Black and white camera,
Hamamatsu, Japan. d) Motorized xyz-stage with an ASI piezo controller for z-displacement
(Visitron, Puchheim, Germany). e) Syringe pumps (Nemesys, Cetoni, Germany). f) Magnetic
rod (1 mm × 1 mm × 2 mm) (Supermagnete, Uster, Switzerland) placed inside the syringe.
g) Rigid tube with small magnet rods blocked inside, ﬁxed to the axis of a DC motor 6/9 V
(Arduino, Ivrea, Italy) and positioned adjacent to the syringe.
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3 Individualized multi-phenotypic
response to drug and genetic cues
of a C. elegans population
Abstract Complex molecular and cellular interactions in multicellular organisms can lead
to heterogeneous phenotypic responses to treatments. This makes individual responses
more informative than population-averaged read-outs for ﬁne analysis. Intra-population
variability should be appreciated when testing new compounds to identify phenotypic
predictors of the therapeutic outcome. In this Chapter, I present a new strategy to
monitor diﬀerent phenotypic traits of individual C. elegans nematodes throughout their
life-cycle. Single worms were isolated and cultured from egg to adulthood in a microﬂuidic
device, in which phenotypic changes during development could be quantiﬁed. Speciﬁcally,
the method was validated by analyzing the response of C. elegans to pharmacological and
genetic treatments used to alter the mitochondrial unfolded protein response (UPRmt).
Importantly, the extensive single-worm phenotyping information revealed, in many cases,
speciﬁc sub-populations that would otherwise be undetectable. From this phenome
data, single worms could be classiﬁed as responders or non-responders to a treatment.
Evaluating the heterogeneity in response and its markers with this method, it would
be possible to elucidate pharmaceutical or therapeutic deviations that are still being
overlooked.
This chapter is an adapted version of the following publications:
• M. C. Letizia, M. Cornaglia, R. Trouillon, V. Sorrentino, L. Mouchiroud, M. S.
B. Sleiman, J. Auwerx and M. A. M. Gijs, "Microﬂuidics-enabled phenotyping of a
whole population of C. elegans worms over their embryonic and post-embryonic
development at single-organism resolution", Microsystems and Nanoengineering,
manuscript accepted.
• M. C. Letizia, M. Cornaglia, V. Sorrentino, J. Auwerx and M. A. M. Gijs,
"A microﬂuidic platform for an automated monitoring of C. elegans embryo-to-
adulthood development at single organism resolution". Proc. of 20th International
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Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS
2016), Dublin, Ireland, October 2016.
Oral presentation
• M. C. Letizia, M. Cornaglia, R. Trouillon, M. A. M. Gijs, "Microﬂuidic high-
content screening in a C. elegans model at single animal-resolution". Proc. of 39th
International Conference of the IEEE Engineering in Medicine and Biology Society
(EMBC2017), Jeju Island, Korea, July 2017.
Oral presentation and poster presentation
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3.1. Introduction
3.1 Introduction
Heterogeneity in response to drugs or treatments can impede the quality of care, thus
spurring the development of individualized therapeutic strategies [40], [41]. The growing
interest in personalized medicine is moving pharmacological research towards the prelim-
inary identiﬁcation of sub-groups of patients who will beneﬁt from a certain treatment,
and separating them from those for whom the treatment will not be eﬀective or even
deleterious. Such a priori knowledge would allow tailoring the treatment to the charac-
teristics of each individual, rather than to a population-averaged behavior. To capture
the individual variability, longitudinal experiments are needed, where large datasets are
collected while maintaining the possibility to observe the response of a single entity. Big
data approaches can be applied to identify diﬀerent sub-groups, correlate them with
markers and phenotypes and therefore provide new patterns predicting the response to
the drug or treatment.
Given the cost and high attrition rate of human clinical trials, animal models are still
widely used in early stages of drug development to elucidate the therapeutic mechanisms
and to extrapolate the drug response to humans. The nematode C. elegans is a popular
animal model for the analysis of complex traits, such as metabolism and aging, at the
molecular, cellular, organ and organismal levels [42]. However, the vast majority of the
current biological knowledge, for any model, is largely based on population measurements,
hiding potentially relevant individual behaviors. In the case of C. elegans, the majority
of the experimental repertoire is based on analyzing and phenotyping large groups of
individuals, hindering the crucial individualized spatiotemporal mapping. The impor-
tance of a phenotypic analysis at single-individual resolution becomes even more crucial
when performing RNAi phenotypic screenings, where signiﬁcant population variability is
expected, and overall phenotypes cannot fully capture the complexity of the response.
Microﬂuidics has been instrumental in enabling single-worm analysis with robust, high-
throughput and reproducible screenings [19], [20], [26], [43]. However, it was not exploited
for systematic longitudinal phenotypic proﬁling of whole organisms. A platform allowing
single-worm based multi-phenotypic measures upon a speciﬁc treatment would pave the
way for high-content, individualized analysis and possibly targeted follow-up treatments.
In this context, this Chapter describes an innovative chip-based strategy for the precise
analysis of the heterogeneous response to pharmacological or genetic treatments – and the
resulting identiﬁcation of heterogeneous biomarkers or phenotypes – amongst a controlled
C. elegans population. In this endeavor, as illustrated in Figure 3.1, a microﬂuidic
platform was designed to isolate naturally-synchronized embryos upon egg laying into
single-worm chambers, where their identity was preserved during their life-cycle. Several
phenotypes were monitored for each animal, resulting in high-content phenome data for
each experimental condition. Once all the individual phenotypes are extracted, one can
match the diﬀerent experimental conditions with phenotypic signatures. Multivariate
methods were employed to navigate the datasets and identify only the most important
phenotypes for each experimental condition. Phenotypic clusters corresponding to dif-
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Figure 3.1 – Illustration of the single-worm based approach to extract diﬀerent phenotypes
upon testing of a pharmacological of genetic compound over the full life-cycle.
ferent sub-populations of single worms were identiﬁed, highlighting intra-population
heterogeneity. Moreover, I validated the method by analyzing the response of C. ele-
gans to pharmacological and genetic tools used to activate the mitochondrial unfolded
protein response (UPRmt), a stress-response that is conserved across species [44]–[46].
The single-worm based analysis method was employed to identify diﬀerent treatment-
dependent markers for mitochondrial stress. Interestingly, while mild intra-population
variations were observed after drug treatments, several worm sub-populations with
markedly diﬀerent stress biomarkers appeared after RNAi feeding.
3.2 An automated platform for isolation and monitoring
of single C. elegans organisms during embryonic and
post-embryonic development
A microﬂuidic chip for the phenotypical analysis and biomarker identiﬁcation at single-
worm level throughout its life-cycle was designed and fabricated in PDMS and glass
(Figure 3.2a), following the fabrication steps described in Chapter 2. To perform the
experiments, the setup described in Section 2.4 was used. First, a non-synchronized
population of C. elegans was loaded in the parent culture chamber (Figure 3.2b,c).
Dedicated ﬁlters were ﬁtted to outlet Out1 to retain only young adult (YA) worms
in the chamber and wash younger worms out. Afterwards, those YA worms were fed
with E. coli bacteria until egg production. Once laid, embryos were transported by
the ﬂow to the progeny culture chamber matrix (Figure 3.2b,d), consisting of an array
of 16 single-worm chambers, each ﬁtted with a trap for single-embryo capture (Figure
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Figure 3.2 – Automated platform for isolation and monitoring of single C. elegans organisms
during full life-cycle. a) Picture of the microﬂuidic device. Scale bar = 5 mm. b) Schematic
of the microﬂuidic device, showing the parent culture chamber and the progeny culture
chamber matrix. Scale bar = 2 mm. c) Zoom on the parent culture chamber including typical
drawings of young adult (YA) C. elegans. Scale bar = 500 μm. d) Schematic representation
of a module of the progeny culture chamber matrix. Scale bar = 200 μm. e) Sketch of
the egg hydrodynamic trapping in a single-embryo micro-incubator and its transfer in the
adjacent single-worm chamber. Scale bar = 100 μm.
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Figure 3.3 – Bacterial ﬂow proﬁle used to perfuse the single worm chamber array over the
full experiment. Diﬀerent ﬂow proﬁles, adapted to the worm’s stage of development, were
chosen for embryonic and larval development.
3.2e). Through hydrodynamic trapping the embryos occupied consecutive traps, forming
a naturally-synchronized population. Using this approach, the traditional aggressive
bleaching step for embryo isolation and the time-consuming manual synchronization
procedures were avoided [13].
The single-embryo traps were presented and discussed in a previous study published
by our group [47]. The device used in the current work pushes further this concept by
connecting a worm-culture chamber to each single-embryo trap (Figure 3.2d,e). With
this approach, the new-born larva remains isolated and can be cultured until adulthood
onset, allowing for the ﬁrst time the on-chip monitoring of embryonic and post-embryonic
development. In fact, after capture, each embryo was simultaneously injected from the
micro-incubator to the adjacent single-worm chamber by high ﬂow rate, exploiting PDMS
elasticity (Figure 3.2e). Each chamber is also provided with ﬁlters (5 μm-spacing) to
allow medium ﬂow while preventing L1 worms from escaping.
A ﬂow proﬁle adapted to larval age was developed, in order to provide enough nutrients
to the progeny generation (Figure 3.3). During the embryonic twitching-hatching stage
and L1 stage, a repetitive loop ﬂow proﬁle of 5 nL/s for 10 min and 20 nL/s for 15 s was
delivered, in order to prevent the newborn larvae from escaping through the single-embryo
micro-incubator, as the incubator aperture dimension matched the L1 size. Afterwards,
a loop ﬂow proﬁle of 10 nL/s for 15 min, 150 nL/s for 15 s and 0 nL/s for 15 min was
used, in order to refresh E. coli bacteria in the chambers, to avoid stressing the worms
with continuous hydrodynamic forces.
The acquisition system (see Section 2.4) was programmed so that brightﬁeld (exposure
time = 2 ms) and ﬂuorescent (exposure time = 150 ms) pictures were recorded every 7 min
on each position. A Zeiss 20× NA 0.22 objective was used for imaging of single-embryos
in the micro-incubator, while a Zeiss 4× NA 0.075 objective was used for imaging of each
single-worm chamber. A single picture was taken to capture each worm at a time-point, as
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the ﬁeld of view of the objective was large enough to accommodate the whole single-worm
chamber. An immobilization method was not needed, as the mobility of the worms was
low. Indeed, the presence of optimized amounts of food along the duration of the whole
experiment limited food-seeking behavior and motion. To capture sharp ﬂuorescent
pictures, the exposure time was ﬁnely tuned to avoid extensive animal movement within
the exposure time window. The ﬂuorescent picture was captured 150 ms (ﬂuorescent
exposure time) after the brightﬁeld picture. Afterwards, the motorized stage moved
to the following single-worm chamber and waited 3 seconds for stabilization, before
brightﬁeld and ﬂuorescent pictures were shot. In this way, the full array could be imaged
in about 50 s. Considering the typical timescale of the evolution of the development of
the worms (∼10 h for embryonal development and 2-5 days for larval development), this
imaging routine was not expected to introduce a development mismatch between the
diﬀerent worms.
3.3 Optimization of the hydrodynamic trapping
The single-worm culture module (Figure 3.2d) was considered as a system described by
ﬂuidic resistances. The resistance given by the serpentine channel Rchannel is in parallel
with Req, which is the resistance given by the embryo micro-incubator, the single-worm
chamber and the ﬁlters, in series (see Figure 3.4a). The embryo delivered towards the
progeny culture chamber matrix is guided by the ﬂow towards the single-embryo micro-
incubator, because Rchannel > Req. Once one single-embryo micro-incubator is occupied,
Req increases becoming higher than Rchannel and the coming embryos occupy the next
available trap. In this way, hydrodynamic trapping ensures that all the micro-incubators
are consecutively occupied in an automated way.
In very ﬁrst approximation, the resistances were estimated by considering the pressure
drop between inlet and outlet of each single-worm culture module along the two parallel
ﬂuidic paths and imposing equal pressure diﬀerence along them, assuming Poiseuille
ﬂow conditions [48] and using Poiseuille Equation 1.3. However, losses due to the design
geometry - such as channel bends or changing in the cross section - were neglected in
this way. Therefore, the design of the microﬂuidic device was later optimized through
the results of a systematic experimental characterization. The trapping eﬃciency was
estimated for 6 similar versions of our device, featuring varying bends or lengths of
the serpentine channel, varying number and shape of the ﬁlters, and therefore varying
Rchannel/Req. Four examples are given in Figure 3.4a, b, c and d. For these tests, 30 μm
polystyrene beads were employed as trapping objects to mimic C. elegans embryos, and
the capture eﬃciency was deﬁned as the percentage of traps containing a single bead
over the total number of available trapping sites, for a constant amount of beads injected
into the microﬂuidic device. From our experimental analysis, we could conclude that a
ratio Rchannel/Req of 2.6 maximizes the system trapping eﬃciency (83%) (Figure 3.4e).
This conﬁguration also ensured that each chamber was occupied by only one bead at a
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Figure 3.4 – Experimental design optimization to improve the eﬃciency of the hydrodynamic
trapping. a-d) Four (out of 6) exemplifying chip designs featuring diﬀerent Rchannel/Req
ratio, fabricated and tested to calculate the trapping eﬃciency. e) Results of the experimental
characterization of the trapping eﬃciency. The highest eﬃciency (83%) was obtained for a
Rchannel/Req of ∼2.6 (red dot). Data is shown as average ± standard deviation (SD).
time, and was therefore chosen to perform the experiments.
3.4 High-content phenotypic analysis at single-organism
resolution
Starting from embryo collection in the progeny culture chamber matrix, I identiﬁed
the milestones commonly used to characterize embryonic and larval development [49],
[50], detailed in Figure 3.5a. C. elegans embryos, laid upon beginning of gastrulation,
were immediately trapped in the embryo-incubator array. Bean stage and twitching
onset were observed in the single-embryo incubator, while egg hatching was detected in
the single-worm chamber. The duration of each larval stage could be unambiguously
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Figure 3.5 – Identiﬁed phenotypes for single-worm based analysis. a) Illustration of the
parallel time-lapse imaging, here shown only for three representative worms, enabled on the
worm array within the progeny culture chamber matrix during the full life-cycle. Arrows
point at the molts seen as detached from the worm body. Scale bar = 50 μm. b) Illustration
of the quantiﬁed phenotypic markers, namely embryo viability or hatching rate, worm length
and diameter at the vulva at the stages L1, larval 2 (L2), larval 3 (L3), L4 and YA, the
ﬂuorescence expression of the gene of interest at the stages L1, L2, L3, L4 and YA, the sex
fate and the percentage of fertile adult worms.
evaluated by measuring the time interval between consecutive moltings, which identify the
actual biological transitions amongst the diﬀerent larval stages (L1 to larval 4 (L4)), up
to the YA stage. Adulthood onset was deﬁned by the vulva protrusion, which normally
coincides with the appearance of ﬁrst self-fertilized embryos inside the worms, and
which determined the end of the life-cycle and therefore of the experiment. Beside the
development times, other important phenotypes were extracted for each animal (Figure
3.5b). First, the hatching rate was calculated to evaluate the embryo viability. Then,
the average body length and diameter at the vulva, as well as the expression of a gene
of interest via ﬂuorescent read-out, were extracted for each larval stage of development.
The sex fate (hermaphrodite or male) and the fertility rate were also recorded.
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3.4.1 Phenotypic biomarker analysis of an UPRmt reporter strain
UPRmt is a stress response that maintains mitochondrial proteostasis via a system
of chaperones and proteases controlling mitochondrial protein folding, assembly and
degradation [44], [51], [52], as reviewed in [45]. It is a prototypical hormetic stress response,
with deleterious or positive eﬀects depending on the level of stress applied to the organism
[53]. In C. elegans, UPRmt activation is observed upon perturbation of the electron
transport chain (ETC), as shown by downregulation of cco-1, a nuclear DNA-encoded
component of ETC complex IV [44], or upon perturbation of mitochondrial proteostasis,
as seen after loss-of-function of the protease spg-7 [52]. Additionally, inhibition of
mitochondrial translation, genetically via silencing of mitochondrial ribosomal genes
such as mrps-5 and pharmacologically by using the antibiotic doxycycline, induces both
nematode and mammalian UPRmt [51], [54]. UPRmt induction during larval development
in C. elegans leads to lifespan extension and reduced mitochondrial function [44], [51],
as well as developmental delay and decreased brood size [44], [51], [55]. However, the
relevance of these biomarkers to the lifespan extension, as well as accurate quantiﬁcation
and relative diﬀerences of these phenotypes due to various mitochondrial stressors are
still being overlooked.
High-content phenotypic data on hsp-6p::gfp worms, a nematode UPRmt reporter strain
[56], was obtained by extracting biologically-informative phenotypic markers from the
images. The durations of the developmental stages along the life-cycle – gastrula-bean
stage (t(E1)), bean-twitching stage (t(E2)), twitching-hatching stage (t(E3)), duration
of L1 stage (t(L1)), duration of L2 stage (t(L2)), duration of L3 stage (t(L3)), duration
of L4 stage (t(L4)) and duration of YA stage (t(Y4)) – were systematically quantiﬁed
for individual worms (16 per array, Figure 3.6a) and averaged over the array (Figure
3.6b). In the absence of treatment, the duration of these stages matched those reported
for worms cultured on agar plates at the same temperature [57]. Moreover, 97% of the
trapped embryos developed, while the rest did not hatch. 100% of the worms became
fertile hermaphrodite adults, as internal eggs were observed (Figure 3.7a). The average
worm lengths, corresponding to the skeleton (later abbreviated as length at L1 stage
(L(L1)), length at L2 stage (L(L2)), length at L3 stage (L(L3)), length at L4 stage
(L(L4)) and length at YA stage (L(YA))), and diameters measured at the vulva (later
abbreviated as diameter at L1 stage (D(L1)), diameter at L2 stage (D(L2)), diameter at
L3 stage (D(L3)), diameter at L4 stage (D(L4)) and diameter at YA stage (D(YA))),
were also obtained (Figure 3.7b). The basal induction of the hsp-6p::gfp was quantiﬁed
as a reporter of the UPRmt activation by processing the ﬂuorescent images to extract
the signal-to-background ratio (SBR). The linear SBR increase over time (Figure 3.7c)
suggests that the UPRmt pathway is weakly activated in basal conditions [51], [56]. The
ﬂuorescent signal per worm area at each larval stage (ﬂuorescent signal at L1 stage
(F(L1)), ﬂuorescent signal at L2 stage (F(L2)), ﬂuorescent signal at L3 stage (F(L3)),
ﬂuorescent signal at L4 stage (F(L4)) and ﬂuorescent signal at YA stage (F(YA))) was
also computed (Figure 3.7d).
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Figure 3.6 – Duration of the main embryonic and larval developmental phases for the
hsp-6p::gfp worms at single-organism resolution. a) Duration of the main embryonic and
larval developmental phases, observed for a matrix of 16 worms. b) Durations of embryonic
and larval developmental stages. Each dot represents the duration of a precise developmental
stage for one worm. Average ± SD values are superimposed. N=16.
3.5 Individualized response to pharmaceutical cues
3.5.1 Nicotinamide riboside homogeneously aﬀects multiple facets of
larval development
We tested the eﬀect of nicotinamide riboside (NR), known for boosting the intra-cellular
levels of the oxidized form of nicotinamide adenine dinucleotide (NAD+) [58]. NR
promotes mitochondrial biogenesis by increasing cellular NAD+ levels and therefore
sirtuin activity, thus elevating the mitochondrial proteins expression and the UPRmt
induction [59]. With our phenotyping platform, we investigated the eﬀect of NR on the
C. elegans life-cycle and mitochondrial stress response. A signiﬁcant eﬀect of NR on
the life-cycle was observed, as revealed by hierarchical cluster analysis (HCA) (Figure
3.8a) and PCA (Figure 3.8b and Table 3.1) (more details about the performed statistical
analysis in Section 3.7.4). In this case, PCA showed that all the investigated treated
animals reacted to NR in a homogeneous fashion.
NR slightly prolonged the embryonal bean-twitching phase t(E2) (Figure 3.9a) and
embryo viability was not compromized, compared to the control group (Figure 3.9b).
Moreover, NR severely extended the larval development time by 75% on average (Figure
3.9c), while reduced larval length and diameter were measured (Figure 3.9d,e). Moreover,
the animals showed proper gonad development and 75% of the treated organisms were
fertile (Figure 3.9f), as presence of internal eggs was observed (Figure 3.9g). Furthermore,
data showed a slight decrease in hsp-6p::gfp expression in the NR-treated population
with respect to the control (Figure 3.9h), indicating that UPRmt, and so mitochondrial
stress, was weakly activated by NR.
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Figure 3.7 – Phenotypic analysis on a control strain at single-organism resolution. a)
Brightﬁeld picture of an adult worm. The red circles indicate internal embryos. Scale bar =
50 μm. b) Average length and diameter at each larval stage. Graph points are expressed
as average ± SD. c) Quantiﬁcation of hsp-6p::gfp expression as SBR for the full life-cycle.
d) Quantiﬁcation of hsp-6p::gfp expression as SBR normalized by worm size at each larval
stage. N = 31.
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Phenotype PC 1 (73.3% of variance) PC 2 (6.5% of variance)
Coordinates Contributions Coordinates Contributions
t(E1) -0.038 0.010 0.021 0.007
t(E2) 0.238 0.064 0.430 0.134
t(E3) -0.012 0.003 0.059 0.018
t(L1) 0.252 0.068 0.107 0.033
t(L2) 0.098 0.026 0.137 0.043
t(L3) 0.294 0.079 0.222 0.069
t(L4) 0.342 0.092 0.116 0.036
t(YA) 0.418 0.113 0.252 0.078
L(L1) -0.192 0.052 -0.139 0.043
L(L2) -0.093 0.025 -0.129 0.040
L(L3) -0.097 0.026 -0.078 0.024
L(L4) -0.135 0.036 -0.101 0.032
L(YA) -0.142 0.038 -0.069 0.022
F(L1) -0.235 0.063 0.434 0.135
F(L2) -0.393 0.106 0.528 0.164
F(L3) -0.293 0.079 0.360 0.112
F(L4) -0.266 0.072 0.003 0.001
F(YA) -0.178 0.048 0.031 0.010
Table 3.1 – Coordinates and contributions of PCs 1 and 2 as result of PCA of phenotypes
of control and NR-treated group. Phenotypes with signiﬁcant contribution are marked in
bold.
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Figure 3.9 – Eﬀect of NR on the C. elegans life-cycle. a-f, Comparison between control
and treated worms of a) the durations of embryonic developmental stages, b) the percentage
of embryos dying before egg hatching, c) the durations of larval developmental stages, d)
the lengths and e) diameters at each larval stage, and f) the percentage of fertile adults. g)
Brightﬁeld picture of an adult treated worm. Red circles point at internal embryos. Scale
bar = 50 μm. h) Comparison of SBR normalized by worm size at each larval stage between
control and treated worms. N= 31 for control; N= 31 for the NR treatment. Untreated
hsp-6p::gfp worms are used as controls (Dataset in Figures 3.6, 3.7).
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Phenotype PC 1 (78.8% of variance) PC 2 (5.2% of variance)
Coordinates Contributions Coordinates Contributions
t(E1) -0.035 0.011 -0.140 0.049
t(E2) 0.292 0.092 -0.098 0.034
t(E3) 0.024 0.007 0.061 0.021
t(L1) 0.253 0.080 -0.050 0.018
t(L2) 0.191 0.060 0.066 0.023
t(L3) 0.337 0.106 -0.069 0.024
t(L4) 0.326 0.103 -0.075 0.026
t(YA) 0.688 0.217 -0.172 0.060
L(L1) -0.049 0.015 -0.034 0.012
L(L2) -0.085 0.027 -0.036 0.013
L(L3) -0.089 0.028 -0.054 0.019
L(L4) -0.117 0.037 -0.042 0.015
L(YA) -0.133 0.042 0.027 0.010
F(L1) 0.034 0.011 0.655 0.230
F(L2) 0.125 0.039 0.461 0.162
F(L3) 0.103 0.032 0.460 0.162
F(L4) 0.157 0.050 0.177 0.062
F(YA) 0.135 0.042 0.169 0.059
Table 3.2 – Coordinates and contributions of PCs 1 and 2 as result of PCA of phenotypes
of control and doxycycline-treated groups. Phenotypes with signiﬁcant contribution are
marked in bold.
3.5.2 Doxycycline prolongs larval development and induces sub-population-
speciﬁc phenotypic changes
The platform was used to phenotypically characterize the eﬀect of doxycycline, a phar-
macological inducer of the UPRmt [51]. HCA (Figure 3.10a) and PCA (Figure 3.10b
and Table 3.2) were ﬁrst run on the dense dataset to identify features of interest, and
provide an overall phenotypic footprint of the eﬀect of doxycycline on the treated worm
population. This antibiotic induced severe deviations from control, as treated animals
showed longer development time, conﬁrming the doxycycline role in prolonging the animal
development and extending its lifespan.
Interestingly, the unexpected permeability of the eggshell to doxycycline induced two
diﬀerent responses on the embryo population. The doxycycline treatment proved to be
lethal for 9.4% of the embryos, that died before hatching (Figure 3.11a). This response is
in line with the eﬀect of other mitochondrial stressors [60], [61]. On the other hand, the
embryo development of the surviving eggs was severely delayed (3.11b), especially during
the bean-twitching phase t(E2). This eﬀect was also observed in a previous study using a
genetic mutation to induce mitochondrial stress [47]. As predicted by HCA and PCA, the
impact of doxycycline was even more severe on the larval development time (3.11c) and
size (3.11d and 3.11e), which featured a 1-fold or higher increase over the negative control,
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especially for the L4 and the YA stages. This observation agrees with previous reports
showing a similar delay in larval development when the electron transport chain function
is compromised genetically [62]. Indeed, during the L3-L4 stages, mitochondria undergo
a period of dramatic proliferation [63], making it the critical time-window, during which
mitochondrial perturbations can have large impact on C. elegans larval development
[62]. Moreover, doxycycline not only impaired gonad development and caused infertility
(3.11f), but also pushed 8% of the individuals towards male development (3.12). These
ﬁndings suggest that doxycycline exerts profound eﬀects on developmental processes
relying on mitochondrial support, favouring a shift towards male progeny formation,
similar to what is observed with other sources of stress [64], but, interestingly, only in
a subgroup of the population. Finally, the tracking of hsp-6p::gfp expression (3.11g),
showed an overall increase starting at the L2 larval stage, which conﬁrms the induction
of mitochondrial stress by doxycycline, followed by the UPRmt.
3.6 Individualized response to genetic cues
hsp-6p::gfp worms were treated with RNAi against either mrps-5 [51] or cco-1 [44], to
investigate variations in the levels of gene silencing amongst the individuals. Brieﬂy,
RNAi technology takes advantage of the cell natural machinery, facilitated by short
interfering RNA molecules, to eﬀectively knock down expression of a gene of interest. This
method can be used to identify and functionally assess genes that potentially participate
in disease phenotypes. In addition, it provides an eﬃcient mean for blocking expression of
a speciﬁc gene and evaluating its response to chemical compounds or changes in signaling
pathways [65].
3.6.1 RNAi treatment on mrps-5 gene induces three sub-population-
speciﬁc responses
Worms treated with mrps-5 RNAi showed a heterogenous response during larval devel-
opment, as revealed by HCA and PCA (Figure 3.13 and Table 3.3).
Interestingly, the embryo development was homogeneously delayed (Figure 3.14a).
Moreover, 12.5% of the embryos died before hatching (Figure 3.14b). Overall, the phe-
notypic data of the surviving larvae indeed revealed longer development times (Figure
3.14c) and smaller body volumes (Figure 3.14d,e). However, a deeper observation of the
phenotypes allowed separating the treated worms in 3 sub-populations, group 1, 2 and 3,
accounting respectively for 46%, 15% and 39% of the treated animals. The treatment
strongly prolonged the development times (Figure 3.14c), reduced the sizes (Figure
3.14d,e) and strongly activated UPRmt (Figure 3.14f,g) of group 1. Group 2 showed a
stronger developmental delay during L3 and L4 (Figure 3.14c) and a strong ﬂuorescent
activation at L4 (Figure 3.14f). Also group 3 showed a delayed development compared
to control (Figure 3.14c). However, these animals did not complete the life-cycle, as
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Figure 3.11 – Eﬀect of doxycycline on the C. elegans life-cycle. a-e, Comparison between
control and treated worms of a) percentage of embryos dying before egg hatching, b) the
durations of embryonic developmental stages, c) the durations of larval developmental stages,
d) the lengths and e) diameters at each larval stage. f) Brightﬁeld picture of an adult treated
worm showing no presence of eggs in the body. Scale bar = 50 μm. g) Comparison of SBR
normalized by worm size at each larval stage between control and treated worms. N= 31
for control; N= 29 for the doxycycline treatment. Untreated hsp-6p::gfp worms are used as
controls (Dataset in Figures 3.6, 3.7).
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a
b
Figure 3.12 – Male individuals upon doxycycline treatment. a,b) Brightﬁeld pictures of
the two adult treated worms that expressed a male sex. The arrows point at the typical
blunt-ended male tail. Scale bar = 50 μm.
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Phenot. PC 1 (50.6% of variance) PC 2 (33.2% of variance) PC 3 (5.2% of variance)
Coordin. Contrib. Coordin. Contrib. Coordin. Contrib.
t(E1) 0.071 0.030 -0.048 0.014 0.078 0.024
t(E2) 0.115 0.048 -0.147 0.042 -0.246 0.075
t(E3) 0.002 0.001 0.004 0.001 0.098 0.030
t(L1) -0.009 0.004 -0.278 0.079 -0.017 0.005
t(L2) -0.005 0.002 -0.234 0.067 0.137 0.042
t(L3) 0.106 0.044 -0.393 0.112 0.254 0.078
t(L4) 0.056 0.023 -0.452 0.129 0.549 0.168
t(YA) 0.852 0.357 -0.138 0.039 -0.218 0.067
L(L1) -0.065 0.027 0.127 0.036 0.066 0.020
L(L2) -0.060 0.025 0.076 0.022 0.041 0.013
L(L3) -0.021 0.009 0.083 0.024 0.043 0.013
L(L4) -0.002 0.001 0.136 0.039 0.149 0.046
L(YA) 0.168 0.071 0.467 0.133 0.091 0.028
F(L1) -0.074 0.031 0.262 0.075 0.420 0.129
F(L2) 0.101 0.042 0.102 0.029 0.104 0.032
F(L3) 0.108 0.045 0.153 0.044 0.137 0.042
F(L4) 0.207 0.087 0.110 0.031 0.478 0.147
F(YA) 0.366 0.153 0.292 0.083 0.138 0.042
Table 3.3 – Coordinates and contributions of PCs 1, 2 and 3 as result of PCA of phenotypes
of control and RNAi-treated group on mrps-5 gene. Phenotypes with signiﬁcant contribution
are marked in bold.
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Figure 3.13 – Phenotypic footprint of phenotypes of the control group and the mrps-5 -
treated group. a) HCA of phenotypes of the control group and the mrps-5 -treated group.
The grey dashed area indicates missing data points, corresponding to the worms who did
not complete their development. b) PCA of phenotypes of control and mrps-5 -treated
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Phenotype PC 1 (61.7 % of variance) PC 2 (24.6 % of variance)
Coordinates Contributions Coordinates Contributions
t(E1) -0.030 0.011 -0.096 0.028
t(E2) 0.027 0.010 0.258 0.075
t(E3) 0.004 0.001 -0.068 0.020
t(L1) 0.074 0.028 0.330 0.096
t(L2) 0.054 0.020 0.193 0.056
t(L3) 0.058 0.022 0.471 0.137
t(L4) 0.483 0.180 0.024 0.007
t(YA) 0.686 0.256 0.324 0.095
L(L1) -0.014 0.005 -0.062 0.018
L(L2) -0.003 0.001 -0.008 0.002
L(L3) 0.008 0.003 0.049 0.014
L(L4) 0.219 0.082 -0.337 0.098
L(YA) 0.169 0.063 -0.416 0.121
F(L1) -0.049 0.018 -0.055 0.016
F(L2) .0078 0.029 -0.175 0.051
F(L3) 0.116 0.043 -0.088 0.026
F(L4) 0.286 0.107 -0.265 0.077
F(YA) 0.321 0.120 -0.207 0.060
Table 3.4 – Coordinates and contributions of PCs 1 and 2 as result of PCA of phenotypes
of control and RNAi-treated group oncco-1 gene. Phenotypes with signiﬁcant contribution
are marked in bold.
they never reached the YA stage (Figure 3.14c). Moreover, UPRmt activation in group 3
was very weak (Figure 3.14f,g), compared to worms from the previous groups and even
from the control. Finally, 93% of worms were infertile (Figure 3.15a), as conﬁrmed by
impaired gonad development and absence of internal progeny (3.15b).
3.6.2 RNAi treatment on cco-1 gene induces two sub-population-speciﬁc
responses
A similar heterogeneity was observed after cco-1 RNAi treatment upon HCA and PCA
(Figure 3.16 and Table 3.4).
RNAi on cco-1 gene homogeneously induced a signiﬁcant diﬀerence on t(E2) and t(E3)
(Figure 3.17a). Moreover, 22% of the embryos died before hatching (Figure 3.17b). The
analysis of the dendrogram and heat map resulting from the HCA, as well as PCA (Figure
3.16), revealed the presence of subgroups 1 and 2, accounting respectively for 72% and
28% of the treated worms. Larval development times and body volumes were similar
to control during the L1 and L2 stages for both subgroups (Figure 3.17c-e). However,
the UPRmt activation was attenuated in group 2 during these ﬁrst larval stages (Figure
3.17f,g) compared to both the control and group 1. Interestingly, group 2 worms died
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Figure 3.14 – Eﬀect of mrps-5 RNAi treatment on the C. elegans life-cycle. Comparison
between control and treated worms of a) the durations of embryonic developmental stages
and b) the percentage of embryos dying before egg hatching. c-f, Comparison between control
and sub-populations corresponding to groups 1, 2 and 3 of treated worms of c) the durations
of larval developmental stages, d) the lengths and e) the diameters at each larval stage,
and f) SBR normalized by worm size at each larval stage. g) Quantiﬁcation of ﬂuorescent
hsp-6p::gfp expression as SBR for full life-cycle from group 1, group 2 and group 3 of treated
worms. N= 31 for control; N= 28 for the mrps-5 treatment. Untreated hsp-6p::gfp worms
are used as controls (Dataset in Figures 3.6, 3.7).
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Figure 3.15 – Eﬀect of mrps-5 RNAi treatment on the C. elegans fertility. a) Comparison
of the percentage of fertile adults between control and treated worms. b) Brightﬁeld picture
of an adult treated worm. Scale bar = 50 μm. N= 31 for control; N= 28 for the mrps-5
treatment. Untreated hsp-6p::gfp worms are used as controls (Dataset in Figures 3.6, 3.7).
after the L3 stage, thus not completing their life-cycle (Figure 3.17c). Moreover, even if
worms from group 1 survived, impaired gonad development and 100% infertility were
observed (Figure 3.18).
Our analysis showed that alteration of the mitochondrial function through genetic manip-
ulation leads to remarkable changes during the developmental phases, which are strongly
dependent on mitochondrial activity. Interestingly, as expected in a RNAi approach,
populations treated with mrps-5 and cco-1 RNAi showed a signiﬁcant heterogeneity
during larval development.
3.7 Materials and methods
3.7.1 Image processing
Image processing was performed with ImageJ software and Matlab R 2015b software
(MathWorks, US), on each stack of brightﬁeld and ﬂuorescent worm images. Brightﬁeld
pictures were processed in order to spot bean stage onset, twitching onset, hatching,
molting times and appearance of protruded vulva for each individual. The number of
surviving embryos was assessed by counting the number of hatching eggs. For each
larval stage, length and diameter (or width, as the worms are assumed cylindrical) were
calculated and averaged over 5 brightﬁeld pictures at the central time point of the larval
stage for each individual. In order to assess fertility, we looked for the presence of internal
embryos from self-fertile reproduction after vulva protrusion. To extract ﬂuorescent SBR
ratio, the region of interest (ROI) corresponding to the worm area was ﬁrst segmented
in the whole stack. We performed background subtraction and applied a median ﬁlter
in order to remove salt-and-pepper noise. SBR was then calculated for each picture as
deﬁned in Equation 3.1
SBR = IROI − IBG
IBG
(3.1)
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Figure 3.17 – Eﬀect of cco-1 RNAi treatment on the C. elegans life-cycle. Comparison
between control and treated worms of a) the durations of embryonic developmental stages
and b) the percentage of embryos dying before egg hatching. c-f, Comparison between control
and sub-populations corresponding to groups 1 and 2 of treated worms of c) the durations
of larval developmental stages, d) the lengths and e) the diameters at each larval stage,
and f) SBR normalized by worm size at each larval stage. g) Quantiﬁcation of ﬂuorescent
hsp-6p::gfp expression as SBR for full life-cycle from group 1 and group 2 of treated worms.
N= 31 for control; N= 25 for the cco-1 treatment. Untreated hsp-6p::gfp worms are used as
controls (Dataset in Figures 3.6, 3.7).
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Figure 3.18 – Eﬀect of cco-1 RNAi treatment on the C. elegans fertility. Brightﬁeld picture
of an adult treated worm. Scale bar = 50 μm.
with IROI the average intensity of the signal in the ROI and IBG the average intensity of
the background. In order to remove noise and artifacts from the obtained SBR, a moving
average ﬁlter (length of moving window = 10 frames) was applied on the stack.
3.7.2 Experimental model and subject detail
C. elegans strains were cultured at 20 ◦C on NGM 90 mm Petri dishes seeded with E.
coli strain OP50. The strain used in this study was the SJ4100 (zcIs13[hsp-6p::GFP]),
provided by the Caenorhabditis Genetics Center (University of Minnesota). For studies
in untreated conditions, hsp-6p::gfp worms were plated on regular NGM plates at the L4,
and collected about 12 hours later at the stage of YA for injection in the system. For
the doxycycline treatment, a concentration of 30 μg/mL was chosen to trigger UPRmt
in hsp-6p::gfp worms. Adult gravid worms were placed on control plates and removed
after 6 hours after egg laying. YA worms from the second generation were then collected
for introduction in the microﬂuidics system, where the treatment with the antibiotic (30
μg/mL) was initiated after egg laying. For the NR treatment experiments, hsp-6p::gfp
worms were grown on regular NGM plates at 20 ◦C until reaching the L4 stage and then
transferred to new plates for treatment (parental generation, F0). NR (1mM) was added
just before pouring the plates. The derived NR-treated (F1 generation) population was
collected at the stage of YA for introduction in the microﬂuidics system. For RNAi
studies, plates were induced overnight at room temperature with 4 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) and seeded with HT115 bacteria expressing either empty
vector RNAi L4440 or the RNAi clones for the indicated genes. F0 adults were removed
after 24 h and F1 YA worms were collected for introduction in the microﬂuidics system.
Worms were suspended in S medium solution prior to each microﬂuidic experiment.
3.7.3 E. coli culture
HT115 E. coli bacteria were grown in luria broth (LB) with 100 μg/mL ampicillin and
12.5 μg/mL tetracycline overnight in a thermal shaker at 37 ◦C. The following day, 50 μL
of the conﬂuent bacterial cultures were used to inoculate freshly prepared LB medium
48
3.7. Materials and methods
containing only ampicillin, so to avoid the presence of tetracycline during the worm
experiments, which has been shown to also aﬀect mitochondrial function, similarly to
doxycycline [54]. The new cultures were grown until reaching an optical density between
0.6 and 0.8, and 90 μL were used for seeding the experimental plates. To feed worms in
the microﬂuidic device, a solution of bacteria in S medium with optical density of 5 was
prepared and used.
3.7.4 Quantiﬁcation and statistical analysis
Statistical analysis was performed using GraphPad Prism (San Diego, CA, US). Graphs
are expressed as mean ± SD overlaid with a cloud of points describing the actual dataset,
unless otherwise as indicated in the ﬁgure legends. For each treatment, the datasets
were independently obtained from two chips, each featuring 16 worm chambers. The
sample number (N) indicates the number of independent viable biological samples for
which parameters were extracted in each dataset. Statistical signiﬁcance was determined
with a two-tailed Mann-Whitney test. p-values were graphically reported as * p ≤
0.05, ** p ≤ 0.01. Statistical tests were performed only to compare the recorded values
of a given phenotypic parameter, at a speciﬁc developmental stage, amongst diﬀerent
treatments/groups of worms.
The on-chip analysis provided a multitude of phenotypic variables which precluded the
identiﬁcation of major phenotypic changes in response to the experimental conditions.
As a consequence, we used a HCA and PCA to reduce the dimensionality of the datasets
and emphasize the driving force that generated the raw data.
Hierarchical cluster analysis
The input experimental variables were the durations of the embryonal stages of develop-
ment, the durations of the ﬁve stages of larval development, the length at the L1 stage
and length increments at the other four stages of larval development, and the ﬂuorescent
SBR at L1 stage and the SBR increments at the other four stages of larval development.
Increments, rather than absolute measurements, were used here to minimize the risk
of unwanted correlations between parameters which are expected to increase as the
worm develops (for instance the length), which may hide smaller variations between the
treatments. Each dataset was normalized and centered to the average of each parameter
for the negative control, and a hierarchical cluster analysis was run using the built-in
algorithm in Matlab R 2015b (MathWorks, US). Data points were organized in clusters
ordered according to the unweighted average Euclidean distance.
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Principal component analysis
As data was spread over a wide range of units and scales, data was normalized to the
mean of each parameter (obtained over all the worms for a speciﬁc condition, i.e. control
and treatment) before performing PCA. This allowed for the direct comparison of the
diﬀerent parameters while still preserving the variability of the data, in regard to the
average, hence allowing for the extraction of the discriminant markers. Additionally, the
algorithm used here centers the dataset by default. A PCA procedure was run using
the built-in algorithm in Matlab R 2015b (MathWorks, US). The components were then
ranked by decreasing order of explained variance (or eigen-value). The data was then
plotted using this new base, and the components revealing the separation of speciﬁc
subgroups were kept for the analysis. For each retained component the contribution of
the initial parameters was computed by normalizing the coordinates of the component to
the L1 norm of the component (i.e. the sum of all the absolute values of the coordinate
for this component). Only the parameters whose contribution was at least 10% of the
component were considered. Finally, by considering the projection of the raw data on
the relevant components (i.e. by considering the scores) and the parameters contributing
to this component, the discriminant parameters for speciﬁc subgroups were identiﬁed.
Using this approach, the contribution of each phenotypic observation could be evaluated,
and the input variables with the highest information content isolated.
3.8 Discussion and conclusion
The platform and analysis method were used to identify appropriate biomarkers and
investigate the phenotypic variability associated with the nematode UPRmt. In worms
treated with doxycycline [54] or fed with bacteria expressing RNAi for mrps-5 [51] and
cco-1 [44] to induce UPRmt, the classic phenotypic hallmarks of mitochondrial stress
were observed, such as delayed development, reduced brood size, reduced fertility and
induction of the UPRmt biomarker hsp-6p::gfp. On the other hand, NR did prolong the
C. elegans life-cycle, without compromising either embryonal viability or worm fertility,
and the UPRmt was weakly activated. The setup revealed a treatment-dependent intra-
population variability that could otherwise not be observed in RNAi experiments run
on plates. Interestingly, exposure to small molecules, i.e. doxycycline and NR, induced
homogenous responses in comparison to mrps-5 and cco-1 RNAi, where very distinct
outcomes were recorded. A possible contributor to this increased heterogeneity during
RNAi treatment is the variability in the transmission of the acquired traits, as the RNAi
pretreatment and conditioning started with the L4 parental worm generation.
Quantifying and elucidating the patterns linking markers to heterogeneous responses
amongst treated individuals is a paramount prerequisite in precision medicine research.
However, this variability in phenome data read-out is often lost owing to the lack of
speciﬁc strategies to tackle this huge analytical challenge. Consequently, we described
here a platform that allows culturing and phenotyping of individual worms from a C.
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elegans population from egg laying until adulthood. Thanks to hydrodynamic trapping,
freshly-laid single embryos were automatically isolated and kept in separate chambers until
adulthood. The single-worm resolution of our chip allowed the longitudinal monitoring
and tracking of multiple phenotypes over the life-cycle of individual organisms. Moreover,
worms showed a physiological development consistent with the one in solid medium
at the same temperature, thus setting a new standard in terms of C. elegans culture
and feeding in liquid environment. Therefore, with respect to previous studies on C.
elegans culture [47], [66] and its use in drug testing [67], we showed a comprehensive
microﬂuidic platform enabling unprecedented C. elegans culture over its full life-cycle
at the single-worm level while longitudinally monitoring multiple phenotypic markers
upon a variety of treatments. In fact, the platform allowed testing pharmacological and
genetic treatments by simply changing the compounds injected into the microﬂuidic chip,
while ensuring perfect control and reproducibility of all the environmental parameters.
Conjugating longitudinal assays over the full development span with individualized
observations in a precisely controlled chemical environment is a clear advancement of
the state of the art and a substantial improvement of the previously proposed analytical
microﬂuidic platforms for C. elegans. This phenotyping strategy paves the way for the
identiﬁcation of appropriate disease biomarkers that would shape the worm response to
the treatment of interest, which would complement ideally similar studies performed on
other species (reviewed in [68]). To compare the high-content phenotypic signature of
worm populations under diﬀerent conditions, we used single-worm based HCA and PCA.
Big data strategies facilitate the identiﬁcation of sub-groups and patterns buried in the
phenome data. Our method also evaluated quantitatively the diﬀerences between diﬀerent
sub-groups, and provided the phenotypic footprint of each treatment. Envisioning a
stratiﬁed medicine, the characterization of such intra-population treatment-dependent
variability allows both inferring the eﬀectiveness of a treatment in a population subset
and identifying personalized follow-up treatments.
After having identiﬁed the diﬀerent sub-groups of a population thanks to our unbiased
and individualized analysis, it is possible to uncover signiﬁcant trends characterizing
the treatments, or the speciﬁc response biomarkers of a sub-group, by considering the
average phenotypes within each sub-group. This analysis allowed for the identiﬁcation of
ﬁrst-order treatment-speciﬁc eﬀects and more global characterization of each experimental
condition, as summarized in Figure 3.19. The sub-groups showed two diﬀerent trends
with respect to the negative control, based on the presence or absence of activation of
the mitochondrial stress response and the severity of developmental delay. On one side,
the third mrps-5 group and in a more severe fashion the second cco-1 group showed
inappropriate stress-response activation and even impossibility to reach adulthood. On
the other side, all the other groups - from NR-treated worms to the second mrps-5
group - showed a progressive increased ability to respond to stress, as testiﬁed by UPRmt
activation, slow growth and reduced size during L4 and YA stages of development.
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Figure 3.19 – Comprehensive high-content phenotypic picture of pharmacological and
genetic treatments eﬀects on C. elegans life-cycle. This hierarchical cluster analysis was
based on the average phenotypes within the control group and treated group, the latter
eventually showing distinct sub-groups. The grey dashed area indicates missing data points,
corresponding to the worms that did not complete their development.
52
3.9. Future outlook
3.9 Future outlook
In the future, if worms are cultured and fed for a longer time, a life-long phenotypic
analysis - from embryogenesis to death - could be performed. This would require
adaptation of the feeding protocol to the adult metabolism of the animals during progeny
production and in the last period of their life. A life-long study at single animal resolution
would also require the periodic removal of progeny (L1) from the chamber, which we
implemented already by providing the single worm chambers with ﬁlters through which L1
worms could escape under high ﬂuidic pressure. Such a platform would be instrumental
to study the eﬀect of compounds related to worms ageing and degenerative diseases.
The possibility to precisely control the drug delivery in time could be further exploited
in the future, by administering the drug at diﬀerent time points, thereby ﬁne-tuning
the animal exposure to the drug of interest. Preliminary experiments were performed
by exposing C. elegans to doxycycline from the L1 stage. The results conﬁrmed the
eﬀect of doxycycline on the extension of the larval development time and on the worms
size (Figure 3.20a,b), phenomena that were already observed at a more severe extent
upon administration of doxycycline from the egg laying stage (Figure 3.11). More
interestingly, 84.6% of worms were fertile (Figure 3.20c) and all the animals developed
as hermaphrodite. These results strongly diﬀer from the infertility and the presence of
male worms observed upon life-cycle-long administration of doxycycline. Despite the cell
lineages that generate the two sexes are clear variant of each other starting from the
early cell divisions [69], our ﬁnding might hint that sex determination could possibly be
modiﬁed during embryonic development.
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Figure 3.20 – Eﬀect of doxycycline on C. elegans larval development. Comparison among
control and worms treated with doxycycline for life-cycle and larval development of a) the
duration of the larval developmental stages, b) the lengths at each larval stage and c) the
percentage of fertile animals. Untreated hsp-6p::gfp worms are used as controls (Dataset in
Figures 3.6, 3.7). The dataset related to worms treated over the full life-cycle is the same as
the one represented in Figure 3.11.
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for multi-parametric drug testing
using a C. elegans model
Abstract When studying drug eﬀectiveness on a target model, one should distinguish
the eﬀects of the drug itself and of all the other factors that could inﬂuence the screening
outcome. A Design of Experiment (DoE) approach in drug-testing is emerging as a robust
and eﬃcient method to reduce the use of resources, while maximizing the knowledge
of the process. Here, I used a 3-factor-Doehlert DoE to characterize the concentration-
dependent eﬀect of the drug doxycycline on the development duration of the nematode
C. elegans. 13 experiments were designed and performed, where diﬀerent doxycycline
concentrations were tested, while varying also the temperature and the food amount,
which are known to inﬂuence too the duration of the C. elegans development. A microﬂu-
idic platform was designed to isolate and culture C. elegans larvae, while testing the
doxycycline eﬀect with full control of temperature and feeding over the entire development.
This approach allowed predicting the doxycycline eﬀect on the C. elegans development
in the complete drug concentration/temperature/feeding experimentation space, maxi-
mizing the understanding of the eﬀect of this antibiotic on the the C. elegans development.
This chapter is an adapted version of the following publications:
• M. C. Letizia, M. Cornaglia, G. Tranchida, R. Trouillon, M. A. M. Gijs, "De-
sign of experiment approach for eﬃcient multi-parametric drug testing using a
Caenorhabditis elegans model", Integr. Biol., Issue 10, p. 48-56, 2018.
• M. C. Letizia, M. Cornaglia, M. A. M. Gijs, "Integrated temperature control
system for microﬂuidic culture of nematodes". Proc. of 5th Micro and Nano Flows
Conference (MNF2016), Milan, Italy, September 2016.
Oral presentation
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4.1 Introduction
Drug discovery and testing research are mostly based on a one-factor-at-a-time variational
approach, in which each experimental parameter is changed at a time, independently
of the others [70], [71]. However, this approach inevitably requires an impressively-high
number of experiments to cover the entire experimental domain, which makes the drug
development costly and time-consuming, limiting the discovery of the number of hits
that exhibit interaction with the biological target of choice. Moreover, this technique
is less prone to studying the eﬀect of the simultaneous change of several factors on the
ﬁnal outcome. Similarly, the one-factor-at-a-time approach hinders the identiﬁcation
of a causal relationship between the experimental parameters and their inﬂuence on
the target, or compromizes discovery of interactions between the parameters. A robust
alternative to this traditional drug discovery method is given by the so-called DoE
approach, whose application in the quality-oriented pharmacological sector was recently
recommended by the European Medicine Agency (EMA) [72]. In this method, the
experimental parameters, called factors, are purposefully varied according to a precise
design, in order to understand their eﬀect on the target response, and a mathematical
relationship is established between the factors and the response [73]. In a DoE approach,
statistical thinking is therefore required before performing experiments rather than doing
it a posteriori, like in a one-factor-at-a-time-approach [71]. DoE enables minimizing the
use of the experimental resources while maximizing the knowledge of the process. In
fact, it allows identifying the signiﬁcance of each factor and its eﬀect on the experimental
outcome, as well as determining the interaction between factors. Moreover, a DoE study
allows to extrapolate in a rigorous mathematical way its ﬁndings into the complete
experimental space [73].
We focused on characterizing the eﬀect of the antibiotic doxycycline in a variable tem-
perature and food concentration environment on the development time of C. elegans as
animal model (see schematic in Figure 4.1).
Doxycycline is mostly employed in animal research to study biological pathways involved
T 
Drug dose  [E. coli]
Figure 4.1 – Illustration of the DoE multi-parametric approach to investigate the change of
the C. elegans development time by simultaneously varying temperature, food concentration
and drug dose.
in the extension of longevity, and C. elegans represents a powerful model for such aging
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and metabolism studies [42], [51], [54], [74], also thanks to its relatively-short life-span of
2-3 weeks [75]. In research, tetracycline antibiotics are generally used to control gene
expression in a variety of animal models [54], [76]. However, beside targeting bacterial
translation, doxycycline also inhibits mitochondrial translation, which is thought to be
a key factor in the lifespan extension [51], [54]. Interestingly, it has been shown that
doxycycline extends the lifespan of cells, worms, ﬂies, plants and mice in a dose-dependent
fashion [54]. It is known to induce mitochondrial stress, leading to changes in nuclear
gene expression and to severely alter mitochondrial function in diﬀerent animal models,
including C. elegans and mice, even at low concentration [54]. Gravid worms and progeny
were treated with doxycycline at concentrations of 60 μg/mL and 120 μg/mL [77]. In
both cases, all the larvae arrested their development at the L3 stage, showed impaired
gonad development and a dose-dependent delay in larval growth. Houtkooper et al.
treated worms with doxycycline (30 μg/mL and 60 μg/mL) for the entire lifespan and
noticed a dose-dependent developmental delay and reduced worm respiration, while no
abnormalities were observed at lower doses [51]. Another group gave doxycycline to a
worm population throughout its larval development at concentrations of 5 μg/mL, 10
μg/mL and 15 μg/mL [54]. Dose-dependent decrease of the respiration rate, increase
of the development time and increase of the percentage of larvae not completing the
development were observed. Recently, microﬂuidic approaches were used as an alternative
to the traditional C. elegans culture on agar plates. Microﬂuidic chips for worm culture
were fabricated and used to test the eﬀect of doxycycline on worms [78]. In particular,
doxycycline at a concentration of 15 μg/mL and 30 μg/mL, given to worms throughout
their larval development, dose-dependently delayed the worm growth [78].
However, diﬀerences in the experimental and environmental parameters combined with
a lack of control of the experimental protocols prevent the exact replication of these
experiments and therefore limit the upfront comparison of the literature. Temperature
[13] and food amount [79], [80] are in fact the two most relevant factors that modulate
C. elegans development and longevity. For example, C. elegans development time can be
2.1-fold shorter at 25 ◦C than at 16 ◦C, and 1.3-fold shorter a 20 ◦C than at 16 ◦C [13].
C. elegans larvae sense the concentration of E. coli bacteria, with severe eﬀect on their
development time [49]. Under-fed worms can reach adulthood in twice the time it takes
for normally-fed worms at the same temperature conditions [81]. Severe underfeeding
conditions may even lead to a non-physiological development of the organism. On the
other hand, overfeeding of wild type C. elegans may reduce their lifespan by 10-20% [82]
and long-term overfeeding may eventually result in bacterial accumulation in the worm’s
mouth and intestine, leading to a diseased state [81], [83]. Moreover, the combination of
temperature and feeding amount has important eﬀects on C. elegans development and
life-span. Low temperature and dietary restriction activate C. elegans pathways that shift
physiology towards cell protection and maintenance, leading to a slower development
and eventually to a longer life-span [80], [84]. However, interestingly, also exposure to
high temperature, e.g. 25 ◦C, if combined with food deprivation and crowding during
the larval development, may arrest the development or reversibly shift it towards a
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long-lasting state of diapause called dauer stage [85], [86].
A precise dose-dependent characterization of the eﬀect of doxycycline on C. elegans, with
full control of the experimental parameters, namely temperature and feeding, is hence
essential to provide rigorous culture conditions, but is currently lacking. The possibility
to parallelize and automatize the experiments promotes microﬂuidic platforms as the
most eﬃcient tool to enable such a systematic characterization. Most of the experimental
repertoire was obtained from traditional C. elegans cultures on solid medium, where the
food amount is not quantiﬁed but is usually abundant [13]. Finding the right feeding
protocol in liquid conditions that are corresponding to culture on solid agar plates is
not straightforward and requires optimization. However, such characterization is of
primary importance for performing reproducible experiments and comparing the results,
to disentangle any variation of food concentration and temperature from the tested drug
response. Moreover, after performing a DoE analysis using controlled liquid media to
culture worms, the correct drug dose that has to be used to achieve the desired outcome
can be predicted, therefore avoiding either side eﬀects due to over-dosage or ineﬀective
treatments due to a sub-optimal drug concentration.
In this study, I investigated the role of doxycycline on C. elegans development, combined
with variations of temperature and concentration of E. coli as food source in a microﬂuidic
platform. A 3-factor Doehlert DoE was chosen to characterize the eﬀect of those 3 factors
on the worm development. A microﬂuidic chip enclosed in a custom-made thermal
incubator was designed, to culture C. elegans larvae with full control of the experimental
parameters, especially temperature and injected food amount. The results revealed the
relative importance of temperature, food concentration and doxycycline dose on the
C. elegans development time. In particular, while doxycycline dose and temperature
exerted a signiﬁcant severe eﬀect on the duration of the larval development, no signiﬁcant
development dependence on the E. coli concentration in the investigated range was found.
4.2 A 3-factors Doehlert experimental design and mathe-
matical model
The factors under consideration were temperature (X1), concentration of E. coli used
as nutrient (X2) and concentration of doxycycline (X3). Temperature was considered
in the range 15-25 ◦C, known as characteristic range for C. elegans survival [13]. The
E. coli concentration was considered in the range 2-6 × 109 cell/mL, as values in this
range were previously used to culture C. elegans worms in microﬂuidic chips [19]. Finally,
given the doxycycline concentrations used in the previously reported experiments, the
range 5-60 μg/mL was chosen for this third factor. The response (Y ) was identiﬁed as
the duration of the larval development, expressed in hours, from the stage L1 until the
onset of adulthood and production of the ﬁrst progeny. The application of a factorial
3-factor Doehlert design was well-suited to characterize the synergic eﬀect of temperature,
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X1  
Temperature
X3
[Doxycycline]
X1  
Temperature
X2
[E.coli]
Figure 4.2 – Representation of the factorial combinations in the experimental space, accord-
ing to a 3-factor Doehlert design. 13 points are uniformly distributed in the experimental
domain. X1, X2, X3 represent respectively temperature, concentration of E. coli bacteria
and concentration of doxycycline. The center point is the center of the interval for the three
variables, therefore describing an experiment performed at a temperature of 20 ◦C, with an
E. coli concentration of 4 × 109 cell/mL and a doxycycline concentration of 32.5 μg/mL.
concentration of E. coli and doxycycline on the larval development, as it oﬀers a uniform
distribution of points in the experimental domain. With k being the number of factors,
the Doehlert design requires k2 + k + 1 number of experiments, 13 in our 3-factor case.
These 13 combinations can be geometrically positioned in the experimental space as the
vertices of a cubo-octahedral, as represented in Figure 4.2. The coordinates used in the
DoE model, called coded values, as well as the corresponding real experimental values
of temperature, E. coli concentration and doxycycline concentration, are given in the
model matrix in Table 4.1. Typically a coded value 1 corresponds to the highest value
of an experimental parameter, -1 to the lowest value and 0 to the linearly-extrapolated
center point.
Experiments corresponding to the central point [0, 0, 0] were performed three times, to
test their repeatability. In order to describe the development time Y as a function of the
factors, a quadratic polynomial model was constructed, as described by the Equation
4.1:
yˆ = b0+b1X1+b2X2+b3X3+b11X21+b22X22+b33X23+b12X1X2+b13X1X3+b23X2X3 (4.1)
This model not only considers the linear factors, but also their interactions, X1X2, X2X3
and X1X3 and their quadratic contributions X21 , X22 and X23 to the response. The
validity of the quadratic model is conﬁrmed a posteriori (vide infra). The model matrix
containing also the interactions and quadratic values of the factors is presented in Table
4.2.
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N Coded values Experimental parameter values
X1 X2 X3 Temperature [E. coli] [Doxycycline]
◦C × 109 cell/mL μg/mL
1 0 0 0 20 4 32.5
2 1 0 0 25 4 32.5
3 0.5 0.866 0 22.5 5.73 32.5
4 0.5 0.289 0.816 22.5 4.58 54.96
5 -1 0 0 15 4 32.5
6 -0.5 -0.866 0 17.5 2.27 32.5
7 -0.5 -0.289 -0.816 17.5 3.42 10.03
8 0.5 -0.866 0 22.5 2.27 32.5
9 0.5 -0.289 -0.816 22.5 3.42 10.03
10 -0.5 0.866 0 17.5 5.73 32.5
11 0 0.577 -0.816 20 5.15 10.03
12 -0.5 0.289 0.816 17.5 4.58 54.96
13 0 -0.577 0.816 20 2.85 54.96
Table 4.1 – Coded values and corresponding values of the experimental parameters temper-
ature (X1), E. coli concentration (X2) and doxycycline concentration (X3).
N I X1 X2 X3 X1X2 X1X3 X2X3 X21 X22 X23
1 1 0 0 0 0 0 0 0 0 0
2 1 1 0 0 0 0 0 1 0 0
3 1 0.5 0.866 0 0.433 0 0 0.25 0.749 0
4 1 0.5 0.289 0.816 0.144 0.408 0.235 0.25 0.083 0.665
5 1 -1 0 0 0 0 0 1 0 0
6 1 -0.5 -0.866 0 0.433 0 0 0.25 0.749 0
7 1 -0.5 -0.289 -0.816 0.144 0.408 0.235 0.25 0.083 0.665
8 1 0.5 -0.866 0 -0.433 0 0 0.25 0.749 0
9 1 0.5 -0.289 -0.816 -0.144 -0.408 0.235 0.25 0.083 0.665
10 1 -0.5 0.866 0 -0.433 0 0 0.25 0.749 0
11 1 0 0.577 -0.816 0 0 -0.470 0 0.332 0.665
12 1 -0.5 0.289 0.816 -0.144 -0.408 0.235 0.25 0.083 0.665
13 1 0 -0.577 0.816 0 0 -0.470 0 0.332 0.665
Table 4.2 – Full model matrix of coded values of the experimental parameters temperature
(X1), E. coli concentration (X2) and doxycycline concentration (X3), their interactions and
quadratic values.
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4.3 Design and fabrication of the microﬂuidic chip for con-
trolled C. elegans culture and analysis
In order to test the 13 combinations of the three factors that contribute to the experimental
variability and to unravel the inﬂuence on the DoE study, a microﬂuidic chip dedicated
to the on-chip culture of C. elegans throughout its larval development was designed
and fabricated in PDMS and glass, following the fabrication steps described in Chapter
2. In fact, compared to heaviliy manual and laborious traditional C. elegans culture
protocols [13], microﬂuidics enables automated, more robust and reproducible culture
experiments [19], [20], [43]. By matching the channels’ dimension with the worm size,
C. elegans larvae of the desired stage can be automatically ﬁltered and the population
can consequently be synchronized [47]. Moreover, by using dedicated syringe pumps, the
feeding protocol can be ﬁrst optimized and standardized, and then repeatedly executed
in an automated way.
The design of our microﬂuidic device is shown in Figure 4.3a. The chip features 8
independent channels. The heigth of the microﬂuidic chambers and channels is 80 μm.
Each channel is an array of 6 chambers separated by ﬁlters, to culture isolated worms
and preserve their identity (Figure 4.3b). The 5 μm-feature ﬁlters are designed to prevent
the uncontrolled passage of L1 larvae to the adjacent chamber, as shown in the optical
micrograph in Figure 4.3c. For feeding the worms and for exposing them to drugs, plastic
reservoirs are ﬁlled with a suspension of E. coli bacteria in S medium, containing the
antibiotic doxycycline.
4.3.1 Experimental set up
The microﬂuidic setup was integrated in a stereo microscope (SteREO Discovery.V8,
Zeiss, Germany) equipped with a camera. A thermal incubator system was designed
and manufactured, to set and maintain a ﬁxed temperature on the chip and in the
reservoirs that contain the bacteria feeding solutions (Figure 4.3d). The incubator box
was made in extruded polystyrene. The top and the bottom of the incubator box featured
a transparent PMMA window to allow for microscopy observation of the chip inside. The
incubator was ﬁxed to a xy motorized stage (Standa, Lithuania). A schematic of the
electronic set up placed inside the polystyrene box is given in Figure 4.4. A temperature
sensor (AD22100, Analog Devices, US) was placed in contact with the glass side of
the chip for monitoring the temperature of the microﬂuidic device. The temperature
signal was exploited to set the power provided to a Peltier thermoelectric module in a
closed-loop conﬁguration, for active control and constant monitoring of the temperature
experienced by the worms inside the chip. An Arduino microcontroller board (Arduino
UNO, Ivrea, Italy) was used to read the signal from the temperature sensor and set
the power to the Peltier thermoelectric module, in a proportional integral derivative
(PID) closed-loop conﬁguration. Generally, a PID controller reads the sensor signal and
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Figure 4.3 – Overview of the microﬂuidic-based platform for controlled C. elegans culture
and DoE analysis. a) Schematic of the microﬂuidic device. The chip consists of 8 channels,
each provided with one inlet and one outlet. The channels are independent and up to 8
conditions can therefore be tested at the same temperature in parallel. Each channel is an
array of 6 chambers separated by 5 μm-feature ﬁlters. Scale bar = 2.5 mm. b) Zoom of
a culture chamber, delimited at the entrance and exit by the ﬁlters, the size of which is
designed in such a way that L1 larvae can pass through only under high ﬂow condition. Scale
bar = 200 μm. c) Picture of a single culture chamber containing a L1, whose maximum
diameter is larger than the ﬁlter size. Scale bar = 200 μm. d) Representative schematic of
the inside of the thermal incubator. The microﬂuidic chip (i) is placed inside the insulating
box (ii). The reservoirs, the tubings connecting the chip with the reservoirs and with the
microﬂuidic pumps outside the box are not represented here. The box features a top and
bottom polymethylmethacrylate (PMMA) window, and is placed on a motorized xy stage
(iii). A thermoelectric module is ﬁxed on the side of the box (iv) and is used to set the
temperature that the worms experience inside the microﬂuidic chip.
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Power 
supply
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Integrated 
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Temperature 
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board
Temperature 
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Figure 4.4 – Schematic of the electric circuit designed to control the temperature into
the thermal incubator. According to the signal measured by a temperature sensor, a
microcontroller sets the power given to an H-bridge connected to a Peltier cell, in a closed-
loop proportional integral derivative (PID) conﬁguration. The temperature set-point can be
adjusted by the user through two dedicated buttons, and is displayed on a LCD with the
actual measured temperature.
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computes the desired output by calculating and summing the proportional, integral and
derivative responses. The output control signal u(t) can be therefore deﬁned by Equation
4.2:
u(t) = Kpe(t) + Ki
∫ t
t0
e(t) dt + Kd
de(t)
dt
(4.2)
Kp, Ki and Kd are respectively the gains of the proportional, integral and derivative
components. e(t) is the the diﬀerence between the set-point value and the output signal.
The proportional, integral and derivative gains were tuned using the open-loop step
response method by Ziegler and Nichols [87] and were then experimentally optimized.
After calculating the three gains, the PID control operations were committed to a
dedicated Arduino library. The electric circuit was provided with an integrated H-bridge
(BTS 7960B, Inﬁneon technologies, Germany), to change the direction of the current
depending on the heating or cooling mode of the Peltier element. The default value of
the set-point, 20 ◦C, could be increased or decreased by 0.5 ◦C by the user, pressing two
dedicated buttons. The temperature set-point and the actual temperature were displayed
on a LCD.
The microﬂuidic operations were controlled using a Kloehn pump (Norgren Kloehn, US)
and Micromanager microscopy software. The acquisition system was programmed so
that brightﬁeld pictures were taken every 20 min of each chamber.
4.4 Eﬀect of temperature, food amount and drug dose
within the chosen experimental range
The larval development was monitored for each C. elegans worm in the chamber array,
following the experimental protocol described in Section 4.5.1. In all the 13 conditions
that I tested, the worms completed their development. All the larval stages (L1, L2,
L3 and L4) were observed, as well as the YA stage and adult (A), with the production
of progeny in the microﬂuidic chamber (Figure 4.5). The image stacks generated by
combining all images of a given chamber over time were processed in order to measure
the duration of the larval development. Completion of the latter was identiﬁed by
observation of the ﬁrst progeny production, i.e. eggs being laid in the chamber. For each
experimental condition, the readout was obtained by averaging the development time
of all the investigated animals. The experimental development times can be considered
as the components of a vector and are shown in the left column of Table 4.3). From
these results, I calculated the coeﬃcients of the quadratic polynomial model in Equation
4.1 (Table 4.4). Afterwards, the components of the theoretical development time were
calculated based on the best ﬁt as well, as shown in the right column of Table 4.3.
The interpolated data obtained from the model showed excellent ﬁtting with the
experimentally measured values, as shown in Figure 4.6. This conﬁrms that choosing a
quadratic model was a correct assumption, as this model accounts for the recorded data.
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L1 L2 L3
L4 YA A, Embryos
Figure 4.5 – Illustration of the time-lapse brightﬁeld imaging, here shown only for one
worm, enabled for each chamber of each chip array during the larval development. The
worms completed their development, from the larval stage L1 until adulthood and ﬁrst
progeny production. Scale bar = 300 μm.
Experimental development time Y Interpolated values of development time
as given by Equation 4.1
[h] [h]
average ± SD (N) yˆ
1 95.8 ± 2.8 (11+13+12) 95.8
2 80.9 ± 2.6 (12) 80
3 89.8 ± 3.7 (13) 89.2
4 103.3 ± 2.4 (12) 104.7
5 115 ± 3.5(14) 115.8
6 109 ± 2.7 (12) 109.6
7 80.5 ± 2.2 (14) 79.1
8 92.4 ± 1.6 (12) 90.9
9 63.5 ± 3.3 (13) 65.7
10 104.9 ± 3.4 (14) 106.3
11 66.3 ± 4.1 (12) 65.4
12 129.3 ± 4 (13) 127.1
13 110.6 ± 2.3 (14) 111.4
Table 4.3 – Averaged experimental results (average ± SD, with the number of animals
tested N in brackets) and interpolated values obtained for the diﬀerent conditions determined
by the Doehlert design.
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b0 b1 b2 b3 b12 b13 b23 b11 b22 b33
95.861 -17.8661 -1.451 27.163 0.914 -5.893 8.588 2.097 3.577 -6.789
Table 4.4 – Coeﬃcients of the quadratic polynomial model in Equation 4.1.
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Figure 4.6 – Scatterplot of the experimental data and the results obtained from the
quadratc model. The development time obtained from the polynomial model agrees with
the experimental results, as also quantiﬁed by a correlation coeﬃcient R2 of 0.995 and a
coeﬃcient of determination of R2adj of 0.981.
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Sum of Square DoF Mean Square F p-value
X1 1276.79 1 1276.79 178.56 0.000905
X2 8.43 1 8.43 1.17 0.356937
X3 2947.96 1 2947.96 412.27 0.000261
X1X2 0.62 1 0.62 0.08 0.786475
X1X3 20.81 1 20.81 2.91 0.186533
X2X3 44.23 1 44.23 6.18 0.088702
X21 2.93 1 2.93 0.41 0.567483
X22 8.53 1 8.53 1.19 0.354517
X23 32.46 1 32.46 4.53 0.122926
error 21.45 3 7.15 1 0.5
Table 4.5 – Analysis of variance for the experimental development time (DoF: degree of
freedom, F: Fisher ratio).
In order to determine the validity of the quadratic polynomial model in relation to the
experimental data, the Analysis of Variance (ANOVA) was performed, too. The results
are presented in Table 4.5. The analysis of the Sum of Squares (SS) and the Mean
Square (MS) values, both giving information about the total variance of the observation,
revealed that X1 and X3, respectively temperature and doxycycline concentration, had
an eﬀect on the larval development time, as their SS and MS are more than 100 times
larger than the SS and MS of the error. A more detailed description of the ANOVA
terms is given in Subsection 4.5.4.
These considerations are also supported by the analysis of the p-values. In fact, high
signiﬁcance was observed for X1 and X3. Interestingly, the second order interactions
between the factors did not have a signiﬁcant eﬀect on the larval development time. The
overall p-value of the model, computed as 0.00258, conﬁrmed the high accuracy of the
quadratic polynomial model, as conﬁrmed by the coeﬃcient of determination R2adj .
The results obtained for the 13 tested conditions were then compared by grouping
them according to the doxycycline dose used and in an increasing temperature-wise
order (Figure 4.7). Moreover, in order to appreciate the eﬀect of the 3 factors on
the worm development in a more comprehensive fashion, the response was color-coded
and represented in the experimental space by interpolating the diﬀerent experimental
conditions from Equation 4.1 (Figure 4.7d). This representation enables to determine the
interpolated development time that would be obtained if diﬀerent values for the 3 factors
would have been taken, beside the chosen 13 in Table 4.1, therefore allowing predicting
the process behavior within the full investigated experimental domain.
The shortest development time was obtained when worms were treated with the lowest
dose of doxycycline and at high temperature (Figure 4.7a and dark blue area in Figure
4.7d). By comparing the development time in Figure 4.7a, b and c, a progressively
dramatic increase in the development time can be observed in correspondence of increasing
amount of doxycycline. In particular, the longest development time was obtained upon
treatment with the highest doxycycline dose and at the lowest temperature (Figure 4.7c
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and yellow area in Figure 4.7d). In contrast to the roles of temperature and doxycycline,
the developmental delay is not feeding-dependent for the used concentrations of bacteria.
Similarly, in the color-coded representation of development time in Figure 4.7d, points
corresponding to the same development time are described by diﬀerent coordinates
along the [E. coli] axis, conﬁrming that food amount does not alter the duration of the
development. Moreover, for a few experimental runs, development times showing no
signiﬁcant diﬀerence (p-value > 0.05, see Table 4.6) were obtained. This occurred when
in pairs of independent experiments (run 6-run 10, run 8-run 3 ) worms were exposed to
the same amount of doxycycline, the same temperature and double E. coli concentrations,
conﬁrming that feeding - in the considered range of bacterial contentrations – does not
play a signiﬁcant role. Moreover, development times not statistically diﬀerent were
obtained also when worms were treated either with a low doxycycline dose at a low
temperature level or with higher doxycycline dose at a higher temperature (run 7-run 2,
run 6-run 13, run 10-run 4). This ﬁnding suggests that the eﬀect of the high temperature
can counterbalance the impact of a strong antibiotic concentration.
These ﬁndings were supported by the isosurface-response representation shown in Figure
4.8, where experimental points corresponding to the same larval development time lay
on the same surface. Interestingly, this representation allows ﬁnding all the possible
combinations of temperature, E. coli concentration and doxycycline concentration that
must be used to achieve a desired eﬀect on the larval development time.
4.5 Materials and methods
4.5.1 Microﬂuidic experimental protocol
Initially, after sterilization by injection of ethanol 70%, the microﬂuidic chip was ﬁlled
with S medium. L1 worms were harvested from the culture plate and suspended in
S medium. Afterwards, they were injected into each channel from the corresponding
inlet and distributed along the array by applying 1 s ﬂow pulses of 2 μL inﬂow, to let
the PDMS ﬁlters expand and the L1 pass through, as described in [78]. A uniform
distribution of the larvae over the array was consistently obtained, conﬁning worms in
separate chambers along each microﬂuidic line. Doing so, overcrowding was prevented
and a proper worm growth was ensured. Typically, 1 to 3 worms get conﬁned in each
chamber, with about 15% of empty chambers and about 65% of the chambers containing 1
isolated worm. Each channel was then perfused with a ﬂow of E. coli bacteria suspended
in S medium, containing also the antibiotic doxycycline. The feeding protocol consisted
of injecting 8 μL of bacterial solution at a ﬂow rate of 100 nL/s, every 30 min. Depending
on the temperature condition, diﬀerent concentrations of E. coli and doxycycline were
used, according to the combinations listed in Table 4.1. For example, the runs 3, 4, 8
and 9 were performed simultaneously, at a set temperature of 22.5 ◦C.
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Figure 4.7 – Eﬀect of temperature, E. coli concentration and doxycycline dose on the
development time, in the range considered by our DoE experiments. Eﬀect of temperature on
the development time with doxycycline concentration of a) 10 μg/mL, b) 32.5 μg/mL and c)
54.96 μg/mL. Cn indicates the bacterial concentration (n × 109 cell/mL). Bars are expressed
as average ± SD. d) Color-coded representation of the interpolated development time values
Y . The vertical plane corresponding to X1=-0.9 was arbitrarily chosen for approppriate
visualization of the response at low-temperature conditions.
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Figure 4.8 – Iso-surfaces representation of the normalized interpolated larval development
time as a function of temperature, E. coli concentration and doxycycline concentration.
The response is re-scaled between 0 and 1, so that these values represent the minimum and
maximum development duration respectively. The factors are considered in their coded
values (see Table 4.1).
4.5.2 C. elegans experimental model and subject detail
C. elegans strain was cultured at 20 ◦C on NGM 90 mm Petri dishes seeded with E. coli
strain OP50. The strain used in this study was the N2, provided by the Caenorhabditis
Genetics Center (University of Minnesota). Before starting the experiments, the plates
were washed with S medium and L1 were harvested.
4.5.3 E. coli culture
HT115 E. coli bacteria were grown in LB with 100 μg/mL ampicillin and 12.5 μg/mL
tetracycline overnight in a thermal shaker at 37 ◦C. The following day, 50 μL of the
conﬂuent bacterial cultures were used to inoculate freshly prepared LB medium containing
only ampicillin. The new cultures were grown until reaching an optical density between
0.6 and 0.8, and 90 μL were used for seeding the experimental plates. After the overnight
culture, 50 mL of the bacterial cultures were centrifuged to remove LB; in this way,
bacteria samples with the desired optical density were obtained by adding S medium
accordingly. The concentration of each bacterial solution was measured using a commercial
spectrophotometer (WPA CO8000, Biochrom, UK).
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Figure 4.9 – Quantile-quantile plot of the quantiles of the sample data (i.e. DoE 13
experimental runs) versus normal distribution of the sample. The theoretical quantiles values
from a normal distribution. The approximately straight lines indicate that the distribution
of our sample is normal.
4.5.4 Quantiﬁcation and statistical analysis
The validity of the quadratic polynomial model in relation to the experimental data was
assessed upon the ANOVA, performed using a built-in Matlab function. The average
value of each of the 13 conditions was used. The normality of the data distribution in
each dataset was assessed by using the Matlab built-in function to display the quantiles of
the sample and the theoretical quantiles from a normal distribution in a quantile-quantile
plot (see Figure 4.9). For each experimental run, the dataset was obtained from worms
uniformly distributed along 2 channels of the same chip. The sample number N indicates
the number of independent biological samples for each experimental run. Statistical
signiﬁcance was determined with a 2-way ANOVA with Tukey correction for multiple
comparisons using GraphPad Prism.
ANOVA is used to determine the validity of the model in relation to experimental data.
The coeﬃcients of the model are related to the factors targeted by the set of experiments
and are then varied during the experiments. The residue is due to unidentiﬁed factors
that are not controlled and thus have changed during the experiments.
For each factor, the total variance of the observations is given by the total SS , which is
the sum of squares of the deviations of all the observation yi from their mean ym. SS
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1 2 3 4 5 6 7 8 9 10 11 12 13
1 - ** ** ** ** ** ** 0.4644 ** ** ** ** **
2 - ** ** ** ** 0.999 ** ** ** ** ** **
3 - ** ** ** ** 0.7438 ** ** ** ** **
4 - ** ** ** ** ** 0.9893 ** ** **
5 - ** ** ** ** ** ** ** *
6 - ** ** ** 0.0682 ** ** 0.9912
7 - ** ** ** ** ** **
8 - ** ** ** ** **
9 - ** 0.6262 ** **
10 - ** ** **
11 - ** **
12 - **
13 -
Table 4.6 – Adjusted p-values from 2-way ANOVA test with Tukey correction for multiple
comparisons. p-values were graphically reported as * p ≤ 0.05, ** p ≤ 0.01.
can therefore be quantiﬁed as in Equation 4.3
SS =
n∑
i=1
(yi − ym)2. (4.3)
The Degree of Freedom (DoF) represents for each factor the number of values (or
levels) that are free to vary in one experiment. Having chosen here a Doehlert design
of experiment, each factor assumes a precise value in each experiment. Therefore, the
number of DoF for each factor is 1.
MS , gives information about the total variance of the observations taking into account
the DoF. It is therefore deﬁned as MS = SS/DoF .
For each factor, the Fisher ratio (F) is the ratio between the MS and the MS of the
error, or residue. The p-value is the probability to obtain a given F by chance. The
smaller the p-value, the higher is the signiﬁcance of the considered factor. The standard
criteria for accepting a factor as signiﬁcant is typically p < 0.05.
The p-values, adjusted according to Tukey correction, are displayed in Table 4.6.
4.6 Discussion and conclusion
In this study, I used a DoE approach to characterize the eﬀect of temperature, con-
centration of E. coli and dose of doxycycline antibiotic on the duration of the larval
development of the nematode C. elegans. In particular, a Doehlert design was chosen to
characterize the eﬀect of those 3 factors on the worm development. A microﬂuidic chip
enclosed in a custom-made thermal incubator, was designed to culture C. elegans larvae
with full control of the experimental parameters.
72
4.6. Discussion and conclusion
Our results conﬁrmed the severe dose-dependent eﬀect of doxycycline on the duration
of the larval development, making the concentration of doxycycline the major player
(p-value = 0.000261). Indeed, worms treated with the highest doxycycline dose (54.96
μg/mL) took about 65% more time to develop, compared to worms treated with the
lowest dose (10 μg/mL) at the same temperature. A milder but highly-signiﬁcant eﬀect
(p-value = 0.000905) on the larval development was induced by temperature. In fact,
worms cultured at 15 ◦C took 42% more time to develop than the ones cultured at 25 ◦C
and treated with the same doxycycline dose.
On the other hand, the food concentration did not aﬀect the larval development time.
This ﬁnding allows us to conclude that E. coli concentrations in the range 2-6 × 109
cell/mL can be alternatively safely used in microﬂuidic culture protocols, without signiﬁ-
cantly aﬀecting the development time. This range could be considered as appropriate
feeding range for microﬂuidic cultures, as it prevented either underfeeding or bacterial
gut invasion.
The DoE approach has established a mathematical relationship between the larval de-
velopment time and culture temperature, food concentration and drug dose, requiring
only 13 well-designed experiments to characterize the eﬀectiveness of the drug, as well
as the inﬂuence of all the considered experimental factors on the treatment outcome.
When performing the experiments, 3, 5 or 7 diﬀerent levels (values) were varied of
each factor over the 13 experiments (see Table 4.1). On the other hand, according to
the standard one-factor-at-a-time approach, where only one factor is changed and the
outcome is not interpolated over the full breadth of the experimental space, to explore
the full combinations of three factors, each assuming 3, 5 and 7 levels (Table 4.1), 105
(3×5×7) experiments would have been necessary. At the same "experimental" cost (13
experiments), the standard approach would have allowed only about 2 levels for each
factor, providing therefore very limited information on the control of the development
time. Practically, as the ﬁtted polynomial then allows for the interpolation of any point in
the considered experimental range with a very limited error, this allows for the continuous
exploration of the experimental setting, and the identiﬁcation of a possible ideal operation
point.
The analysis showed that there are only limited interactions between the diﬀerent factors.
It is worth to notice, however, that the ANOVA showed a p-value of 0.088 for the
interaction between food amount and doxycycline dose. This p-value is too high to
indicate a relevant impact, but is the third lowest recorded in the analysis. This may
hint that there may be some interactions beyond the boundaries of the experimental
space that I considered here. Indeed, a higher dose of doxycycline, which is an antibiotic,
might damage or kill the bacteria and make them less nutritious for the worms, possibly
aﬀecting their life-cycle. This ﬁne contribution would have been impossible to observe
with a standard experimental approach, thus highlighting the relevance of the DoE and
the quadratic ﬁtting.
Moreover, such a DoE approach allowed predicting the process behavior in the experimen-
tal space, by revealing the drug eﬀect even upon additional combinations of experimental
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factors, not limiting the study to the 13 tested conditions. The use of a DoE approach
would therefore tremendously increase the eﬃciency of a drug screening process, by mini-
mizing the use of the resources – and therefore costs – while maximizing the knowledge
of the process.
In this endeavor, the use of microﬂuidic platforms represents a crucial step towards
the standardization and the optimization of the drug testing protocols based on the
use of small model organisms such as C. elegans. Thanks to our microﬂuidic platform,
I automatized the C. elegans culture and delivered the drug doxycycline in a precise
spatio-temporal way. Moreover, our microﬂuidic device enabled reducing the overall drug
testing time, by parallelizing the experiments. In fact, not only multiple animals were
simultaneously exposed to the same compound, but also multiple conditions were tested
in parallel within independent channels of the same device.
4.7 Future outlook
Continuous longitudinal monitoring throughout the entire larval development was per-
formed and other phenotypes of interest could be extracted in future via image processing.
Such a systematic drug dose test, following the principles of a DoE approach, would
have high added value to predict the optimal conditions to eventually use in follow-up
targeted drug experiments. A factorization approach will be instrumental in ensuring the
drug eﬀectiveness and disentangle its eﬀect from any undesired eﬀects of other possible
contributors.
In order to deepen the understanding of the drug eﬀect on C. elegans, other phenotypic
read-outs could be considered besides the development time. In fact, by using the same
microscopy set up and the same microﬂuidic device, one could also measure the eﬀect
of doxycycline on the worms size or on the ﬂuorescent expression of a gene of interest,
similarly to what I described in Chapter 3.
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Abstract Envisioning a microﬂuidic platform where C. elegans feeding is fully controlled
and food consumption is quantiﬁed as additional phenotype, in this Chapter I describe a
method to measure the absorbance of solutions of planktonic E. coli bacteria in a microﬂu-
idic chip. The latter consists of two independent micro-chambers, one used to measure the
concentration of the bacterial solution, the other used for a reference measurement. Each
chamber is placed in between a light emitting diode and a photodiode, to simultaneously
measure the light transmittance across each chamber, from which the absorbance of the
bacterial solution is calculated by applying Lambert-Beer’s law. I calibrated the device
and obtained a linear relation between the absorbance and the concentration of the
injected solutions. Afterwards, to assess the turbidity of the solution on the long-term,
the on-chip absorbance was monitored over 10 h in absence of ﬂow: the absorbance
dropped after 1 h, revealing that the solution became more optically-transparent than
expected, and this in a concentration-dependent fashion. These results can be understood
by the phenomena of bacterial settling and aggregation, which were further investigated
by video microscopy. I hypothesized a simple mathematical model for the over-time
change of absorbance, according to which, bacterial settling and aggregation were shown
to aﬀect absorbance measurements of the solutions.
This chapter is an adapted version of the following publications:
• M. C. Letizia, P. G. Testa and M. A. M. Gijs, "Monitoring bacterial concentrations
in micro-chambers by optical absorbance measurements", Manuscript in preparation.
• M. C. Letizia, P. G. Testa and M. A. M. Gijs, "Bacterial feeding control system for
on-chip culture of the nematode Caenorhabditis elegans". Proc. of 21th International
Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS
2017), Savannah, Georgia, US, 2017.
Poster presentation.
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• M. C. Letizia and M. A. M. Gijs, "Accurate quantiﬁcation of bacteria concentra-
tion as a nutrient for C. elegans worm culture on chip", 19th Edition of Nano Bio
Tech, Montreux, Switzerland, 2015.
Oral and poster presentation
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5.1. Introduction
5.1 Introduction
Bacteria are of great interest in the ﬁelds of medicine, microbiology, and ecology. A
major reason for their success in nature is that they multiply at extraordinary rates
when food is available, and can switch easily from a mobile planktonic state to a colonial
bioﬁlm state for optimum species survival. Bacteria were not only used as a model
organism to investigate phenomena involved in surface colonization and bioﬁlm formation
[88], [89], but also several behaviours related to their planktonic state were investigated
[90]–[93]. In this frame, diverse aspects of microbial insight received interest, such as
the eﬀect of bacterial motion on mixing or transport of particles [94], the eﬀect of ﬂow
on nutrient uptake and encounter rate of bacteria [95], [96], or their interaction with
boundaries and surfaces [97]–[99]. The ways bacterial cells interact with each other via
chemical signalling pathways, such as quorum sensing or virus-host interaction, were
investigated too [100]. The bacterial resistance to antimicrobial compounds is being
of great interest as well, as it increasingly aﬀects both human and wildlife populations
[101], [102]. Indeed, in applications such as waste-water treatment, medicine, seawater
desalinization or production of biofuels, the quantiﬁcation of the amount of planktonic
microbes in the region of interest is of crucial importance [103]. In fact, the majority
of the experimental outcomes depends crucially on the bacterial amount/concentration,
which is therefore a very important parameter that should always be determined.
Microﬂuidics facilitated research about bacterial cultures [103]. Microﬂuidic chips usually
are optically transparent, therefore enabling direct and quantitative observation of the
bacteria behaviour via microscopy. Environmental cues can be mimicked in microﬂuidic
chips, where chemo- and thermo-gradients can be generated in an accurate and ﬂexible
way [104]. Controlled ﬂows and shear rates can be advantageously applied to bacteria to
assess the eﬀect of ﬂow on their behaviour [105], [106]. Microﬂuidics was also used to
study surface interactions, by dedicated chip areal micro-patterning and by tuning of
the hydrodynamic parameters [107]–[109]. Interestingly, many papers reported attempts
to monitor the growth of bacterial colonies and quantify their concentration [103]. In
particular, bacteria and yeast cells were cultured in precise chemostatic and thermostatic
conditions; the growth of the colony was monitored over time, by taking ﬂuorescent
pictures, from which the bacterial number was assessed as ratio between total ﬂuorescent
area and the background [110]. Others fabricated a microﬂuidic bioreactor for long-term
culture of E. coli bacteria and monitored the colony growth by processing brightﬁeld
images and counting the number of isolated bacteria in the micro-chamber [111]. Similarly,
the bacterial growth was monitored in a microﬂuidic chip by real-time counting the
number of bacteria in a known volume at regular time intervals by brightﬁeld microscopy
[112]. Considered this state of the art about microﬂuidic bioreactors, the quantiﬁcation
of planktonic bacterial concentration and growth in a microﬂuidic chip is currently
mostly based on bacterial counting – manual or automated – starting from ﬂuorescence
or brightﬁeld pictures. This is indeed accurate, but presents many drawbacks: ﬁrst,
especially when performed manually, bacteria counting is time-consuming and error-
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prone, and cannot be executed in a continuous and real-time fashion; second, such a
quantiﬁcation requires complex equipment dedicated to optical and ﬂuorescent microscopy.
For applications focused on cell detection rather than bacterial culture, more sophisticated
and automated approaches for cell counting have been developed [113]–[116]. These
studies rely on the Coulter principle and exploit the non-conductivity of bacterial cells: a
bacterium passing through an aperture, concurrent with an electric current, produces an
impedance change proportional to its size. Dedicated microﬂuidic chips were therefore
designed, all featuring a small sensing channel or a constriction allowing the passage of a
single cell. This technology allowed detecting single bacteria in an automated way, even
when high ﬂow rates were applied. However, these microﬂuidic devices do not represent
the best solution for long-term experiments, as the continuous ﬂow of bacteria through
an aperture of a few μm might lead to the formation of bioﬁlms and eventually chip
clogging [117].
A signiﬁcant improvement in the state of the art was shown by Jakiela et al. [118]. They
exploited droplet microﬂuidics principles to compartmentalize bacterial cells and nutrient
in microdroplets, creating in this way many parallel chemostats. The growth of the
colony was monitored by periodically measuring its absorbance in a 5 mm-thick on-chip
optical path, using an external commercial spectrophotometer coupled with a waveguide.
However, this approach required a relatively-complex ﬂuidic design and the use of multiple
valves. Moreover, such droplet-based measurements are not representative of the dynamic
behavior of bacteria in a three-dimensional and gas-permeable micro-chamber. Jung et al.
[119] monitored the growth of bacteria microcolonies spotted on a container eventually
sealed with a CMOS chip for direct real-time observation. Such a system, however, is
limited by the recommended cellular density in the 10-100 cell/cm2 range and, similarly
to the previous example, prevents gas and media exchange. Interestingly, Meyer et
al. developed a bench microﬂuidic reactor to probe the role of quorum sensing in the
formation of bioﬁlms by measuring their optical absorbance [120]. To this purpose, a
simple straight microﬂuidic channel was fabricated and inoculated with E. coli bacteria.
An array of light emitting diode (LED) illuminated the channel and the absorbance was
measured in two diﬀerent points of the channel, each provided with a photodiode (PD).
Similarly, Kim et al. monitored bioﬁlms using LEDs and a charge-coupled device camera,
upon treatment with antibiotic and electric current [121]. This approach resembled the
measurement of the optical density (OD) performed by commercial spectrophotometers.
However, unlike spectrophotometers, the absorbance signal that was measured was not
compared to a reference signal provided by a transparent solution, which is a prerequisite
for accurate and noise-free absorbance and optical density measurements.
In this Chapter, I present a method to measure the optical absorbance of solutions of
planktonic E. coli bacteria. I designed an opto-electronic device that was integrated and
optically aligned to a microﬂuidic chip, as sketched in Figure 5.1. The latter consists
of two identical independent micro-chambers, one used to measure the concentration of
the bacterial solution, the other used for a reference measurement. Each chamber has a
volume of 7.2 μL and functionally replaces a 1 mL cuvette, as traditionally used in most
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Figure 5.1 – Schematic of the quantiﬁcation of bacterial concentration in a microﬂuidic
chamber.
of the commercial spectrophotometers, thereby considerably reducing the required sample
volume. Each chamber was placed in between a LED and a PD, conveniently designed
to simultaneously measure the light transmittance across each chamber, from which
the absorbance of a bacterial solution was calculated according to the Lambert-Beer’s
law. The device was tested and calibrated with diﬀerent bacterial solutions of known
concentration, obtaining a linear relation between the absorbance and the concentration
of the injected solutions. Afterwards, I measured the on-chip absorbance over 10 h in
absence of ﬂow, to assess the turbidity of the solution on the long-term. I found that
the measured absorbance consistently dropped after 1 h of measure, revealing that the
bacterial solution became more optically-transparent than expected, in a concentration-
dependent fashion. In order to explain this ﬁnding, the phenomena of bacterial settling
and aggregation were investigated with further experiments. Based on our observations,
I hypothesized a simple mathematical model for the change of absorbance over time,
according to which, bacterial settling and aggregation phenomena were shown to aﬀect
absorbance measurements of planktonic solutions over time.
5.2 Double-beam absorbance measurement setup
The on-chip absorbance A of a planktonic bacteria solution was obtained applying the
Lambert-Beer’s absorption principles, according to which
A = log10
I0
I
= kλCL. (5.1)
I0 is the intensity of a light beam that illuminates a liquid sample, I is the intensity of the
light transmitted through the sample. kλ [M−1cm−1] is the molar extinction coeﬃcient
of the sample, which depends on the wavelength of the incident light and the sum of
the extinction coeﬃcient due to scattering, kscattλ , and the extinction coeﬃcient due to
absorbance by the sample, kabsλ . Both scattering and absorption result in a diminished
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I. C [M] or [cell/mL] is the concentration of the bacterial solution, while L [cm] is the
length of the optical path of the sample, i.e. the thickness of the microﬂuidic chamber
containing bacteria.
A microﬂuidic chip featuring two identical and independent micro-chambers (Figure 5.2a)
was designed in PDMS and glass, following the fabrication steps described in Section 5.5.1.
The measurement chamber is ﬁlled with a bacterial solution whose concentration has to
be measured, while the other chamber is ﬁlled with S medium (C = 0 cell/mL, optically
transparent) for reference. The microﬂuidic chip was fabricated from a 1 mm-thick
PDMS layer, and a microscope glass slide. Each device has a 60 μm-thick inlet and
outlet channel, and a round chamber (4 mm in diameter) with 575 μm thickness (see
magniﬁcation in Figure 5.2a). The sample volume that ﬁlls each chamber is scaled down
to 7.2 μL, enough to ensure the necessary sensitivity for optical detection. The light
absorbance in both chambers was measured by identical pairs of LEDs and PDs (Figure
5.2b). Each PD was inserted in an opaque cylindrical cavity to reduce cross-talks between
each LED-PD pair. One extremity of the cylindrical cavity was glued to a magnetic ring
and another magnetic ring was ﬁxed to each LED. LED and PD were then magnetically
ﬁxed to each other, with the micro-chamber in between. A schematic of the electronic
circuit is given in Figure 5.2c. Red LEDs (λ = 630 nm) (UR502DC, Chengguangxing,
China) were chosen as excitation source, motivated by their use in commercially-available
spectrophotometers, which measure the OD at 600 nm (OD600), and because high
absorption was expected at this wavelength [122]. In order to detect the transmitted light,
PDs with an excellent spectral sensitivity of 0.45 A/W at 630 nm were chosen (S10784,
Hamamatsu, Japan). Moreover, their sensitive area had a diameter of 3 mm, matching
the microﬂuidic chamber size, and the compact packaging favored the integration of
the PD in the microﬂuidic set up. The two LEDs were powered by a microcontroller
(Arduino, Ivrea, Italy) digital output port (5V) and were connected in series with a
low-pass RC ﬁlter, to reduce any diﬀerence in their electrical behaviour and to stabilize
the LED emission. A potentiometer was used to ﬁnely adjust the intensity of the LEDs’
emission, not to damage the downstream PDs. The photocurrent generated by each PD –
in the nA order – was ampliﬁed and converted to a voltage by a trans-impedance ampliﬁer
board (Multiboard, SGlux, Germany). The voltage signals from the measurement and
reference channels were processed by an external 16-bit analog-to-digital converter (ADC)
(ADS115, Adafruit, US), which provided a resolution of 0.125 mV and supported the I2C
serial interface protocol to communicate with the microcontroller. A sampling frequency
of 1 Hz was chosen for the microcontroller, as it allowed detecting subtle changes in the
concentration of the investigated bacterial solution. A digital 2nd-order Butterworth
low pass ﬁlter (LPF) with cut-oﬀ frequency of 0.05 Hz was ﬁrst designed in Matlab
(Mathworks, US) and then implemented on the microcontroller, to remove signal spikes
that were present at higher frequencies.
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Figure 5.2 – Overview of the miniaturized optoelectronic device. a) Design of the microﬂuidic
PDMS-glass chip featuring two independent micro-chambers. The measurement chamber is
ﬁlled with the bacterial solution with unknown concentration, while the other chamber is
ﬁlled with an optically transparent liquid, S medium, and it is used for reference. Scale bar
= 2 mm. b) Assembly of microﬂuidic chip and sensing elements. Two LED-PD pairs, one
to measure the absorbance, the other for reference, are aligned and ﬁxed to each other by
magnetic rings, holding the micro-chamber in between. Scale bar = 5 mm. c) Schematic
of the optoelectronic setup. Two red LEDs illuminate the reference and the measurement
chambers, and the transmitted light is detected by the corresponding PD. The read-out
signal, inversely proportional to the concentration, is ampliﬁed, digitally converted, sampled
and ﬁltered by a microcontroller.
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5.3 Validation and testing of the setup
The absorbance calculation (Equation 5.1) was readapted as
A = log10
Vref − V 0ref
Vmeas − V 0meas
, (5.2)
where Vref and Vmeas indicate the ADC read-out values from the reference and measure-
ment channels, respectively; V 0ref and V 0meas indicate the corresponding voltage values
in absence of light. The subtraction of V 0ref and V 0meas was necessary to refer the two
detectors read-out to the same baseline in dark condition and to cancel any read-out
diﬀerence due to the photodiode dark current or to the environment light. Afterwards, the
two chambers were ﬁlled with S medium and the respective ADC read-out were compared,
to check and correct for discrepancies due to possible misalignment of PDs, LEDs and
the detection chambers. Then, ﬁve bacterial solutions of known concentration (1, 2, 3, 4,
5 × 109 cell/mL, later referred as C1, C2, C3, C4 and C5, respectively) were prepared
and consecutively injected into the measurement micro-chamber starting from C1. The
reference chamber was ﬁlled with S medium for all the duration of the experiment. The
ADC read-out related to the measurement and the reference chambers are shown in
Figure 5.3a. Due to the compliance and deformability of the PDMS chamber upon
injection, the overpressure increased the chamber height and the following relaxation
decreased it, resulting in a like-wise change of the optical path with consequent peak
artefacts in the signal. To disentangle such artefact from the measurement, the ﬂow
was stopped for 1 min after the chamber was ﬁlled with the bacterial solution. The
absorbance values were computed in 40 s time windows (yellow bars in Figure 5.3a) in
which the signal was stable, and the averaged values are reported in Figure 5.3b. A
calibration curve was also obtained upon repeated measurements (Figure 5.3c). Our
optoelectronic device shows very good linearity (linear correlation coeﬃcient R = 0.9976)
and the calibration curve has the equation A=0.0170C, where A is the absorbance and
C the E. coli concentration.
5.4 Time dependence of absorption
I typically measure the absorbance of a bacterial solution over a time interval of 10 h.
Solutions with concentration C2, C3 and C4 were used in three diﬀerent experiments.
Upon injection, the ﬂow was stopped and inlet and outlet were clamped. Results are
given in Figure 5.4. The initial value measured at t = 0 h agrees with the absorbance
values previously obtained (Figure 5.3b,c). However, the measured absorbance decreased
during a period of 1-2 h after the injection. The amplitude of such a drop seemed to be
concentration-dependent, the strongest decrease being observed for the C4 solution, whose
absorbance value became 0.05 - correspondent to a C3 solution – after 2 h. After this
time-window, the measured absorbance underwent a slight linear increase, the amplitude
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Figure 5.3 – Testing of the absorbance-measurement setup and calibration curve. a) Real-
time change of the measured optical signal related to the reference channel ﬁlled with S
medium (dashed blue line) and the measurement channel (red line) when S medium and then
5 bacterial solutions with increasing concentration – C1, C2, C3, C4 and C5 – are consecutively
injected. Yellow bars indicate the measuring 40 s-windows for each injected solution. b)
Absorbance values for the bacterial solutions measured by our opto-electronic platform. Bars
are expressed as average ± SD. c) Calibration curve of our absorbance-measurement setup,
showing a linear relation between the absorbance and the concentration of the injected
solutions. The curve is expressed as mean (solid line) ± SD (dashed line) and is obtained
from 4 experiments performed in diﬀerent microﬂuidic chips using freshly-prepared bacterial
solutions.
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Figure 5.4 – Change of the absorbance over 10 hours of bacterial solutions having concen-
tration C2, C3 and C4, as calculated from our absorbance data. The graph shows raw data
(black line) and a double-exponential ﬁtting curve (red line).
of which is inversely proportional to the initial concentration of the solution.
In order to explain the initial absorbance drop measured by the absorbance-measurement
setup, the phenomena of bacterial settling and aggregation were investigated in our
micro-chamber. These two phenomena are in fact known to occur in bacteria colonies
[123], [124]. A solution with concentration C4 was studied, as the most severe absorbance
decrease was observed for this concentration.
Image processing was performed with ImageJ software and Matlab R 2015b software
(MathWorks, US), on each stack of images.
5.4.1 Monitoring and quantiﬁcation of bacterial settling and aggrega-
tion in the micro-chamber
The bacterial settling phenomenon was investigated in a 575 μm-thick chip, with same
geometry as the one in Figure 5.2a. The micro-chamber was ﬁlled with a bacterial
solution of concentration C4 and inlet and outlet were closed. In order to capture the
bacterial settling and their migration in the vertical direction, brightﬁeld pictures at
diﬀerent focal planes were taken with a 20× objective (scheme described in Figure 5.5a).
Given the depth-of-ﬁeld of the objective of ± 5.7 μm (nair = 1.0002772, λ = 550 nm,
numerical aperture NA = 0.22), a spacing of 30 μm between consecutive focal planes
ensured that the bacteria behaviour in diﬀerent vertical positions of the chamber was
captured. The vertical 30 μm-shift of the focal plane was committed to a piezo transducer
mounted on the motorized stage holding the microﬂuidic chip. Starting from the bottom
of the micro-chamber (0 μm), focal planes at 30 μm, 60 μm, 90 μm, 120 μm and 150 μm
were chosen, the range of investigated focal planes being limited to the 150 μm vertical
span of the piezo transducer. According to Stokes’ law, a bacterium should take about 90
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min to sink from the top to the bottom of the chamber of height L = 575 μm. After this
time window, all the bacteria that sank to the bottom of the micro-chamber should form
a layer of thickness zmax. zmax can be estimated by dividing the volume occupied by all
bacteria, VE.coli,tot, by the surface of the micro-chamber, having radius R, according to
Equation 5.3
zmax =
VE.coli,tot
πR2
. (5.3)
VE.coli,tot can be estimated by multiplying the volume occupied by a single bacterial
cell, Vcell, if considered as a sphere of radius r=1 μm, and the total number of bacterial
cells, N , calculated by multiplying the bacterial concentration C with the volume of the
bacterial solution (i.e. the volume of the micro-chamber having radius R), as in Equation
5.4:
VE.coli,tot = Vcell × N = 43πr
3 × C × πR2L. (5.4)
By replacing Equation 5.4 in Equation 5.3, Equation 5.4 can be re-written as
zmax =
VE.coli,tot
πR2
=
4
3πr
3 × C × πR2L
πR2
= 43πr
3CL. (5.5)
Therefore, according to Equation 5.5, bacteria from a solution of concentration C = C4
will precipitate forming a layer of thickness zmax = 10 μm.
To capture the full dynamics of the settling process, pictures of a given focal plane in the
micro-chamber were taken every 20 s for 120 min. Initially, pictures taken at diﬀerent
focal planes after the injection of bacteria in the micro-chamber (Figure 5.5b, T = 0
min) appeared similar, as bacteria were in a planktonic regime. However, after 2 h
the bottom of the micro-chamber appeared richer in contrast (Figure 5.5b, 0 μm) as
bacteria sedimented. Pictures taken at superior focal planes appeared more clear because
of bacterial depletion from the planktonic state due to settling (Figure 5.5b, 150 μm),
conﬁrming the absorbance decrease as shown in Figure 5.4. Images belonging to all focal
planes showed an average gray scale value that increased over time (on our scale, white
corresponds to 1 and black to 0) (Figure 5.5c). The layer of settled bacteria of thickness
zmax was clearly captured by images taken at the 0 μm focal plane (Figure 5.5b, T =
120 min), which also revealed that bacteria settled to the bottom of the micro-chamber
as aggregates, and no longer as dispersed bacteria. Aggregation was conﬁrmed also
by the increase of the image SD calculated for the 0 μm plane (Figure 5.5d), which
clearly deviated from the one calculated for the other planes (30 μm, 60 μm, 90 μm,
120 μm and 150 μm), for which the layer of settled bacteria appeared blurred (Figure
5.5b, 150 μm plane, T = 120 min). The diverging "fan-shape" of the curves, happening
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after about 40 min and considering the superior focal planes (from 30 μm to 150 μm),
is probably due to diﬀusive light scattering, which increases with the increase of the
distance between the objective focus and the scattering layer of already present settled
bacteria. The small initial rise in all curves of Figure 5.5d eventually could be explained
by minor aggregation phenomena happening from the beginning in each focal plane.
Considering these results, we think that settling and aggregation are together responsible
for the initial decrease in the absorbance measured by our device (Figure 5.4). In fact,
upon settling, bacteria leave behind an increasingly-thick layer of transparent medium,
approximatively saturating towards a value of L – zmax after 1-2 h. A medium with
higher transparency would evidently result in a lower absorbance. The role of settling
in the initial decrease of the measured absorbance is also supported by the observation
that settling and the absorbance drop occurred in the same time window of 1-2 h after
injection of the bacterial solution in the microﬂuidic chip.
To deepen our understanding about bacterial aggregation separately from the bacterial
settling, a dedicated microﬂuidic chamber with the same layout as in Figure 5.2a, but with
60 μm-thick chambers, was used. The bacterial solution was injected in the microﬂuidic
chamber and inlet and outlet were closed. Brightﬁeld pictures were taken every 30 s
using a 5× objective, to monitor the bacterial aggregation in the micro-chamber over
10 h. The resulting 1200 frames-stack was then processed to quantify the dynamics of
the aggregation, using the image-processing algorithm illustrated in Figure 5.6a. After
applying a moving-average ﬁlter with a 5 min-window, the inverted background was
subtracted to the image stack, removing in this way artefacts due to dust or particles
along the optical path of the microscope or on the PDMS chip. Then, the contrast was
enhanced and a threshold was applied to binarize the image, segmenting therefore black
bacteria or aggregates over a white background. Figure 5.6b shows exemplifying images
from the stack before applying the image-processing algorithm (Figure 5.6bi and 5.6bii)
and after (Figure 5.6biii and 5.6biv). Finally, the size of the aggregates was measured
for each frame (Figure 5.6c). The segmentation algorithm was able to detect planktonic
bacteria at the beginning of the experiment (Figure 5.6biii) and the formation of bacterial
aggregates (Figure 5.6biv), which started immediately after the injection and led to the
formation of aggregates with about twice the size of planktonic bacteria after 1-2 h. This
time-window matches our observations related to settling (Figure 5.5b, 0 μm focal plane).
After this pronounced aggregate formation during the initial 2 h, the aggregation rate
decreased and a plateau was reached after about 7 h.
Upon bacterial aggregation, the medium appeared more clear and transparent, as visible
by comparing Figure 5.6biii and 5.6biv, leading to a higher transmittance when the
absorbance is measured. Therefore, we think that, beside depletion of the planktonic
bacterial concentration due to settling, aggregation is a key-player in the initial decrease
of the absorbance (Figure 5.4). This is also supported by the observation that bacterial
aggregation and absorbance drop occurred in the same time window of 1-2 h after
injection of the bacterial solution in the microﬂuidic chip.
After the ﬁrst 1-2 h window, a slight increase in the absorbance was measured, indicating
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Figure 5.5 – Monitoring of bacterial settling in the micro-chamber via brightﬁeld microscopy.
a) Illustration of the settling movement of bacteria over time towards lower planes of the
micro-chamber. Eventually bacteria are only present on the micro-chamber bottom (plane0).
b) Representative brightﬁeld pictures over time of a micro-chamber ﬁlled with a bacterial
solution at the 0 μm focal plane (bottom) and at the 150 μm focal plane (top). Scale bar
= 10 μm. c, d) Quantiﬁcation of the settling dynamics as variation of (c) the mean gray
intensity and (d) the standard deviation of the gray scale values of each image of the 6 stacks
taken at 0 μm, 30 μm, 60 μm, 90 μm, 120 μm and 150 μm, respectively.
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Figure 5.6 – Monitoring of bacterial aggregation in a 60 μm-thick micro-chamber via
brightﬁeld microscopy. a) Schematic of the image-processing algorithm applied to the 10 h
stack of images, which was used to segment planktonic bacteria and the aggregates. After
cleaning the images from undesired dust or particles with a moving average and background
subtraction, the contrast was enhanced and a threshold was used to binarize the image.
Finally, the size of the bacterial aggregate particles was measured. b) Two representative
brightﬁeld pictures of the micro-chamber, taken with a 5× objective after it was ﬁlled with
the bacteria solution, (i) before applying the segmentation algorithm at the beginning of
the sequence, (ii) after 2 h, and after applying the algorithm (iii) at the beginning of the
sequence and (iv) after 2 h. Scale bar = 50 μm . C) Time-dependent change of the average
aggregate dimension. The curve is expressed as average ± SD.
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an increase in the turbidity of the solution (Figure 5.4), which can be attributed to
bacterial settling on the glass surface coupled with more frequent and stronger intercellular
interactions triggered by close proximity and conﬁnement of bacteria at the micro-chamber
bottom. The fact that aggregation continued even after 1-2 h and reached a plateau
after about 7 h (Figure 5.6c), could be an indicator of the reorganization among the cells
[88], [89]. In fact, literature data already showed that optical absorbance of a solution
of cells varied with respect to the level of interaction between cells, which continue
to reorganize themselves over time [120]. However, deviations from the linear relation
between concentration and absorbance described by the Lambert-Beer law were reported
in case of highly concentrated and non-dispersed media [125], [126]. For this reason, once
bacteria aggregated and sedimented at the micro-chamber bottom forming a very dense
colony, its concentration might not be safely derived from the absorbance.
5.4.2 Mathematical model for the absorbance dynamics of bacterial
solution in micro-chambers
In order to unravel the inﬂuence of contributions from planktonic vs. settled and
aggregated bacteria to the absorbance, a mathematical model of the change in the
absorbance was designed to ﬁt the experimental results. The volume of the micro-chamber
can be subdivided into three parts Vx, Vy, Vz of height x, y and z respectively (Figure
5.7a). Vx is the "depleted" volume, ideally transparent because bacteria disappeared from
the solution when settling down. Vy and Vz are respectively the volume in which bacteria
are in their planktonic state and the volume occupied by settled bacteria. According
to the Lambert-Beer law for multiple absorbers, Equation 5.1 can be generalized in
Equation 5.6
A = log10
I0
I
= kλ(Cxx + Cyy + Czz), (5.6)
where Cx, Cy and Cz are respectively the concentrations of the solution in the volumes
Vx, Vy and Vz. In particular, Cy corresponds to the initial concentration of the solution
C. Neglecting the contribution from Vx, which ideally is optically transparent, the
absorbance can be calculated according to Equation 5.7
A = kλ(Cyy + Czz) =
y
y0
+ z
z0
, (5.7)
where y0 = 1/kλCy and z0 = 1/kλCz. According to our hypothesis, bacteria start
aggregating upon injection at time t0, in clusters having a radius of about 1.5 μm, and
settle with velocity v. I assumed as negligible the initial contribution of Vz, given that
the solution in Vy has about the initial concentration C and that y  z. After about 1.5
h (at time t1), settling is saturated and all the bacteria occupy a volume of height zmax,
y = 0 and ideally only Vz contributes to the absorbance. The change of absorbance over
time A(t) can be expressed according to Equation 5.8 and the time-change of A(t) is
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Figure 5.7 – Model of the absorbance change over time. a) Schematic of the lateral view
of the measurement chamber of height L. Three parts are identiﬁed, having respectively a
height of x, y and z. x represents the depleted zone, optically transparent because bacteria
disappeared there when settling, and therefore does not contribute to the overall absorbance.
y represents the region where bacteria are in a planktonic state. Finally, sedimented bacteria
occupy a region of height z. Dimensions not in scale. b) The change of absorbance measured
for a solution of concentration C4 by our absorbance measurement setup, as reported in
Figure 5.4 (solid red line) and change of absorbance from the model that was designed to ﬁt
the measured data and the experimental results (dashed black line).
plotted in Figure 5.7b.
A(t) =
⎧⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎩
L − vt
y0
, t < t1
zmax
z0
(β + αt), t ≥ t1
(5.8)
α is a ﬁtting constant of the model equal to z0
zmaxA(t = t1)
.
5.5 Materials and methods
5.5.1 Fabrication of the microﬂuidic chip
All the chips were fabricated starting from a 60 μm-thick SU-8 silicon mold by traditional
photolithography as described in Chapter 2. Starting from these wafers, to fabricate the
chips used to measure the absorbance and to study settling, tape disks were laminated on
top of the measurement and reference chambers, increasing the thickness in a single step
process. Such 515 μm-thick self-adhesive round-shaped tape (diameter of 3 μm) were
previously cut by a laser cutter (Plotter Cutter RoboPro CE5000-40-CRP, Graphtec
America, US). On the other hand, for the chip used to study bacterial aggregation, no
additional layer was patterned on top of the initial 60 μm-thick SU-8 pattern. For all the
wafers, the mold was used for PDMS casting, following the steps described in Session 2.3.
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5.5.2 Bacterial preparation
HT115 E. coli bacteria were grown in LB with 100 μg/mL ampicillin and 12.5 μg/mL
tetracycline overnight in a thermal shaker at 37 ◦C. The following day, 50 μL of the
conﬂuent bacterial cultures were used to inoculate freshly prepared LB medium containing
only ampicillin and were grown overnight. After the overnight culture, 50 mL of the
bacterial cultures were centrifuged to remove LB; in this way, bacteria samples with the
desired optical density were obtained by adding S medium accordingly. The concentration
of each bacterial solution was measured using a commercial spectrophotometer (WPA
CO8000, Biochrom, UK). Fresh bacterial solutions were prepared before each experiment.
5.5.3 Image acquisition and platform control
Image aquisition and platform control were performed by using the setup described in
Section 2.4. The acquisition system was programmed so that pictures were automatically
captured. For the settling experiments, pictures were recorded every 20 s for 2 h using a
Zeiss 20x NA 0.22 objective. For the aggregation experiments, pictures were recorded
every 30 s for 10 h using a Zeiss 5x NA 0.13 objective. The microﬂuidic chambers were
ﬁlled either with S medium (reference chamber) or with the bacterial solution under
investigation, using a ﬂow rate of 1000 nL/s. After chip ﬁlling, the chamber inlet and
outlet were clamped and kept in this condition over the full experiment. The experiments
were performed at 25 ◦C.
5.6 Discussion and conclusion
I presented in this Chapter a miniaturized optoelectronic platform integrated in a mi-
croﬂuidic device, which was able to measure the on-chip absorbance of planktonic bacteria
in the 1-5 × 109 cell/mL concentration range. Relying on the Lambert-Beer’s absorption
principles, I designed two independent ﬂuidic chambers, the reference and measure-
ment chambers, each conﬁgured with a LED-PD pair to measure the corresponding
transmittance. By connecting in series the two LEDs, relating the signal from the
measurement chamber to the one from the reference channel and ﬁltering opportunely, a
nearly noise- and ﬂuctuation-free absorption measurement was obtained. Compared to
previous solutions, this platform permitted the quantiﬁcation of bacterial concentrations
in an automated way, and is therefore less error-prone and time-consuming. Furthermore,
the quantiﬁcation of a bacterial concentration, which is currently microscopy-based and
often involves manual counting, was here assured using a system of small commercial
opto-electronical components that made the measurement aﬀordable and the device
portable. The system was able to measure the concentration of a bacterial sample with
a volume of about 7 μL, which is three orders of magnitude smaller than the volume
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required by most of the commercial spectrophotometers. Moreover, this general-purpose
device can be possibly put in ﬂuidic connection with a separate microﬂuidic chip inocu-
lated with bacteria of unknown concentration, in a modular fashion, with a negligible
dead volume. Upon testing the device with bacterial solutions of diﬀerent and known
concentration, a linear calibration curve was obtained. The on-chip absorbance was
measured over 10 h in absence of ﬂow for solutions with concentration C2, C3 and C4.
For the three cases, I found that the measured absorbance consistently dropped after 1
h, revealing that the bacterial solution became more optically transparent, and this in a
concentration-dependent fashion. I hypothesized that the driving forces of such a change
in the turbidity of the solution could be found in the phenomena of bacterial settling
and aggregation. Tailored experiments were performed to investigate bacterial settling
and aggregation using the concentration C4, for which the most dramatic changes were
observed. I found that bacterial settling and aggregation promptly started upon the
injection of the solution in the micro-chamber and lasted for 1-2 h. This time window
matched the dynamics of the absorbance change measured by our optoelectronic device.
The two phenomena were not independent and the initial absorbance drop was likely to
be due to a combined process, during which settling increases the chances of intercel-
lular interactions and bacterial clusters of increasing size settle down easier, reaching
eventually the chamber bottom in about 1-2 h. The absorbance measured for a solution
with concentration C4 showed the highest drop, while a milder decrease was observed
for more diluted solutions. This inverse-dependence of the absorbance decrease on the
concentration of the solution can be explained with the fact that aggregation and settling
of a massive number of bacteria signiﬁcantly altered the transparency of the solution.
On the other hand, the fewer intercellular interactions and settling events occurring in a
diluted solution did not result in an as dramatic absorbance change as the one observed
for more concentrated solutions. Based on our observations, a simple mathematical
model for the change of absorbance over time was hypothesized, according to which,
bacterial settling and aggregation were the major players. Moreover, the absorbance
change over 10 h can be ﬁtted with a double-exponential trend (decreasing ﬁrst and
increasing afterwards), while the model here features an initial linear decrease due to
settling and aggregation and a following slower linear increase.
5.7 Future outlook
From a future perspective, this platform could be used as a complementary stand-alone
device that, on demand, can be put in ﬂuidic connection with a separate microﬂuidic chip
inoculated with bacteria of unknown concentration, and this in a modular fashion. More
speciﬁcally, I could aim at measuring the concentration of the bacterial solutions that are
used to culture C. elegans worms in microﬂuidic environments, to properly control their
feeding. As C. elegans worms preferentially eat dispersed bacteria [19], [20], this study
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revealed that injected bacterial solutions remain in the planktonic state only for about
1 h, after which they sediment. Therefore, after this short time window, the feeding
solution in the worm culture chamber should be refreshed or stirred to re-suspend the
bacteria. Envisioning a microﬂuidic platform where C. elegans worms are cultured on
chip and their feeding is fully controlled, our miniaturized device can be connected to
the feeding line of the C. elegans culture chip, either upstream or downstream. In this
way, the same solution used to feed the worms could ﬁll the measurement chamber of
the device, to allow a real-time measure of its concentration. The exact control of the
C. elegans feeding would allow performing reproducible culture experiments or precisely
tuning the bacterial concentration to perform underfeeding or overfeeding experiments,
paving the way for future worm metabolism studies.
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6 Motility assay to evaluate the
behavioral response to glucose on
a C. elegans population
Abstract C. elegans being a relatively simple animal model, its motility gives direct
information on its neuromuscular system and an indirect assay of the health of this
nematode. Therefore, a quantitative evaluation of C. elegans motility can be used to
assess the action of a drug at the whole-animal level. In this Chapter, I propose a
simple yet powerful approach to assess the eﬀect of small molecules, namely glucose
and dynasore, at the behavioral level on YA worms by quantifying and comparing their
motility before and after the compounds administration. I designed and fabricated a
dedicated microﬂuidic device to deliver drugs to a YA population of worms in a precise
spatio-temporal way, which made the experimental protocol robust and reproducible.
A motility assay protocol was designed, where ﬂow proﬁle and video recording were
synchronized. The designed image-processing routine was able to segment and quantify
the motility for 10-12 animals in the micro-chamber. The results point at a critical role
for dynamin in the cellular ability to uptake glucose, which was observed ﬁrst at the
behavioral level by quantifying worms motility and then conﬁrmed at the whole organism
level with the quantitation of glucose in C. elegans.
This chapter is an adapted version of the following publications:
• R. Trouillon, M. C. Letizia, K. J. Menzies, L. Mouchiroud, J. Auwerx, K. Schoon-
jans and M. A. Gijs, "A multiscale study of the role of dynamin in the regulation
of glucose uptake", en, Integr. Biol., Issue 9, p. 810-819, 2017.
• R. Trouillon, M. C. Letizia, M. A. M. Gijs, "Assessing electrochemically the
chemical activity of cells in a cells-on-paper system". Proc. of 20th International
Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS
2016), Dublin, Ireland, October 2016.
Poster presentation
• R. Trouillon, M. C. Letizia, M. A. M. Gijs, "Quantitative analysis of chemical
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release and uptake in cells-on-paper microsystems". Proc. of 39th International
Conference of the IEEE Engineering in Medicine and Biology Society (EMBC2017),
Jeju Island, Korea, July 2017.
Oral presentation and poster presentation
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6.1 Introduction
C. elegans motility is a direct readout of the neuromuscular system and an indirect assay
of the health of the animal [127]. Therefore, motility can be used to quantify the action
of a drug at the whole-animal level. In this perspective, both the detection of the drug’s
action on worms and worms handling should be automated. In fact, precise speciﬁcation
of diﬀerent locomotion phenotypes, such as velocity, amplitude of the movement, angles
of body bends etc., cannot be provided through mere visual observation, and machine
vision approaches for automated behavioral analysis are required. Many machine vision
methods have been described to quantify behavioral phenotypes [128]. The majority
of these algorithms share the same image-processing-based features: extract individual
frames from a movie, segment the area occupied by worms by applying a threshold,
compute the skeleton of each worm and ﬁnally extract motility parameters, such as center
of mass and body curvature.
Although many sophisticated methods have been proposed [128]–[133], they are optimized
for worm culture in solid medium, and are not ideal to quantify the swimming behavior
characteristic in microﬂuidic devices [128]. In fact, C. elegans in liquid media shows
substantially diﬀerent moving patterns compared to worms in agar plates: when placed
in a liquid, worms thrash, i.e. swim with a rhythmic and oscillating body motion [127].
Swimming oﬀers a useful measurement, well-suited for the readily-scorable, phenotypic
readout required for a screening, as it can be quantiﬁed as simple scalar numbers, such
as the amplitude of its movement or the number of body bends per minute. Approaches
based on worm segmentation and skeletonization were developed [134]. Other groups
proposed methods based on measuring the diﬀerences between consecutive frames to
quantify motility [135], [136]. However, microﬂuidic devices were not used in all these
motility assays, and to perform the experiments, worms were on purpose transferred to
microwells. Therefore, the worms handling was not automated, and the drug delivery
protocol could not be carefully synchronized with the video recording. Moreover, these
methods required that only one animal was present in the ﬁeld of view. Interestingly,
another group recently used an adapted version of a previous tracker [131], modifying the
parameters to track the motility of multiple worms in a microﬂuidic chamber by using a
segmentation/skeletonization approach [137].
In this Chapter, I propose a simple method to evaluate the eﬀect of chemicals on a
population of C. elegans worms in a microﬂuidic chamber. The method allowed precise
synchronization of drug delivey and video recording. Moreover, in order to evaluate
the drug eﬀect, a motility score was obtained in a diﬀerential approach, by comparing
motility values calculated before and after drug exposure.
The method was validated by investigating the links between glucose uptake, via insulin-
regulated glucose transporter (GLUT4) exocytosis, and dynamin in a population of
synchronized C. elegans worms. Dynamin is a molecular motor normally involved in
endocytosis but also found to contribute to exocytosis through the dilation of the fusion
pore, as exposure to the selective inhibitor dynasore was found to block exocytosis
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Figure 6.1 – Microﬂuidic-based approach for worm motility assay. a) Design of the
microﬂuidic chip, featuring three inlets - one for worm loading and two for the injection of S
medium and drugs - and two outlets. b) Time line of the worm motility assay protocol.
[138]. A custom microﬂuidic setup allowed for a controlled and reproducible drug testing
assay, perfectly synchronized with the video recording. Our quantitative analysis of
the nematodes behavior suggested that dynasore alters worms response to high glucose
exposure.
6.2 A microﬂuidic-based approach for worm motility phe-
notyping assay
Microﬂuidic chips were designed to quantify worm motility before and after animals are
exposed to the compound under investigation. Chips were prepared by standard soft
lithography using a 2-layer SU-8 master as described in Chapter 2. The chip design is
shown in Figure 6.1a. The main feature of the chip is a 2×2 mm2 microﬂuidic chamber,
dedicated to adult nematode maintenance and treatment, connected to three inlets –
In1, In2 and In3 – dedicated respectively to worms loading, S medium refreshing and
treatment injection, and two outlets – Out1 and Out2 – ﬁtted respectively with 60 μm
and 30 μm ﬁlters. These ﬁlters allow for size selection of the nematodes, so that only
adult hermaphrodite worms are retained in the chamber. Microchannels are 40 μm-high,
while the height of the chamber is 130 μm. The microﬂuidic chip was integrated into the
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a b c
Figure 6.2 – Schematic of the image processing routine to quantify the worm motility score.
a) Image cropping by manual selection of the region of interest, corresponding to the worm
square chamber. b) Image binarization by thresholding. c) Diﬀerentiation of the binary
video to quantify the number of non-null pixels, characteristic of the worms motility. Scale
bar = 500 μm
microﬂuidic setup described in Section 2.4. A 5×/0.12 A-Plan Zeiss objective was used.
Videos were recorded with a Pixelink B681 CMOS Camera (Pixelink, US).
The worm loading and synchronization procedures resemble the ones described in Chapter
3. A mixed population of worms was suspended in 200 μL of S medium and aspirated
into a tubing connected to the device. With a ﬂow ranging from 200 to 800 nLs−1, the
unsynchronized worms were injected in the microﬂuidic chamber from inlet In1. Worm
synchronization was automatically performed hydrodynamically through Out1. This
outlet ﬁlter was tailored with 60 μm-wide and 800 μm-long channels, in such a way that
only adult worms were retained in the chamber, while younger worms were washed away
by the ﬂow. The number of worms retained in the chamber was controlled by adjusting
the volume of the injected solution, from 5 μL up to 20 μL. After worm synchronization,
Out1 was closed and Out2 opened. The worms were then exposed to a constant ﬂow of
30 nLs−1 of S medium, from In2 for 5 min, to remove the residues of OP50 bacteria and
any metabolic waste from the chamber, and also to expose the worms to a basal level of
hydrodynamic conditions. The tailored ﬁlters cast on the Out2 side, i.e. 30 μm-wide
channels, prevented the adult worms from escaping. Then, the ﬂow was stopped, and
the ﬁrst video was recorded (5 sec, 20 fps). After the ﬁrst recording, the second solution
(S medium without/with the investigated drug) was injected for 20 min, at a ﬂow of 30
nLs−1, from In3. Finally, the second video was recorded. In order to avoid any eﬀect
of the ﬂow on worm motility, the ﬂow was stopped for 3-5 min before starting both
recordings. The time sequence of the worm motility assay is shown in Figure 6.1b.
Each video was converted to grayscale and processed using a custom routine written
in IgorPro (WaveMetrics, US) to extract a motility score. The data processing routine
is summarized in Figure 6.2. First, the area of interest, corresponding to the central
chamber, was selected and extracted from each frame (Figure 6.2a). Each of these
reduced frames was then converted to a binary image using a user-deﬁned threshold
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(Figure 6.2b). This threshold was adjusted so that the shape of the worms appeared
clearly, but all the other features, such as debris or the edges of the PDMS channels,
were cancelled. The same threshold was used for each frame of the video. The number of
white pixels, corresponding to a "1" value, were counted for each frame and averaged over
the duration of the video, thus providing a measure of the fraction of the image occupied
by the worms. In a second step, the binary video was diﬀerentiated using the forward
diﬀerence method (Figure 6.2c). Brieﬂy, the number of non-null pixels, indicative of
worm motion, was counted for each frame, and these values were averaged over the whole
video. This value, describing the rate of change of the frames and therefore the worm
activity, was normalized to the average worm area computed above, thus providing the
motility score for this video. Finally, motility was quantiﬁed as the variation of this
motility score, before and after the drug treatment, which was deﬁned as the ratio of the
score after the treatment to the score before the treatment. To prevent from overloading
the memory of the computer, the algorithm was typically run over 3 s of the video. The
rest of the ﬁle was used to ensure that the behavior of the worm was consistent over
the duration of the video. To guarantee the relevance of the computed motility value, I
ensured that the worms were not overlaid or crowded, which would have impaired the
computation of the worm area, for instance. Also, stopping the ﬂow allowed the worms
to swim freely and therefore to spread evenly in the chamber. Finally, the videos were
captured at a point where the worms were found to be isolated from each other.
6.3 Eﬀect of glucose uptake and inhibited glucose uptake
on C. elegans motility
A motility assay was performed to quantify the eﬀect of glucose and dynasore exposure on
C. elegans adult worms. Brieﬂy, glucose uptake by muscle cells upon insulin signaling is a
fundamental mechanism for metabolism [139]. Insulin binds to its membrane receptor on
a muscle cell, thus triggering an intracellular kinase cascade leading to the mobilization
of GLUT4 storage vesicles. These vescicles are translocated to the rim of the cell, where
they can tether and fuse with the cell membrane following an exocytosis process. This
allows for the integration of the GLUT4 into the membrane, where they can take up
glucose. Diseased states, such as diabetes, in which cells are not able to respond to an
insulin stimulus, are characterized by the inability to mobilize the speciﬁc GLUT4 [140].
Dynamin is a molecular motor normally involved in endocytosis [141] but also found to
contribute to exocytosis [142] through the dilation of the fusion pore [138], as exposure
to the selective inhibitor dynasore was found to block exocytosis [143].
Cell experiments indicated the role of dynamin in glucose uptake [74]. However, cell
models are too simple to account to the complexity of life. The aim of the present study
is to understand if dynasore interacts or inhibits glucose uptake at the whole-animal level,
and if behavioral responses to glucose are triggered in a C. elegans population. High
glucose concentrations are known to have deleterious eﬀects on nematodes development
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[144] or to provoke oxidative stress [145], and to reduce the motility of hermaphrodite
worms [146]. First, a motility assay was performed to characterize the concentration-
dependent eﬀect of glucose (Figure 6.3a). It was found that the worm motility is
progressively reduced by increasing concentrations of glucose, and that a motility drop
by 50% is reached when a glucose concentration of 200 mM is used. Therefore, a
concentration of 200 mM glucose was chosen to maximize the eﬀect of the treatments
in the following experiments. The concentration-dependent eﬀect of dynasore was then
tested on untreated worms and on worms exposed to 200 mM of glucose (Figure 6.3b).
In the absence of glucose, the motility decreased with increased dynasore concentrations
as this drug impairs membrane traﬃcking. This agrees well with a toxic eﬀect in vivo
of dynasore at high concentrations. Interestingly, in the presence of 200 mM glucose,
the dose response to dynasore changed dramatically and became "U-shaped". Low
concentrations (up to 100 nM) seemed to increase the observed glucose toxicity, the
lowest motility being recorded for 100 nM. However, for dynasore levels higher than
the 100 nM-limit, the motility increased too, up to the levels of motility observed in
the absence of glucose with 10 μM dynasore. This ﬁnding suggests that high dynasore
concentrations cancel the eﬀect of glucose, possibly by blocking GLUT4 exocytosis and
glucose uptake.
L-glucose, an enantiomer of glucose that cannot enter glycolysis was used to investigate
the speciﬁcity of D-glucose (otherwise referred to as glucose in the text) in the observed
variations in motility. In particular this molecule was used to disentangle the physical
(osmolarity, viscosity) and the enzymatic, metabolic or biological eﬀects of the previous
treatments. L-glucose has a low aﬃnity with GLUT4 [147], [148] and was previously found
to show none of the typical harmful eﬀects of glucose on C. elegans: the lifespan [144]
and egg laying rate [149] were unaﬀected, and it displayed no toxicity in glucose-sensitive
mutants [150]. Exposure to 200 mM L-glucose decreased the worm motility in a smaller
magnitude than glucose (p-value= 0.004, motility ratio 0.75 for L-glucose vs. 0.52 for
glucose) (Figure 6.3c). This drop can be attributed to the physical eﬀect of the molecule,
principally the increase in osmolarity, on the nematodes. From this result, it can be
estimated that the ∼48% drop in motility due to glucose exposure is the sum of a ∼25%
decrease due to the diﬀerent physical conditions and another ∼23% drop in motility
that can be attributed the biological impact of high glucose, probably leading higher
oxidative stress. The L-glucose tests were also repeated for diﬀerent concentrations of
dynasore. Interestingly, the U-shaped response previously observed in the presence of
glucose is abolished, and the trend of the response was comparable to the one recorded
when no glucose is added. This further supports that the speciﬁc response seen for the
co-exposure to glucose and dynasore arises speciﬁcally from the biological activity of
glucose in C. elegans, and that dynamin takes part to this phenomenon.
Finally, to conﬁrm the speciﬁc role of dynamin and its inhibition, worms were treated
with a feeding RNAi targeted at dyn-1, the gene coding the dynamin isoform present in C.
elegans (Figure 6.3d) [151]. The decrease in motility due to 200 mM glucose was less than
for the untreated worms (motility ratio 0.67 for the RNAi vs. 0.52 for the untreated).
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Additionally, the decrease in motility was similar for both glucose enantiomers, thus
showing that the bioactivity of glucose does not alter the behavior of these RNAi-fed
worms. As with dynasore, inhibiting the activity of dynamin via RNAi feeding blocks
the biological response to glucose.
In order to support the hypothesis that dynasore blocked glucose uptake, the worm
glucose content was measured under diﬀerent conditions. To do so, unsynchronized
populations of about ∼2700 worms were exposed to high glucose concentration (200
mM), either without or with 1 μM dynasore. Those populations were then lysed and the
total glucose content of the lysate was quantiﬁed electrochemically, with the help of a
collaborator (Figure 6.4). Our results showed that dynasore blocked the accumulation of
glucose in the worms.
Overall, this set of experiments further established the role of dynamin in glucose
uptake, as its activity modulates the magnitude of the nematode response to glucose.
Additionally, it also hints at complex whole organism eﬀects, e.g. behavioral alterations,
mediated by the altered biochemical status of the animal.
6.4 Materials and methods
6.4.1 Worm maintenance and preparation
C. elegans were cultured at 20 ◦C, in 90 mm Petri dishes, on NGM seeded with E. coli
strain OP50 bacteria. The strain used in this study was the wild-type N2 strain, as
obtained from the Caenorhabditis Genetics Center (University of Minnesota). RNAi
clones dyn-1 (C02C6.1) were purchased from GeneService and sequenced.
For the RNAi studies, HT115 E. coli bacteria for the control and RNAi experiments were
grown LB with 100 μg/mL ampicillin and 12.5 μg/mL tetracycline overnight in a thermal
shaker at 37 ◦C. The following day, 50 μL of the conﬂuent bacterial cultures were used to
inoculate freshly prepared LB medium containing only ampicillin (100 μg/mL). The new
cultures were grown until reaching an optical density between 0.6-0.8. Plates were induced
overnight at room temperature with 2 mM isopropyl β-D-1-thiogalactopyranoside (IPTG)
and seeded with 90 μL of the culture of HT115 bacteria expressing the RNAi clones
for the dyn-1 gene. L4 worms were transferred on the RNAi plates and removed after
24 h of treatment. YA worms were then collected for introduction in the microﬂuidics
system. In all the experiments, YA worms were harvested from the plates and suspended
in solution prior to each introduction in the microﬂuidic system by rinsing the plates
with fresh S medium.
6.4.2 Statistical analysis
Where applicable, the data are reported as average ± SD, and the number of individual
measurements is described using the notation n. A Shapiro-Wilk test was run on
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Figure 6.3 – Eﬀect of glucose and dynasore on C. elegans motility. a) Eﬀect of diﬀerent
glucose concentrations (2 mM, 20 mM and 200 mM) on worms motility. The number in
each bar corresponds to the number of microﬂuidic chip used for each condition. A maximal
drop in motility of 50% reached for 200 mM (p-value= 1.6 10−5 versus 0 mM glucose). b)
Variations in motility score for diﬀerent levels of dynasore, for 0 and 200 mM of glucose
(p-value= 1.9 10−9 overall). c) Variations in motility score upon glucose and L-glucose
exposure and diﬀerent concentrations of dynasore. (p-value= 0.004, motility ratio 0.75 for
L-glucose vs. 0.52 for glucose). d) Variations in motility score for upon glucose and L-glucose
exposure nematodes treated with RNAi on dyn-1 gene. *: p-value < 0.05. **: p-value <
0.01.
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Figure 6.4 – Total glucose content measured electrochemically in worm lysates after exposure
to 200 mM glucose, without or with 1 μM dynasore and control without dynasore or glucose
(n = 3 for each case, each repeat corresponds to the lysate of ∼2,700 worms).
the diﬀerent control datasets obtained in the study to test the normality of the data.
Comparisons between two diﬀerent datasets were performed with a two-tailed Student’s
t-test, or with a 1-way ANOVA in the case of more than 2 datasets, followed by a post-hoc
two-tailed Student’s t-test if further comparisons are required.
6.5 Discussion and conclusion
In this Chapter, I propose a simple yet powerful approach to quantify the C. elegans
motility as a phenotype. This method enabled assessing the drug eﬀect at the behavioral
level and was exploited upon exposure of C. elegans YA worms to glucose and dynasore.
The results presented in this Chapter point at a critical role for dynamin in the ability of
cells to uptake glucose upon insulin stimulation. Importantly, evidence for this was found
in vivo, by taking advantage of microﬂuidics and the ease of culture of C. elegans. The
role of dynamin in glucose uptake was observed ﬁrst at the behavioral level by quantifying
worms motility and then conﬁrmed at the whole organism level with the quantitation
of glucose in C. elegans, thus providing an extensive mapping of the role of dynamin.
The experimental ﬁndings, in agreement with the literature, underline the fundamental
role of dynamin in exocytosis. Dynasore blocked glucose uptake in C. elegans, but also
altered the behavioral response of the nematodes to high glucose levels. The use of C.
elegans is here relevant, as the insulin pathway is well conserved from this nematode to
mammals. Altogether, these ﬁndings suggest that dynamin is involved in the response
to insulin by mediating the membrane expression of GLUT4, probably by facilitating
exocytosis, as previously reported in other systems [138], [142].
The use of a dedicated microﬂuidic device allowed chemical delivery in a precise spatio-
temporal way, with full control of injection times and doses, which made the experimental
protocol robust and reproducible. Moreover, I designed a motility assay protocol, where
ﬂuidic ﬂow proﬁle and video recording were coupled in a synergistic fashion. Compared
to methods previously presented in literature, this approach can handle multiple worms
in the same video frame, being able to segment and distinguish up to 10-12 animals.
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Quantitation of worm motility upon exposure to drugs proved to be a powerful indicator
of the molecule eﬀect at the whole-organism level.
6.6 Future outlook
In the future, depending on the biological question, this method could be used to measure
the long-term worms response to a drug, by taking small videos also at later time points
and comparing the change in motility over time. Moreover, other more subtle phenotypes
could be measured, such as angles of body bends, thrashing frequency, amplitude of the
sinusoidal movement, velocity of head, tail and body center, etc.
Furthermore, fabricating a micro-chamber with ﬁlters of a diﬀerent size would allow
sorting and conﬁning of worms of another developmental stage. Comparing the glucose
eﬀect among populations of diﬀerent age could reveal a possible stage-dependent eﬀect
of glucose.
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7 Design of 3D-printed micro-
channel for NMR spectroscopy of
a C. elegans subsection
Abstract Nuclear magnetic resonance (NMR) is successfully applied in a great variety of
ﬁelds, from diagnostic imaging to in vivo spectroscopy of large living animals. Potentially,
NMR could also allow for metabolic phenotyping on small organisms as C. elegans, but
methods enabling the translation of this technique to the study of smaller volumes were
not developed yet. In fact, experiments on subnanoliter (sub-nL) volumes are hindered by
the limited sensitivity of the detector and by diﬃculties in positioning and holding such
small samples in proximity of the detector. While the detectors sensitivity is optimized
by miniaturizing its dimensions to match the size of the specimen, the sample handling
becomes more diﬃcult as the size of the detector is scaled down. In this Chapter, I
report NMR experiments on C. elegans, immersed in liquids having volumes down to
100 pL. To do so, a microﬂuidic device was designed to allow positioning and holding
of C. elegans over the sensitive region of the detector. The device was fabricated using
a high spatial resolution 3D printing approach, which allowed placing the sample and
the coil in close proximity, crucial to exploit the volume of maximum sensitivity of the
detector. The system was ﬁrst tested and calibrated in water, and then used to collect
NMR peaks from a C. elegans subsection. The obtained results indicate a promising
route for NMR studies at the single-organism level of important biological entities having
sub-nL volumes, such as living microscopic organisms and eggs of several mammalians,
including humans.
This chapter is an adapted version of the following publications:
• E. Montinaro, M. Grisi, M. C. Letizia, L. Pethö, M. A. M. Gijs, R. Guidetti,
J. Michler, J. Brugger and G. Boero "3D-printed microchannel for sub-nL NMR
spectroscopy", en, PLOS ONE, manuscript accepted.
• E. Montinaro, M. Grisi, M. C. Letizia, M. A. M. Gijs, J. Brugger, G. Boero,
"Nuclear magnetic resonance spectroscopy of subnanoliter samples by single chip
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detector and microﬂuidic channels". Symposium LATSIS, 2016, Lausanne
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7.1 Introduction
Methods based on the NMR phenomenon are widely used in physics, chemistry, medicine
and biology [152]–[154]. In traditional NMR experiments, the sample is placed in a
static magnetic ﬁeld and excited with electromagnetic ﬁelds at frequencies and strengths
that are not harmful to biological entities. Due to this property and to its resolving
power, NMR is successfully applied in a great variety of ﬁelds, such as diagnostic
imaging [155], [156] and in vivo spectroscopy [157], [158] of large living animals. The
use of NMR methodologies for the study of sub-μL volumes is hindered by sensitivity
limitations. The search for methods enabling the translation of this powerful technique
to the study of smaller volumes is therefore an active research domain. These eﬀorts
include both the miniaturization of inductive methods [159]–[164] and the use of more
sensitive but less versatile non-inductive approaches [165]–[167]. Various techniques
allowed optimizing NMR inductive detectors for volumes ranging from 1 μL down to a
few nL. Some of these were used to perform pioneering studies of small collections of
microorganisms [168]–[170], perfused tumor spheroids [171], and large single cells and
embryos [172]–[175]. However, NMR-based studies of intact single biological entities
were, until recently, demonstrated down to volumes of 5 nL [173], [176], whereas typical
volumes of most cells and microorganisms are below the nL scale [177]. Recently, the
use of ultra-compact single-chip NMR probes as convenient tools to deliver state-of-art
spin sensitivity for sub-nL volumes was reported [163], [178]. Such probes consist of
a multilayer microcoil and a co-integrated low-noise electronic transceiver. Thanks to
the achieved sensitivity, researchers were able to perform the ﬁrst NMR spectroscopy
studies of single untouched sub-nL ova of microorganisms having active volumes down
to 0.1 nL [178]. These experiments, however, were conducted by manually placing the
sample on top of the microcoil using a polystyrene cup ﬁlled with agarose gel [178].
This study demonstrated the detection of highly concentrated endogenous compounds,
but improvements concerning sample manipulation are required to enable long-lasting
experiments in more biocompatible environments. A microﬂuidic-based approach would
improve many aspects of NMR experiments. First, the study of biological samples in
liquids would provide a more biocompatible environment, where oxygen and nutrients
are continuously provided to the sample. Second, the use of a microﬂuidic device would
facilitate a non-invasive sample handling and would provide a controllable environment
during the experiments. Moreover, a microﬂuidic-based approach would possibly allow
performing NMR experiments upon delivery of drugs, to compare the metabolic content
before and after the drug administration. To perform NMR spectroscopy studies on
small biological entities in a liquid environment, relatively complex microfabrication
techniques are required, in particular for the placing and holding of the samples in the
sensitive region of the miniaturized detector. Several approaches to combine microﬂuidic
structures with microsolenoids [159], [168], [179]–[181], and planar microcoils [182], [183]
have been reported. Various techniques were developed to reduce the size of solenoids
and pattern them on capillaries [184]–[186] or around hollow pillars via wire bonding
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[179], [187]. At the sub-nL volume scales, an eﬃcient combination of microsolenoids
with microﬂuidic structures would require signiﬁcantly more complex microfabrication
processes than the one for planar microcoils with planar microﬂuidic structures.
In this Chapter, I report the design and fabrication of a microﬂuidic device capable
to deliver and hold a C. elegans nematode in a sub-nL sensitive volume of a planar
microcoil, used for NMR signal excitation/detection, integrated on a silicon chip. The
single chip detector oﬀers a robust planar working surface, but its very small detection
volume of about 0.2 nL requires the nematode to stay in close proximity to the microcoil
without introducing signiﬁcant static magnetic ﬁeld inhomogeneities. To overcome these
challenges, a microﬂuidic device was fabricated using a 3D printer and able to provide
resolution better than 1 μm3. This approach enabled the fabrication of micro-channels
capable to conﬁne the samples under investigation at a distance of about 10 μm from the
microcoil surface. Upon calibration of the system using pure water, experiments on C.
elegans were performed. Despite the C. elegans volume of about 100 pL and the broad
intrinsic linewidth (about 30 Hz at 300 MHz) of these samples, the achieved sensitivity (2.5
× 1013 spins/Hz1/2) was suﬃcient to detect highly concentrated endogenous compounds.
The microﬂuidic channels were connected to a robust ﬂuidic interface that tolerates the
application of ﬂows as strong as 7 μL/s and guarantees an eﬃcient sealing for several
days. The results of the reported experiments indicate that our approach allows for the
non-invasive and eﬃcient handling and trapping of C. elegans for NMR investigations at
the sub-nL volume scale, in conditions of high sensitivity and sample limited spectral
resolution.
7.2 Single-chip CMOS detector
The setup described in this Section was developed by collaborators at Laboratory of
Microsystems 1, under the supervision of Professor G. Boero.
The single chip NMR detector, described in details in a previous publication [163], has an
integrated excitation/detection multilayer microcoil with a diameter of 150 μm (Figure
7.1a). The integrated planar microcoil has a high sensitivity in a distorted spherical
volume having a diameter of about 100 μm. The planar microcoil lies in the yz plane,
with the static magnetic ﬁeld B0 along the z axis. Using the principle of reciprocity
[188], the signal contribution per elementary volume dS(r) (i.e. the local sensitivity) is
proportional to Bxy(r)sin(ϑ), where Bxy(r) =
√
Bx(r)2 + By(r)2 is the ﬁeld component
in the xy plane (i.e., perpendicular to B0) produced by the microcoil carrying a unitary
current, ϑ = γBxy(r)Iτ is the ﬂip angle, γ is the nuclear gyromagnetic ratio, τ is the
pulse length, and I is the current carried by the coil during the excitation pulse [152].
The maps of sensitivity of the integrated microcoil shown in Figure 7.1b were obtained
computing Bxy(r)sin(ϑ), starting from the computation of Bxy(r) via a Biot-Savart
code implemented in Matlab. The sensitivity of the microcoil decreases rapidly with the
distance along the x axis. As a result, the microﬂuidic system used to hold the sample on
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Figure 7.1 – Integrated electronic setup for NMR spectroscopy. a) Microphotograph of
the NMR single-chip detector, fabricated using a 130 nm CMOS technology from STMicro-
electronics. The integrated planar microcoil is realized using four copper metal layers. The
total number of turns is 22 and the outer diameter is 150 μm. The details of the microcoil
and of the co-integrated electronics are reported in Reference [163]. Scale bar = 150 μm.
b) Normalized-sensitivity maps of the microcoil. The sensitivity is deﬁned as Bxy(r)sin(ϑ).
The microcoil lies in the yz plane and the static magnetic ﬁeld B0 lies along the z axis.
The sensitivity in the xz (top) and xy (bottom) planes are computed for a pulse length
τ = 3.7 μs and an excitation current I = 9 mA. Dark red color identiﬁes the region of
maximum sensitivity. c) Illustration of the approach used to place the sample subsection, here
represented as a sphere, onto the most sensitive area of the excitation/detection microcoil.
The ﬂow drives the sample in proximity of the integrated microcoil. The dashed arrow
indicates the direction of insertion of the sample. A 10 μm-thick crosslinked photoresist layer
deﬁnes the spacing between the sample and the chip surface.
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top of the microcoil needs a thin separation layer. Variation of the pulse length τ implies
a variation of the local ﬂip angle ϑ, thus a variation of the spatial distribution of the
sensitivity. The integrated NMR signal S is proportional to the integral of dS(r) over
the total volume of the micro-channel. Figure 7.1b shows the sensitivity maps for τ = 3.7
μs, which is the pulse length that maximizes the integrated signal, assuming a separation
d = 10 μm between the microcoil and the sample. Upon normalization of the integrated
NMR signal to Sd=0μm=1 for the case of the channel volume placed in direct contact
with the chip, the signals Sd=10μm and Sd=20μm, evaluated in conditions of optimal τ ,
are respectively of about 0.7 and 0.5. Hence, a separation layer of 10 μm (Figure 7.1c)
is an acceptable compromise between the loss of sensitivity and the robustness of the
structure.
The single chip integrated NMR detector consisted of a radio-frequency (RF) power
ampliﬁer, a RF low-noise pre-ampliﬁer, a frequency mixer, an audio-frequency (AF)
ampliﬁer, transmit/receive switches, and an excitation/detection microcoil. All NMR
experiments described in this Chapter consisted of a RF pulsed excitation (about 300
MHz, pulse duration τ of a few μs) immediately followed by a detection time TD (50 ms
to 10 s). This simple excitation/detection sequence is repeated n times (1 to 106) with a
repetition time TR (50 ms to 10 s).
7.3 Design of a micro-channel to trap and immobilize a
single C. elegans adult for NMR spectroscopy
A microﬂuidic device was designed to gently deliver, position and hold the sample in
proximity of the detector microcoil, while providing a stable sealing over the duration of
the experiments (Figure 7.2a). To easily align the sample with the microcoil under a
microscope, the structural material of the micro-channel has to be optically transparent.
The geometry of the channel is designed to minimize static magnetic ﬁeld inhomogeneities
and maximize the detected NMR signal amplitude. The microﬂuidic chip was conﬁgured
with one inlet and one outlet, featuring a main entrance that splits into three channels
that re-join at the outlet. The central micro-channel was designed to match tightly the
size of an adult hermaphrodite worm, which is about 60 μm-wide, 50 μm-high and 1.3
mm-long. An array of 50 μm-high pillars with a 12 μm spacing was placed at the end of
this channel in a V-shaped conﬁguration, and used to block either the tail or the head of
C. elegans (Figure 7.2b-d). The other two 55 μm-wide lateral channels were designed
to ﬁll the rest of the chip with nutrients, for animal survival during the measurement.
To prevent the undesired trapping of other worms in the lateral feeding channels, one
pillar was placed at their entrance (Figure 7.2a). A cross-section of the central part
of the microﬂuidic structure is shown in Figure 7.2e,f. The gradual narrowing of the
channels along their length was designed to facilitate the hydrodynamic trapping of the
samples. The size and shape of the inlet and outlet parts were designed to match the
capillaries used for the ﬂuidic connection with the external pumps, limiting the presence
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Figure 7.2 – Microﬂuidic chip to delivery and immobilize single C. elegans worm for NMR
spectroscopy. a) Sketch of a cross-section of the microﬂuidic chip. b) Scanning electron
microscope (SEM) picture of a 3D printed channel section showing the trapping pillars. Scale
bar = 20 μm. c) Sketch and d) top view optical microscope picture of the pillars array used
to trap the head or tail of C. elegans. Scale bar = 20 μm. e) Sketch and f) SEM picture of
a 3D printed channel section showing the central trapping micro-channel and two lateral
feeding micro-channels, closed from the top by a 10 μm-membrane. Scale bar = 60 μm.
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Figure 7.3 – Fluidic interface and holder of the microﬂuidic chip for NMR spectroscopy. a)
The microﬂuidic channel was attached to a PMMA rod and connected to PMMA capillaries
to create a ﬂuidic assembly. b) The micro-to-macro interface was completed by connecting
tubes to the PMMA capillaries and performing the casting of epoxy resin to create the
sealing and give robustness to the ﬂuidic system. Scale bar = 5 mm.
of dead volumes. Similarly, the thickness of the separation layer gradually changes over
the micro-channel length, with a thickness of only 10 μm in correspondence of the most
sensitive region of the detector (i.e. above the excitation/detection microcoil). With this
design, the requirements of proximity for the maximization of the NMR signal amplitude
and robustness of the structure were both respected.
In order to precisely position and tightly hold the microﬂuidic chip in contact with
the single-chip integrated CMOS detector and to connect its micro-channels to the
external pump, an interfacing structure was fabricated. The 3D printed microﬂuidic
chips were ﬁrst glued on a 200 μm × 2 cm PMMA rod for support using a cyanoacrylate
adhesive (ECS500, 3M, US) (Figure 7.3a). Afterwards, PMMA capillaries (Paradigm
Optics, US) were ﬁtted in the inlet and the outlet of the 3D printed micro-channels.
Finally, the realized assembly shown in Figure 7.3a was introduced into a 3D printed
plastic holder (Figure 7.3b) fabricated by a conventional stereolithographic 3D printer
(Form+1, Formlabs, US). The holder was patterned out of a photosensitive resin (Clear
FLGPCL02, Formlabs, US) and was constituted of two complementary parts to allow
for the insertion of the ﬂuidic assembly. A system of tubes was connected to the ﬂuidic
assembly through the PMMA capillaries and a casting of epoxy resin was performed to
seal the ﬂuidic system and to give robustness to the structure. The assembled ﬂuidic
interface (Figure 7.3b) was manually brought into contact and aligned to the integrated
excitation/detection microcoil under an optical microscope. Wax was used to hold the
interface in position. A central squared aperture in the holder provided visibility for the
alignment. With this system, we repeatedly achieved a good sealing, easy handling of
the liquids, and a positioning of the sample within 10 μm precision.
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Figure 7.4 – 1H NMR measurements on pure water in water performed at 7.05 T (300
MHz). V = 100 pL, number of averages = 1000, TR = 4 s, τ = 3.5 μs, matching ﬁlter decay
time constant TM = ∞.
7.4 NMR spectroscopy of liquid samples
NMR measurements and data analysis were performed by collaborators at the Laboratory
of Microsystems 1.
1H spectra obtained from liquid samples (water and lactic acid in water) at 7.05 T (300
MHz) in the micro-channel were collected to characterize the spectral resolution limits of
the setup and to measure the spin sensitivity of the detector. This NMR spectrum was
also used to calibrate the sensitivity of the detector in combination with the microﬂuidic
channel. All chemical shifts are expressed in ppm deviation from the resonance frequency
of tetramethylsilane (TMS). Since this standard reference compound was not present
in C. elegans, a chemical shift of 4.8 ppm was assigned to the peak of water, which is
contained in the worm. The excitation pulse length used in the reported experiments (τ
= 3.5 μs) corresponds to the experimental condition of maximum sensitivity, in good
agreement with the value of 3.7 μs computed with simulations via sensitivity maps
(Figure 7.1b). Figure 7.4 shows the 1H NMR spectrum of pure water (Sigma-Aldrich, US)
after averaging 1000 scans. The lorentzian ﬁt of the data indicates a linewidth of 2 Hz
full-width-at-half-maximum (FWHM). The baseline width, deﬁned as the peak width at
0.55% height of the peak of water, is 24 Hz. These spectral resolutions were systematically
achieved in six separated experiments employing six diﬀerent micro-channels with the
same nominal design. The obtained eﬀective spin sensitivity is 2.5 × 1013 spin/Hz1/2.
Better spectral resolutions (down to 0.6 Hz) have been reported in literature [184],
[189]–[191] but with probes having a worse spin sensitivity.
115
Chapter 7. Design of 3D-printed micro-channel for NMR spectroscopy of a
C. elegans subsection
−20246810
0
0.01
0.02
0.03
δ ppm
N
M
R
 s
pe
ct
ru
m
 [a
.u
.]
   C. elegans subsection
   12   h
worm trapped in 
the microchannel 
Figure 7.5 – 1H NMR measurement on a C. elegans subsection at 7.05 T (300 MHz). The
dashed circle indicates the 150 μm outer diameter of the integrated microcoil. V = 100 pL,
number of averages = 113664 (12 hour), TR = 200 ms, τ = 3.5 μs, matching ﬁlter decay
time constant (TM ) = 30 ms. Arrows point at the peaks possibly associated to yolk lipids.
7.5 NMR spectroscopy of C. elegans subsections
NMR measurements on C. elegans were performed in collaboration with the Laboratory
of Microsystems 1. Data analysis was performed by collaborators at the Laboratory of
Microsystems 1.
In the experiments, the sensed portion of the C. elegans worm was given by the inter-
section of the sensitive region of the coil with the volume of the sample. Deﬁning the
active volume as the fraction of the sample that contributes to the 70% of the total
signal and considering the geometries in play and their position with respect to the
microcoil, an active volume of about 100 pL was estimated. The chemical shifts scale
was obtained assigning a chemical shift of 4.8 ppm to the peak of water contained in
the sample. Figure 7.5 shows the NMR spectrum obtained from a single C. elegans
subsection, after averaging over 12 hours. During the experiment, C. elegans went
through a delicate squeezing process when entering the micro-channel, whose size tightly
matches the worm. Consequently, the channel section was entirely occupied by the
worm. For this experiment, a subsection of the worm containing ova with was aligned the
microcoil. As shown in Figure 7.5 (inset), a great part of the sensitive region was indeed
occupied by about eight eggs contained in C. elegans abdomen. The peaks assignment
was challenging due to the reduced size of the sample combined with the relatively poor
spectral resolution. The peaks observed at about 0.9, 1.5, 2.1, 2.6 ppm may be mainly
associated to yolk lipids. Some qualitative information can be obtained from previous
1H high resolution magic angle spinning NMR studies on a collection of C. elegans [169]
and on a single worm [176].
A prominent signal arises at a chemical shift of about 3.9 ppm. As shown in the Figure
7.6, the same resonance appears in the spectrum of E. coli in S medium, which is used
as a base to feed the worm during the experiment. Therefore, such a resonance may
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Figure 7.6 – 1H spectrum of E. coli in S medium. NMR measurement performed at 7 T
in the micro-channel. V = 100 pL; number of averages = 19800; TR = 2 s, τ = 3.5 μs,
matching ﬁlter decay time constant TM = 60 ms.
result from the ingestion of nutrients operated by the microorganism. The linewidths are
broader than the ones measured with water (Figure 7.4).
Although the performances of the system promote NMR spectroscopy as a promising
technique to quantify the concentration of metabolites in C. elegans, the sample number
is low and further experiments are indeed required to conﬁrm the in vivo results.
7.6 Materials and methods
7.6.1 Fabrication of the micro-channel
The fabrication of the micro-channel was carried out by collaborators at EMPA, Switzer-
land.
The micro-channels were fabricated via a two-photon polymerization technique using a
high resolution 3D printer (Photonic Professional GT, Nanoscribe GmbH, Germany).
This additive manufacturing technique provides a resolution better than 1 μm3 in a more
versatile manner compared to traditional microfabrication methods. The structures were
patterned into IP-S photoresist, a negative tone cross-linking polymer proprietary to
Nanoscribe GmbH, which is optically transparent and gives an extraordinary geometrical
freedom in the design of the micro-channels. An indium tin oxide (ITO) coated glass
slide served as a substrate. The refractive index diﬀerence between the two materials
guaranteed a facilitated detection of the interface. For the release of the micro-channels,
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a 500 nm-thick dextran layer (Sigma-Aldrich, US) was spin-coated onto the substrate.
This sacriﬁcial layer was subsequently dissolved in water, enabling the release of the
structures at the end of the fabrication process. A 25× objective (LCI Plan-Neoﬂuar
25/0.8 Imm Korr DIC M27, Zeiss, Germany) was used in direct immersion mode into
the photoresist. The refractive indices of the objective and the photoresist were matched
to enable high spatial resolution. The voxel diameter was determined by a preceding test
exposure, and the results were fed into the modelling software which imports Solidworks
STL ﬁles to generate machine speciﬁc data. Using the 25× objective and 50 m/s writing
speed, the voxel size was about 0.3 × 0.3 × 2 μm3 (with a 63× objective the voxel
size was about 0.15 × 0.15 × 0.45 μm3). A droplet of IP-S resist was placed onto the
substrate, in which the objective was immersed. The objective was ﬁxed in space, while
the positioning of the substrate was given by the combination of galvanometric MEMS
mirrors and a piezoelectric unit. In the xy plane, the galvanometric mirrors traveled
within a 200 μm radius at each ﬁxed piezo position. A slicing distance of 1 μm was
deﬁned to split the structure into equal distance horizontal planes which were set by the
piezoelectric stage. This parameter was set to ensure proper overlapping and adhesion
in between the horizontal planes. To decrease writing time, a scaﬀolding technique was
implemented within the bulk volumes. A triangular support structure was used, with
a 20 μm spacing between planes and a scaﬀolding wall thickness of 3 μm. The writing
time for a single microﬂuidic structure was approximately 5 hours. To provide control
over the resist-air interface, and to maintain mechanical resistance over an extended
period of development, an 18 μm-thick outer shell was deﬁned, which was patterned as
a bulk area. The accessible area of the galvanometric mirror was limited by the beam
deﬂection and it was conﬁned in a 200 μm-radius circle. The block consisted of a volume
that could be written at a single xy piezoelectric stage position, only by moving the
galvanometric mirrors and the piezoelectric stage in the z direction. The block shape
had hexagonal shape to optimize the volume accessible from the galvanometric mirror
and to facilitate stitching by having large neighbouring block surfaces. The blocks were
written in a consecutive manner: a piezoelectric stage xy position was chosen, which
was exposed thanks to the synergy of the galvanometric mirrors and the piezoelectric z
stage. Once the block writing was ﬁnished, the piezoelectric stage moved to the next,
neighbouring position and restarted exposure as before. A block shear angle of 13◦ was
used in the z direction to avoid a shadowing eﬀect, which occurs at overlapping block
edges due to increased exposure. A block overlap of 2.5 μm enhanced the stitching by
reinforcing the adhesion between blocks. The block size was chosen to be x = 220 μm, y
= 190 μm, z = 250 μm. Applying the shear angle and overlap, the total block dimension
became x = 259.5 μm, y = 259 μm, z = 250 μm.
The laser power was 65 mW at the point of entering the objective. For writing the shell
of the structure, the laser power was reduced to 42%. For the internal scaﬀolding, the
laser power was increased to 50%, which increased the robustness at the cost of the
spatial resolution. Following exposure, the objective was removed from the photoresist,
and the substrate was placed into PGMEA (Sigma-Aldrich, US) for development. The
118
7.7. Discussion and conclusion
substrate was positioned in a way that the channels could stand vertically. A continuous
stirring in the beaker enhanced the removal of developed photoresist residues from inside
the channel. The development duration was typically 6 hours. Once development was
ﬁnished, the substrate was immersed into isopropanol in an identical conﬁguration for one
hour. A second rinsing step, with ultra-high purity isopropanol (99.99 %) was performed
over 30 minutes to further clean the inside of the channels. Finally, the substrate was
left to naturally dry in vertical position.
7.6.2 C. elegans preparation and microﬂuidic operations
C. elegans wild type worms were cultured at 20 ◦C on NGM 90 mm Petri dishes seeded
with E. coli strain OP50. Worms were provided by the Caenorhabditis Genetics Center
(University of Minnesota). HT115 E. coli bacteria were grown in LB with 100 μg/mL
ampicillin and 12.5 μg/mL tetracycline overnight in a thermal shaker at 37 ◦C. The
following day, 50 μL of the conﬂuent bacterial cultures were used to inoculate freshly
prepared LB medium containing only ampicillin. The new cultures were grown until
reaching an optical density between 0.6 and 0.8, and 90 μL were used for seeding the
experimental plates.
The microﬂuidic chip and tubes were ﬁrst ﬁlled with S medium using the ﬂuidic setup
described in Section 2.4. A worm of desired size was transferred, using a worm picker,
from the agarose plate to an S medium reservoir, from which it was sucked up in a tube
connected to the device. Afterwards, with a ﬂow of 500 nL/s, the worm was injected
in the microﬂuidic chip from the inlet. In order to insert the animal in the trapping
channel, a ﬂow of 1 μL/s was applied. Once trapped, a gentle ﬂow of 50 nL/s of E. coli
bacteria was used to replace the S medium in the chip and therefore provide nutrients to
the worm through the lateral channels. Afterwards, the ﬂow was stopped and the tubes
clamped. The whole operation, and the following NMR experiments, were performed at
20 ◦C. Once the sample was trapped and the microﬂuidic chip was clamped, the device
was moved and transferred under the setup described in Section 7.2.
7.7 Discussion and conclusion
In this Chapter, I described the implementation of a microsystem to perform NMR
spectroscopy on C. elegans subsections. A microcoil integrated in a silicon chip previously
described by [163] was used for NMR signal excitation/detection. The 0.2 nL-detection
volume of the single chip detector required the sample to be immobilized and in close
proximity to the microcoil. To answer to this requirement, a microﬂuidic device was
designed, to load and hold a single adult C. elegans on the microcoil. The device fea-
tured a main channel, whose dimensions matched the size of an adult animal, and two
lateral parallel micro-channels for the delivery of nutrients, necessary for the sample
survival. The device was then fabricated by collaborators at EMPA, using a two-photon
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polymerization technique by mean of a high resolution 3D printer, which provided a
resolution better than 1 μm3. Using this channel, the sample could be kept at a dis-
tance of about 10 μm from the microcoil surface. A robust ﬂuidic interface was then
fabricated by collaborators at the Laboratory of Microsystems 1, in order to connect the
micro-channel with the microﬂuidic setup, guaranteeing a stable sealing over the entire
NMR measurement. After the system was calibrated by measuring the NMR from pure
water, we performed experiments on a C. elegans worm. The active area of the detector
was covered by a subsection occupied by about eight eggs inside the adult. NMR peaks
presumably corresponding to yolk lipids were found after 12 hours of measurements.
The results of the reported experiments indicate that the approach proposed here allows
for the non-invasive and eﬃcient handling and trapping of C. elegans for NMR investiga-
tions at the sub-nL volume scale, in conditions of high sensitivity and sample limited
spectral resolution.
7.8 Future outlook
The obtained spin sensitivity of 2.5 × 1013 spin/Hz1/2 allowed detecting highly concen-
trated endogenous compounds in the C. elegans subsection, at the cost of a relatively long
experimental times. In order to perform measurements and capture possible age-related
changes in the metabolic content of the animal, the spin sensitivity should be improved,
to allow for shorter experimental times. To do so, one could either scale down the detector
size to improve the ﬁlling factor, which, however, would make the sample positioning
more challenging, or use a higher magnetic ﬁeld. Typical age-related changes occur
every 8-12 hours [75]: this timing requires a maximum measurement time of 3-4 hours.
Moreover, if the C. elegans subsection contains embryos, a measurement time as short as
1 h should be achieved, as the average in utero embryonic development time lasts about
2.5 hours [50].
In order to increase the throughput of the NMR recordings, a new silicon chip including
parallel independent microcoils, opportunely spaced to avoid any crosstalk, could be
fabricated. Such array of coils would allow investigating the metabolic content in diﬀerent
subsections of the same individual or in the same subsection of diﬀerent individuals.
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Despite being an invertebrate that lacks many vital organs and a circulatory system, C.
elegans is a powerful tool for drug testing and for the understanding of the molecular
and genetic mechanisms underlying several human diseases. Its ability to mimic human
disease and disease pathways oﬀers higher chances of identifying drugs that will ultimately
be more eﬃcacious in humans, and cannot be reproduced in in-vitro or cellular-based
models. Moreover, the availability of genetic tools such as a RNAi feeding library can be
exploited, to simplify the identiﬁcation of drug targets.
Despite its low complexity, C. elegans oﬀers a vast portfolio of measurable phenotypes:
several physiological traits and behaviors can be measured, such as size, growth rate,
feeding, locomotion, fertility, respiration rate, motility. In a drug screening scenario, C.
elegans would make an excellent candidate for whole animal-based screening and would
nicely feed the drug discovery pipeline, between cell-based assays and tests on rodents.
The use of microﬂuidics would make such drug tests more eﬃcient, standardized and
cost-eﬀective.
In Chapter 3, I showed a comprehensive microﬂuidic platform enabling the unprecedented
C. elegans culture over its full life-cycle at the single-worm level while longitudinally
monitoring multiple phenotypic markers upon a variety of treatments. In fact, the
platform allowed testing pharmacological and genetic treatments by simply changing
the compounds injected into the microﬂuidic chip, while ensuring reproducibility and
perfect control of all the environmental parameters. This phenotyping strategy paves
the way for the identiﬁcation of appropriate disease biomarkers that would shape the
worm response to the treatment of interest. The method was used to identify the pheno-
typic footprint and investigate the phenotypic variability associated with the nematode
UPRmt. In worms treated with doxycycline or treated with RNAi for mrps-5 and cco-1
to induce UPRmt, I observed the typical phenotypic hallmarks of mitochondrial stress,
such as delayed development, reduced size, reduced fertility and induction of the UPRmt
biomarker hsp-6p::gfp. On the other hand, NR did prolong the C. elegans life-cycle,
without compromising either embryonal viability or worm fertility, and weakly activat-
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ing the UPRmt. Moreover, this phenotyping strategy revealed a treatment-dependent
intrapopulation variability that could otherwise not be observed in RNAi experiments
run on plates. In a personalized medicine perspective, the characterization of such intra-
population treatment-dependent variability allows both characterizing the eﬀectiveness
of a treatment in a population subsets and identifying personalized follow-up treatments.
In Chapter 4, I described a Doehlert design of experiments to characterize the eﬀect
of temperature, food amount and drug concentration on the worm development. A
microﬂuidic chip enclosed in a custom-made thermal incubator was designed to culture
C. elegans larvae with full control of the experimental parameters. Such a device allowed
testing multiple conditions in parallel, reducing therefore the overall drug testing time.
Only a limited number of well-designed experiments (13, in this case) was required to
characterize the eﬀectiveness of the drug, as well as the inﬂuence of all the considered
experimental factors on the treatment outcome. According to the standard one-factor-
at-a-time approach, to explore the full combinations of three factors, 105 experiments
- instead of 13 - would have been necessary. Moreover, such a DoE approach revealed
the drug eﬀect even upon additional combinations of experimental factors, not limiting
the study to the 13 tested conditions, maximizing in this way the knowledge of the
process. Furthermore, this approach could provide information about second or higher
order interactions among the factors, even if no signiﬁcant interactions were shown
in the experimental space chosen in this work. Finally, this testing strategy allowed
identifying appropriate drug concentration and environmental conditions to obtain the
desired experimental outcome.
In Chapter 5, I described a miniaturized opto-electronic platform integrated in a microﬂu-
idic device, which was able to measure the on-chip absorbance of planktonic bacteria in
the 1-5 × 109 cell/mL concentration range, applying the Lambert-Beer’s absorption prin-
ciples. Compared to previous solutions, this platform made the quantiﬁcation of bacterial
concentration in an automated way, therefore less error-prone and time-consuming, as
well as nearly noise- and ﬂuctuation-free. Furthermore, the quantiﬁcation of a bacterial
concentration was here assured using a system of small commercial opto-electronical
components that made the measurement aﬀordable and the device portable. The system
was able to measure the concentration of a bacterial sample, requiring a dead volume
which is three orders of magnitude smaller than the volume required by most of the
commercial spectrophotometers. Afterwards, envisioning long-term experiments, I used
the customized platform to monitor the change of bacterial absorbance over 10 h. A
concentration-dependent absorbance drop was observed after 1-2 hours. In order to
explain this measurement, tailored experiments were performed, investigating the phe-
nomena of bacterial settling and aggregation. Based on our observations, I hypothesized
a simple mathematical model for the change of absorbance over time, according to which,
bacterial settling and aggregation were the major players. Finally, our general-purpose de-
vice can be possibly put in ﬂuidic connection with a separate microﬂuidic chip inoculated
with bacteria of unknown concentration, in a modular fashion, with a negligible dead
volume. Speciﬁcally, such a platform could be used to measure the concentration of the
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bacterial solutions that are used to culture C. elegans worms in microﬂuidic environments,
to properly control their feeding.
In Chapter 6, I described a simple yet powerful motility assay, to assess the drug eﬀect
at the behavioral level upon exposure of C. elegans YA worms to glucose and dynasore.
A dedicated microﬂuidic device allowed delivering chemicals in a precise spatio-temporal
way, which made the experimental protocol robust and reproducible. Moreover, ﬂuidic
ﬂow proﬁle and video recording were coupled in a synergistic fashion and the video-
processing routine could segment and distinguish up to 10-12 animals swimming in the
same microﬂuidic chamber. I validated this method by investigating in vivo the role of
dynamin in glucose uptake in C. elegans, given that the insuline pathway is well-conserved
from these nematodes to mammals. The role of dynamin in glucose uptake was observed
ﬁrst at the behavioral level by quantifying worms motility and than conﬁrmed at the
whole organism level with the quantitation of glucose in C. elegans, thus providing an
extensive mapping of the role of dynamin. Quantiﬁcation of worm motility upon exposure
to drugs proved to be a powerful indicator of the molecule eﬀect at the whole-organism
level. This quantiﬁcation could be extended to other time points beside YA stage and to
more subtle phenotypes, e.g. body bends and swimming frequency.
Finally, in Chapter 7, I described the design of a micro-channel to accurately position
and immobilize a single C. elegans to perform NMR measurements. The device was
fabricated at EMPA, using a two-photon polymerization technique by mean of a high
resolution 3D printer, which provided a resolution better than 1 μm3. Using this channel,
the sample could be kept at a distance of about 10 μm from the microcoil surface, inside
the detection volume of the single chip detector. A robust ﬂuidic interface was then
fabricated to connect the micro-channel with the microﬂuidic setup, guaranteeing a stable
sealing over the entire NMR measurement. After the system was calibrated by measuring
the NMR from pure water, experiments were performed on a C. elegans worm, and NMR
peaks presumably corresponding to yolk lipids were found after 12 hours of measurements.
Throughout this Thesis, I described diﬀerent microﬂuidic-based phenotyping assays
dedicated to the quantiﬁcation of worms growth, length, fertility, survival, ﬂuorescent
expression of a gene of interest and motility. Ideally, these analyses could be easily
integrated in a unique phenotyping platform, taking advantage of the modularity and
versatility of each assay. In such a comprehensive phenotypic scenario, an exception is
given by the metabolic phenotyping enabled by NMR, as it requires a dedicated chip and
setup. However, NMR spectroscopy can be performed in a separate step. For example
it could be useful to compare the metabolic content of C. elegans before and after the
administration of a drug, to obtain complementary information about the drug eﬀect.
In the drug discovery pipeline, testing several compounds on C. elegans using microﬂuidic-
based phenotypic screenings, would allow approaching the follow-up tests on mammals
with a more clear vision and higher probability of success.
To start, a DoE approach, where diﬀerent doses of a compound are varied, would ﬁrst
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allow excluding those ineﬀective drugs that, regardless the dose, do not trigger any
response in the nematode. At the same time, a working dose could be identiﬁed for the
other compounds. The microﬂuidic platform that I described in Chapter 4 could be
perfectly used for this purpose. If needed, a microﬂuidic chip featuring a higher number
of channels and chambers could be used, to increase the throughput of the screening.
Depending on the compound, the read-out of the assay could be the development time
as well as size or motility, quantiﬁed either at the population level or at single-animal
resolution or both.
In a second step, once the eﬀective dose of a compound is identiﬁed, a high content
phenotypic screening could be performed. The phenotyping strategy that I described in
Chapter 3 would allow monitoring the response to the drug at a population level but
also at single-animal resolution, if required by the assay. A single-worm-based readout,
if coupled with appropriate clustering algorithms, would allow identifying a possible
heterogeneous response to the drug, as demonstrated in Chapter 3. Clustering analyses
as PCA would also allow isolating the most signiﬁcant phenotypes, that could be worth
investigating in follow-up experiments on rodents. Anyway, both in a single-animal- and
in a population-based response, a sample number higher than 16 is recommended to
increase the throughput of the assay, and can be achieved by fabricating a design with
higher number of micro-chambers, capitalizing the modularity of the chip design.
Testing a signiﬁcant number of compounds on C. elegans and extrapolating the most
important phenotypic markers before investing in experiments on more complex animals,
would allow narrowing the portfolio of molecules to test. Moreover, tests on C. elegans
would provide a more precise idea of the molecule’s mechanism of action and would ideally
suggest which type of phenotypic readout should the follow-up preclinical experiment on
rodent be addresses to. From an economical and business perspective, this translates in
a reduced amount of ad hoc tests on animals, and eventually in a faster and less-costly
animal testing phase. Finally, even if tests on animals are nowadays still impossible
to replace with an equivalently-powerful and alternative model, C. elegans research,
whenever able to reduce the use of higher-order animal, would be advantageous also from
an ethical point of view.
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